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Abstract 
Background: Children with cerebral palsy often suffer from inability to tolerate enteral 
feeds. This may manifest as retching, vomiting, abdominal pain and faltering weight 
(previously referred to as failure to thrive). This study has three stages the aim of the first 
stage was to develop and establish an animal model of cerebral palsy (CP) and foregut 
dysmotility so as to better understand the clinical association seen in paediatric practice 
and to develop new therapies for this condition in the future. The second stage involved 
performing an experimental technique of splanchnectomy to assess whether this could be 
used as a surgical tool for such patients who fail to respond to conventional therapy. The 
third and final stage involved an examination of human biopsies from children with CP and 
known foregut dysmotility. 
Methods: Ethical approval was obtained in accordance with the Animals (Scientific 
Procedures) Act 1986 (PPL 60/4262). In phase one neonatal Sprague-Dawley rat pups 
aged postnatal days 5-6 (P5-6) underwent midline craniotomies under anaesthesia to allow 
either unilateral or bilateral brain injections of the neurotoxin, ibotenic acid (IBA), in the 
medial prefrontal (MPFC) or insular cortex (IC) using a digital stereotaxic frame. P5-6 was 
chosen as this has been shown to correspond to the stage of white matter vulnerability and 
that neurotoxin injections at this stage can mimic lesions that appear histologically similar 
to human peri-ventricular white matter injury as seen in cerebral palsy. A further group 
underwent sham injections with normal saline. All animals were monitored with a 
modified APGAR score post-operatively. Gastric emptying studies were then performed 
between 7 and 21 days postoperatively to look for any delay in gastric emptying times 
(GET) and animals were weighed regularly. GET was recorded by gavaging water soluble 
contrast and performing time lapsed x-rays. The pups were perfused on day 28 of life and 
their brains and foregut were examined. Phase two then involved repeating the creation of 
our CP model and performing unilateral splanchnectomy via a midline laparotomy to 
investigate whether we could improve the GET in our model. In both phase 1 and phase 2 
immunohistochemistry was performed looking at several antibodies to compounds 
implicated in the pathogenesis of dysmotility. In phase three, a retrospective analysis of 
archived human biopsies from children with CP and dysmotility was performed. 
Main results: In Phase 1 forty-five pups were injected in total (28 male and 17 female). 
The median weight at time of operation was 13.5 grams (range 7.5-21 grams). Four pups 
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died at the start of the study two intra-operatively from haemorrhage and two in the 
immediate post-operative period presumably from anaesthetic complications. GET was 
significantly prolonged in each IBA group compared to shams, and interestingly 5 out of 6 
of those with bilateral MPFC lesions demonstrated reflux during their contrast studies. In 
Phase 2, twenty-six rat pups were injected (14 female and 12 male). 13 pups underwent 
IBA injection and 13 sham injections. One pup died post brain injection from postoperative 
apnoea, the remainder progressed to splanchnectomy. Two pups, one from each group, 
died post laparotomy from intraoperative bleeding. The median GET was significantly 
longer in the CP model 58 minutes compared to 45 minutes (p=0.0024). Splanchnectomy 
reduced the GET in the CP group to 40.5 minutes (p<0.0001) Our results from phase 3 
revealed that we were unable to compare our animal specimens to our cohort of archived 
human biopsies.  The reasons for this are discussed in detail. 
Conclusion: In conclusion, we have developed a new and reproducible animal model of 
cerebral palsy and foregut dysmotility. We have shown that lesions in the brain cortex can 
lead to structural changes in villous and crypt architecture in the gut and that 
splanchnectomy improves gastric emptying in our model. Further work needed is needed 
to explore the mechanistic pathways and provide insight into the pathogenesis of impaired 
gastrointestinal motility in cerebral palsy and may lead to much needed development of 
new treatments. 
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Chapter 1 
Introduction 
1.1 The clinical problem 
The role of a paediatric surgeon is demanding yet extremely rewarding. There are, 
however, certain groups of patients that present an enormous challenge not just to 
paediatric surgeons, but to paediatricians and indeed nursing staff and their carers alike; 
none more so, perhaps, than those children who are neurologically impaired with complex 
enteric feeding difficulties. Many of these patients suffer from cerebral palsy often as a 
result of extreme prematurity increasing the risk of white cerebral matter injury and/or 
intraventricular haemorrhage. In recent years with advancements in antenatal and neonatal 
care more and more children with cerebral palsy are surviving. (Babcock et al., 2009) 
Paediatricians have long recognized that many children with cerebral palsy have a poor 
quality of life because of severe retching, vomiting, and inability to tolerate feeds. (Reyes, 
Cash, Green, & Booth, 1993) We now live in an age of individualised health care which 
ought to be patient centred and evidence based, however, these children have very few 
options open to them. Those treatment options that do exist for such patients, whether it be 
medical or surgical, are often aimed at alleviating gastro-oesophageal reflux rather than 
improving motility and may in fact make some elements of intestinal dysmotility worse. In 
addition, as a group, these patients are difficult to study, let alone be entered into any form 
of randomised controlled trial. In fact, a recent Cochrane review concluded that no 
randomised control trial could be found in the existing worldwide literature with regards to 
the best way to manage enteral feeding issues in children with cerebral palsy and the need 
for such a study was highlighted. (Gantasala, Sullivan, & Thomas, 2013) Indeed, a similar 
Cochrane review in 2004 (Sleigh, Sullivan, & Thomas, 2004) found exactly the same 
almost ten years earlier and hence our impetus for developing a much needed animal 
model. 
Introduction  
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1.1.1 What is cerebral palsy? 
Cerebral palsy was first described over 150 years ago by Little (Little 1862) and then 
clinically by Freud (Freud, 1897). Despite it now being over a century since its recognition 
there is no curative treatment or method of prevention and management strategies are 
limited. Cerebral palsy can be defined as “a group of disorders of the development of 
movement and posture causing activity limitations that are attributed to non-progressive 
disturbances that occurred in the developing foetal or infant brain” (Rosenbaum et al., 
2007). As suggested by this commonly used definition and by the classification of cerebral 
palsy into hemiplegic, diplegic and quadriplegic cerebral palsy there is often much focus 
on the effect on movement (Kuban et al., 2008), however, it is widely recognised that 
many of these patients have problems with food intolerance, abdominal pain, vomiting and 
retching. These are the symptoms of foregut dysmotility and by this term we include a 
group of disorders that involve failure of the normal peristalsis of the gastro-intestinal tract. 
(V. V. Smith, 2001) Gastro-intestinal dysmotility remains a major problem in paediatric 
clinical practice especially in the treatment of neurologically impaired children. (Ravelli & 
Milla, 1998; Staiano, Cucchiara, Del Giudice, Andreotti, & Minella, 1991) 
1.1.2 What causes cerebral palsy? 
The cause of cerebral palsy is most likely multifactorial. There may be a history of anoxic 
brain injury either ante- or perinatally and this can lead to subsequent periventricular 
leukomalacia (PVL). PVL is commonly regarded as the heralding sign of a child being 
diagnosed with cerebral palsy. There are many theories as to why white matter injury or 
PVL occurs in preterm infants including maternal infection and high levels of glutamine 
(Follett et al., 2004) and raised interleukins in umbilical cord blood. (Minagawa et al., 
2002) (Thomas & Speer, 2011) Other contributing factors may include low levels of 
thyroid hormone or glucocorticoids. The study of such contributing factors may prove 
helpful in identifying babies at risk and help to devise preventative strategies. (O'Shea, 
2002) Indeed the recently conducted ELGAN (Extremely Low Gestational Age Newborns) 
study was a prospective study looking at inflammatory markers in the blood in the first two 
weeks of life in infants born before 28 weeks gestation and who were then diagnosed with 
cerebral palsy and who were clinically re-examined at 2 years of age. (Kuban et al., 2014) 
This study found that not only were raised levels of inflammatory markers on two separate 
days more than a week apart predictive of cerebral palsy, but also elevated protein levels 
corresponded to particular types of cerebral palsy. 
Introduction  
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More recently there has been increased focus on what is now referred to as the gut brain 
axis or GBA. The GBA is now believed to potentially play a pivotal role in the 
development of CP. Much of this work has followed on from new techniques using 
magnetic resonance imaging (MR)) known as diffusion tensor tractography. Tractography 
is a 3D modelling technique which can identify neural tracts using data collected by 
diffusion weighted images. Not only can long tracts from the brain to the rest of the body 
be mapped but also the shorter connections between different cortical regions in the brain. 
It has been shown by tractography that in CP these networks are disrupted. (Englander et 
al., 2013) This concept is critical to the development of our animal model. Indeed there is 
evidence in the literature that changes in the medial prefrontal cortex can lead to functional 
disorders of the bowel such as IBS. (Seminowicz et al., 2010) (Tillisch & Labus, 2011) It 
is now also hoped that with advances in MRI technology that our understanding of the 
human connectome, the map of white matter containing the complex neural connections in 
the premature infant’s brain, may become more detailed and accurate and help define 
further the cause of CP and predict clinical outcome. (Panigrahy et al., 2012) 
It is not just the neural connections that have been investigated in CP but also there has 
been a vast project known as the Human Microbiome Project (HMP) which was a 
government funded project in the United States which involved the National Institutes of 
Health. This project aimed to identify the microorganisms which are found in association 
with healthy subjects and those suffering from different diseases, hence the term “the 
human microbiome“. As part of the work done by the HMP, one study focused on 
analysing the faeces from preterm and term infants. The findings of this study called for 
further work into the bidirectional signalling along the GBA and that certain microbes in 
the gut are essential for a healthy symbiotic relationship between a healthy gut and a 
healthy developing brain. It therefore, implicated changes in the microbes in the gut of 
premature neonate with the development of CP and other neurodevelopmental disorders 
and raised the possibility that targeting certain bacteria may lead to new preventive 
measures for conditions such as CP.(Borre et al., 2014) The two concepts of the GBA and 
the human microbiome therefore go together and there is now the belief that potential gut-
microbiome-brain communication may be pivotal in the aetiology of CP. It has been 
suggested that the sympathetic nervous system may in fact alter gut flora by means of 
adrenergic stimulation of enterocytes and this may in turn lead to increased gut 
permeability and possible damage to the developing brain. (Forsythe & Kunze, 2013) 
Introduction  
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1.2 What controls normal foregut motility? 
In order to understand what may be causing dysmotility of the foregut in children with CP 
we must first have a detailed understanding of what controls normal foregut motility in 
healthy children. There are many factors that are involved in normal human foregut motility 
such as dietary, postural, humoral and neural including pathways from higher centres. We 
can break down foregut motility into gastric emptying and antroduodenal motility i.e. the 
coordination between the pylorus and duodenum during the process of emptying. 
1.2.1 Control of Gastric Emptying 
The human stomach is basically a bag-like reservoir that breaks down food both 
mechanically and chemically and passes it on to the duodenum, the first part of the small 
bowel. This needs to be in a controlled and measured fashion making sure that it goes in 
one direction i.e. does not reflux back. This may sound straightforward but the control of 
gastric motility and gastric emptying is complicated as illustrated in the Figure 1 below. 
 
Figure 1. A schematic diagram of some of the many factors that control normal 
gastric emptying and antroduodenal motility. +ve = positive and –ve = negative, ACH 
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= acetylcholine, NO = nitric oxide, VIP = vasoactive intestinal peptide, CCK = 
cholecystokinin, ffas = free fatty acids and HCl = hydrochloric acid. Modified from 
Ehrlein, H. J., & Schemann, M. (2005). Gastrointestinal motility. Technische Universität 
München: Munich.  
It is not only affected by what the patient consumes in terms of solids, liquids, calorific 
and protein content, but also whether the child is in a fed or fasting state. This has been 
eloquently shown in studies combining fibre-optic recordings and MRI and showed that 
the effect of calorific load on gastric emptying varies depending on whether the patient 
was postprandial or not. (Kwiatek et al., 2009) Liquids are known to pass through the 
pylorus easily, but solids need to be broken down to pass through and this is done by a 
churning movement. These gastric contractions are in fact quite sophisticated. When 
solids are consumed the process of gastric emptying occurs in two phases the first being 
the lag phase. This lag time is typically 20 to 30 minutes as shown in the graph below, 
compared to liquids which exit promptly. (Ziessman et al., 1996) Presumably this is a 
reflection of the fact that peristaltic waves are continuing to breakdown the solids to a 
small enough size before they are allowed to progress through the pylorus and onward 
into the small bowel. It is important to note that this does not hold true for all liquids and 
that gastric emptying does vary according to what is commonly referred to as the nutrient 
load and therefore if the liquid is rich in fat content then it follows that this will empty 
from the stomach much more slowly. A higher calorie load has also been shown in 
children and adults to prolong gastric emptying times (GET) probably as a result of 
secretion of Cholecystokinin (CCK) as discussed below. (Cornwell & Killenberg, 1965; 
Franco, Collares, & Troncon, 1985; Kwiatek et al., 2009) Posture has been shown to 
affect the rate of gastric emptying by groups including Moore et al. They demonstrated 
that gastric emptying, as perhaps expected, is significantly slower in the supine position as 
opposed to sitting or standing position. (Moore, Datz, Christian, Greenberg, & Alazraki, 
1988; Steingoetter et al., 2006) 
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Figure 2. Difference in gastric emptying rate depending on solid or liquid meal. 
Modified from Ehrlein, H. J., & Schemann, M. (2005). Gastrointestinal motility. 
Technische Universität München: Munich. 
There is in addition what is known as a physiological divide or band separating the 
stomach into two when it deals with solids, something which is poorly understood, but 
which has also historically been noted in cadaveric studies. (Moore, Dubois, Christian, 
Elgin, & Alazraki, 1986) The apex of the greater curvature of the stomach has been known 
for some time to house the gastric pacemaker where contraction starts and where their rate 
is thought to be controlled. (Hinder & Kelly, 1977) Interestingly, Hinder et al found that 
vagotomy made no difference to the potentials coming from the gastric pacemaker. Since 
this sentinel paper there has been much work undertaken on what exactly the gastric 
pacemaker cells are and where their site varies in different animal species. 
1.2.2 Interstitial Cells of Cajal 
We now know that the pacemaker cells of the stomach and the rest of the bowel are the 
interstitial cells of Cajal (ICC). These cells were first described by the Nobel laureate 
Santiago Ramón Y Cajal who was a Spanish pathologist over one hundred years ago (Cajal 
1911) He discovered this new type of “nerve-like cell” that was intricately woven along the 
ends of motor neurons especially in the enteric smooth muscle cells. It wasn’t until well 
after the invention of the electron microscope in the 1930s that in 1989 Langton et al 
Introduction  
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beautifully demonstrated that the ICC had electrical rhythm. (Langton, Ward, Carl, Norell, 
& Sanders, 1989). 
The next big step in our understanding of the role of the ICC was by a group of scientists 
in Japan who were investigating the role of the proto oncogene product “Kit”. Nishikawa 
et al developed an antibody to block Kit, now commonly referred to as the “anti- ckit 
antibody” (Nishikawa et al., 1991). The same group then went onto give neonatal animals 
the antibody which led to huge gastric and intestinal distension soon after birth (Maeda et 
al., 1992). The majority of the cKit positive cells in the GI tract were ICC and blocking the 
Kit pathway in mice greatly reduced the population of ICC, potentially alterating the 
course of the cell’s development in the GI tract and destroyed the previously described 
pacemaker activity (Torihashi et al., 1995). Murine Kit mutant offspring were then 
developed and further studies confirmed that there are at least two populations of ICC in 
the GI tract. One group, found at the periphery of the muscle layers and generate and 
propagate electrical slow wave activity and the other group which is found within the 
muscle alongside the enteric neurons. It appears again from mutant work with W/WV mice 
that the subpopulation within the muscle is needed to generate pacemaker activity 
(Huizinga et al., 1995; Ward, Burns, Torihashi, Harney, & Sanders, 1995). Several studies 
have implied a ‘division of labour’ between the two types of ICC (Sanders, 1996). 
Intramuscular ICC are now thought to also act as stretch receptors that can influence and 
regulate the frequency of pacemaker activity (Won, Sanders, & Ward, 2005). 
Gastroparesis is a term now broadly used in adult practice to describe delayed gastric 
emptying without a specific cause or any sign of obstruction. Indeed, there are many 
different causes of delayed gastric emptying aside from cerebral palsy. These include 
infections and diabetes mellitus and so called idiopathic gastroparesis. Two groups from 
the United States have analysed full-thickness biopsies from the antrum and pylorus of 
gastroparesis patients and found reduced numbers of myenteric ICCs, increased myenteric 
inflammation and increased evidence of fibrosis. (Harberson, Thomas, Harbison, & 
Parkman, 2010; Moraveji et al., 2016). More recently such findings have led to the use of 
the term “Cajalopathy”. Indeed, Bashshati et al have described both reduced numbers of 
ICC in addition to structural changes within the cell architecture. They have also 
demonstrated changes in the gastric slow waves in gastroparesis patients. (Bashashati & 
McCallum, 2015a, 2015b) The presence and number of ICC cells in the foregut is 
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therefore, one of the main types of cells we will be examining when it comes to analysing 
our animal model. 
1.2.3 What is the Migrating Myoelectric Complex? 
The Migrating Myoelectric Complex (MMC) can be defined as a rhythmic pattern of 
electric response activity (ERA) or more simply rhythmic cycles of motor activity which is 
initiated by the gastric pacemakers cells or ICC we have discussed above. The 
interdigestive motor cycle typically occurs every 90-120 minutes and each MMC is 
thought to have four distinct phases. Phase I consists of little or no ERA; phase II consists 
of intermittent ERA phase III consists of periodic ERA on every control wave cycle and 
phase IV has intermittent ERA, is shorter than phase II but may not always occur. 
(Carlson, Bedi, & Code, 1972) Despite the experiments by Carlson et al in the 1970s there 
was little progress into what controlled the MMC until almost ten years later when a 
Canadian group undertook innovative experiments on dogs were different drugs where 
used to block different aspects of the enteric nervous system and the effect on the 
propagation or progress of the MMC was then studied. These drugs included atropine, 
hexamethonium and tetrodotoxin and all three were found to impede MMC propagation. 
(Sarna, Stoddard, Belbeck, & McWade, 1981) We know now, therefore, that the MMC 
starts in the stomach and its progress is under the control of the enteric nervous system. 
That is not to say that the extrinsic nervous system cannot have an effect as can humoral 
factors on the MMC’s progress, but these pathways are not essential. (Bueno, Praddaude, 
& Ruckebusch, 1979) (Sarna et al., 1981) 
1.2.4 Control from higher cortical centres 
Next let us consider the neural mechanisms that have a role to play in a cranio-caudal 
fashion i.e. starting with the cortical centres first. Despite the renewed focus into the gut 
brain axis or GBA it is not a new concept that higher cortical centres influence 
gastrointestinal autonomic function. It was first described as early as 1902 when Pavlov 
famously described Pavlov’s dog, beautifully illustrating that at the sight of food the dog 
produced more saliva and that higher cortical centres must be involved. Since then with the 
advances in neurotracer techniques, such as using horseradish peroxidase, it has been 
possible for scientists to trace connections from the dorsal vagus complex (DVC) to areas 
in the cerebral cortex and then stimulate these and measure the effect on gastric pressures. 
The insular cortex and the medial prefrontal cortex are two areas in the cortex of the brain 
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that have been identified and shown to have an effect on gastric motility. Work from the 
Pavlov Institute in Russia has shown that the insular cortex communicates directly with the 
gastric part of the DVC and effects gastric motility. (Bagaev & Aleksandrov, 2006) This 
work also confirmed that the insular cortex is arranged in a viscerotopic manner similar to 
the homunculus of the motor cortex and that just beside the gastrointestinal part of the 
insular cortex are areas that effect cardiovascular and respiratory autonomic centres. 
The second centre identified is the medial prefrontal cortex (MPFC). Previously similar 
experiments by a group from Illinois, USA found that the MPFC may also have a 
viscerotopic organisation and communicates directly with the nucleus tractus solitarus and 
subsequently the vagus nerve and that electrical stimulation of medial frontal prelimbic and 
infralimbic cortex (distinct areas within the MPFC) dramatically reduces ongoing gastric 
motility (Hurley-Guis KM 1986). The role of the vagus nerve is complicated as it has been 
demonstrated that there are at least two types of neurons within the nerve one excitatory 
and the other inhibitory and so its ultimate effect on the gastrointestinal tract is not 
straightforward or completely understood. (Aihara, Nakamura, Sato, & Simpson, 1978) 
The hierarchy of neural control would appear to be complicated but involve cortical 
centres such as the insular cortex and the MPFC, the DVC and the hypothalamus followed 
by vagal pathways.  This hierarchy is summarised in the schematic diagram (Figure 3) on 
the next page.   In addition, Aihara et al in the same set of experiments demonstrated that 
stimulation of the splanchnic nerves inhibited gastric motility. Some years later another 
Japanese group showed that by injecting capsaicin into lower thoracic interspinous tissues 
in rats again that they could increase gastric sympathetic nerve activity and subsequently 
inhibit gastric motility mainly by fibres passing through the coeliac ganglion. (Budgell & 
Suzuki, 2000) The input and balance of the autonomic fibres i.e. parasympathetic and 
sympathetic and the efferent and afferent fibres from the enteric nervous system also 
respond to what is happening in the lumen of the bowel for example levels of fatty acids, 
bile salts and CCK. (McMenamin, Travagli, & Browning, 2016) 
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Figure 3. Schematic diagram of the hierarchy of neural control on foregut 
motility from higher cerebral centres down to vagal centres and the intestinal wall 
and lumen. The intraluminal content such as protein load, hormones and resident gut flora 
or microbiotia all have the potential to stimulate vago-vagal reflexes. The enteric nervous 
system and extrinsic nervous system are akin to a complex circuit board further 
complicated by effects of humoral factors and the intestinal microbiome. Adapted from 
Ehrlein, H. J., & Schemann, M. (2005). Gastrointestinal motility. Technische Universität 
München: Munich. 
1.2.5 Humoral factors involved in gastric emptying 
There is a long list of humoral factors involved. Table 1 briefly outlines some of the main 
stakeholders. The list in this table is by no means exhaustive but focuses on the main 
players and also serves to illustrate the intimate relationship between neural and humoral 
mechanisms involved in the control of gastric emptying. It could pose much like the 
microbiota’s influence on neural mechanisms another pathway that could be modulated 
and could reveal a new part of the axis that could be targeted in terms of developing new 
treatments for poor gastric emptying. This has been tried for example with the 
administration of ghrelin. In both animal and human studies ghrelin has been shown to 
increase appetite and food consumption. (Fujitsuka, Asakawa, Amitani, Fujimiya, & Inui, 
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2012; Peeters, 2013; Wren, 2008; Wren et al., 2001; Yang, Liao, Qiu, Yan, & Wang, 2014; 
Yang et al., 2013) This is thought to be a result of stimulation of neurons in the 
hypothalamic arcuate nucleus. Animal studies have shown increased gastric emptying after 
ghrelin administration (Fujitsuka et al., 2012), which is why the use of ghrelin for 
treatment of postoperative ileus has been proposed. In human studies published so far, 
(Sanger & Furness, 2016) (Wren et al., 2001), no effect was seen on gastric emptying. 
Another interesting finding is the high ghrelin levels seen in obese patients with the 
Prader–Willi syndrome. (Solomou & Korbonits, 2014) Ghrelin, therefore, may prove to be 
an important link in the chain of the brain–microbiome-gut axis. (Shin & Wo, 2015) As 
well as ghrelin there is another compound that is now known to have an extremely 
important role and that is nitric oxide (NO). NO, despite being one of the smallest 
substances in the body, it has been dubbed “the molecule of the millennium”. It is 
produced from many sources including the gut either by enzymatic from nitrate in the diet, 
non-enzymatic from the reaction of arginine with hydrogen peroxide or by anaerobic 
bacterial production. (Kochar et al 2011) It functions as an inhibitory neurotransmitter and 
not only influences secretion and absorption in the gastrointestinal tract and has an 
essential role in the control of relaxation and contraction of the smooth muscle of the gut. 
(Groneberg et al., 2013; Groneberg, Voussen, & Friebe, 2016) 
Table 1. Humoral factors that are involved in gastric emptying. 
Hormone Action 
 Gastrin Stimulates secretion of hydrochloric acid by parietal cells of the stomach and 
aids in gastric motility by relaxing the proximal stomach and promoting 
contractions in the distal stomach 
Cholecystokinin (CCK) Stimulates digestion of fat and protein 
Insulin  Produced by beta cells in the pancreas and promotes absorption of glucose. 
Glucose levels themselves affect gastric emptying. 
Motilin Stimulates the MMC and promotes gastric emptying 
Ghrelin Produced by the fundus of the stomach. Activates growth hormone, prolactin, 
cortisol and ACTH. Signals hunger and increases gastric motility 
GLIP 1 Produced by the ‘L cells’ in the intestinal mucosa stimulated by nutrients in the 
gut; stimulates insulin, inhibits glucagon release. Inhibits on gastric emptying 
and initiates the ‘ileal brake’ via the vagus nerve. Also reduces gastric acid and 
pancreatic exocrine secretion via the vagus and signals satiety. 
PYY PYY also produced by L cells in the intestine; inhibits foregut motility, inhibits 
gastric acid secretion.  
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The exact mechanistic pathway is still not understood but the development of knockout 
mice that lack the enzymes needed in the signalling of NO has greatly improved our 
understanding and reinforced the idea that NO is at the centre of gut motility. Groneberg et 
al demonstrated that in their knockout mouse model (SM/ICC-GCKO) by blocking 
nitrergic signals these mice had increased gut transit time compared with controls. NO, 
therefore, plays a crucial role in the function of the gut and in its development. The smooth 
muscle cells of the gut and the interstitial cells of Cajal are both involved and need to 
respond to NO signalling in order for the bowel to relax. (Groneberg et al., 2013) 
Arab et al found in their series of chick embryo experiments that depriving embryos of NO 
lead to impaired development of the enteric nervous system. (Arab, Muhammadnejad, 
Faghihi, Hassanpour, & Muhammadnejad, 2014) Other authors have focused on 
developing animal models showed decreased NO function and increased inflammation in 
the stomach as well as abnormal motor function of the fundus suggesting that depleted NO 
may lead to poor gastric function. (Vanormelingen et al., 2016; Vanuytsel et al., 2014) A 
French group have shown that by inhibiting NO with the nitric oxide synthase inhibitor L-
NAME (N(G)-nitro-L-arginine methyl ester) they could delay gastric emptying 
significantly in pigs, again reiterating the importance of NO in controlling gastric 
emptying.(Lefebvre, Dick, Guerin, & Malbert, 2005) There is a renewed interest in 
pharmacological research as new drugs are sought that could enhance NO production to 
help various gastrointestinal disorders including those affecting motility. (Savidge, 2014) 
NO is not the only substance at play and both vasoactive intestinal peptide (VIP) and 
acetylcholinesterase (ChAT) have been shown to also be important. The vagus nerve is 
imperative in the neural control of the bowel and more recently has been thought to have a 
role in immunity. This remains somewhat controversial, but what is clear is that the vagus 
may not interact directly with macrophages but is does interact with all three: nNOS, VIP 
and ChAT enteric neurons indirectly influencing nearby intestinal macrophages. (Cailotto 
et al., 2014) In addition to examining the ICC as discussed above we aim to perform 
immunohistochemistry on biopsies of the foregut from the animal model we aim to create, 
looking at NO production and levels of ChAT compared to controls or shams. 
1.2.6 Antroduodenal motility 
Normal antroduodenal motility consists of the pattern known as the triphasic interdigestive 
MMC (IDMMC) and a separate pattern in the fed state. The IDMMC has three stages, 
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phase one has no contractile activity, phase 2 is irregular activity and phase consistent 
activity both in the antrum and in the duodenum. During phase 2 there are secretions into 
the intestine from both the pancreas and the biliary tree and then by phase 3 these 
secretions are cleared and this is what is referred to as the “intestinal housekeeper” of the 
small bowel. (Code & Pickard, 1973) The duodenal contractile activity also influences 
gastric emptying. This was classically demonstrated by Ormsbee et al in 1976 in which 
dogs underwent pyloroplasty or were given various medications and a citrate-fat test meal. 
The greater rate of emptying occurs when there is relatively high antral and low duodenal 
activity; conversely, the slowest emptying occurs when there is relatively low antral and 
high duodenal activity. (Ormsbee & Bass, 1976) Gastrin secretion in the stomach leads to a 
lowering of the pH in the lumen of the antrum and the duodenum and this in turn 
suppressed the second and third phases of the MMC. (Verkijk, Gielkens, Lamers, & 
Masclee, 1998) Whatever the mechanisms involved it is clear that the processes that 
govern antroduodenal motility are complex as are affected by humoral and neural factors 
including signalling and pathways from higher centres. 
1.3 Why do children with CP have foregut dysmotility? 
Despite many advances in the understanding of how the enteric nervous system develops, 
such as the role of the interstitial cell of Cajal and the involvement of humoral 
factors.(Young, 2008) (Burns & Pachnis, 2009; Burns, Roberts, Bornstein, & Young, 
2009; Burns & Thapar, 2014; Goldstein, Hofstra, & Burns, 2013; Sasselli, Pachnis, & 
Burns, 2012) the pathogenesis of foregut dysmotility in children with cerebral palsy is 
poorly understood. It was traditionally thought that the enteric nervous system (ENS) could 
be conceived as a “second brain” i.e. an independent nervous system out with the influence 
of the central nervous system (CNS). It is now clear, however, that there are many complex 
connections between the central, autonomy tic and enteric nervous systems and that the 
CNS can affect the function of the ENS by way of the vagus nerves amongst others. 
Children with cerebral palsy have, by definition, damage to higher cortical centres and it 
has also now been suggested that the ENS in these children may also be inherently 
abnormal. (Ravelli & Milla, 1998) More recently with developments in neuroimaging 
techniques such as diffusion tension tractography the brain of the child with cerebral palsy 
can be studied in more detail. This is technique involved magnetic resonance imaging and 
computer analysis whereby data is collected from diffusion weighted images and computer 
analysis then builds 3D picture which represent neural tracts both from the cortex of the 
Introduction  
26 
brain to the rest of the body but also between different cortical and subcortical areas of the 
brain. In 2013 Englander et al performed the first known study of CP patients using this 
technique and showed that not only was there evidence of global white matter loss 
throughout the brain not simply limited to sensorimotor areas. This study found that there 
was a statistically significant difference in the number of long-range connections in the 
brains of patients with severe CP compared to those classed as moderate CP. (Englander et 
al., 2013)  This important work gives further credence to the concept that children with CP 
have abnormal long fibre pathways from cortical centres and that this may well explain 
some of the changes we see clinically e.g. poor gastric emptying, reflux and a poorly 
coordinated antroduodenal motility pattern. 
1.4 Current investigations 
As with any clinical investigation the assessment begins with a comprehensive history and 
examination of the child prior to moving on to investigations such as imaging. In recent 
years there have been advances in how motility of the oesophagus stomach and duodenum 
can be measured with new tools such as the use of breath tests to measure gastric emptying 
(Pandolfino, Fox, Bredenoord, & Kahrilas, 2009) and the use of combined pH and 
multichannel intraluminal impedance studies and high resolution manometry (Roman, 
Pandolfino, & Mion, 2009). It is now increasingly recognised that dysmotility may be 
underdiagnosed and that with more specific and sensitive investigative modalities surgical 
management in the future needs to be and potentially could be more individualised and 
tailored to the patient’s particular needs. In 2001, the North American Society for Pediatric 
Gastroenterology and Nutrition published their official recommendations of the 
investigation of children with gastrooesophageal reflux disease (GORD). This is the 
condition whereby gastric contents reflux retrogradely back up the oesophagus. Such 
reflux is common in babies but when present and causing symptoms, is referred to as 
GORD. The guideline considers the pros and cons of each investigation depending on the 
age of the child and their symptom.(Rudolph et al., 2001) The focus of this guideline is 
looking for GORD rather than gastric emptying or foregut motility and is not particular to 
children who are neurologically impaired. It is still how we would begin our assessment of 
such patients and it would be useful to briefly consider each investigation in turn. 
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1.4.1 Upper gastrointestinal studies 
Upper gastrointestinal studies involve using radiopaque dye to outline the foregut i.e. 
oesophagus, stomach and duodenum. Traditionally, barium was used by more commonly 
now is water soluble contrast such as Iohexol (Omnipaque). This type of study may show 
gross reflux but is more useful in looking at whether the anatomy of the foregut is normal, 
whether the stomach empties, the shape of the stomach and whether or not there is any 
cause of gastric outlet obstruction or rotational anomaly such as that shown in the figure 
below. 
 
Figure 4. An upper GI study using the contrast agent Barium.  (A) outlines the 
child’s distal oesophagus and the fundus of the stomach.  (B) shows some reflux into the 
oesophagus and contrast exiting the stomach and outlining the duodenum.  (C) shows a 
lateral image of the stomach and duodenum and finally (D) confirms the child has normal 
rotation with the duodenal/jejunal flexure lying to the left of the midline at the level of L1. 
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1.4.2 pH studies 
For many years a 24 hour pH probe study was regarded as the gold standard for 
investigating and diagnosing gastroesophageal reflux disease (GORD) It involves passing a 
tube with two channels usually down the patients nose, occasionally the mouth, with one 
channel and probe in the stomach and the other in the distal oesophagus. It was first 
described by Johnson and Demeester who designed the electrode used to monitor the 
patients oesophageal pH over 24 hours and they defined six parameters that once measured 
resulted in the Demeester score for diagnosing GORD. (Johnson & Demeester, 1974) The 
parameters are shown in the table below. In the 1990s working groups from both sides of 
the Atlantic described how such studies should be performed and interpreted in children. 
(Colletti, Christie, & Orenstein, 1995; Vandenplas et al., 1993) Various groups have 
employed pH studies in children with cerebral palsy and have found that around 70% of 
children with CP suffer from GORD. (Reyes et al., 1993) 
Table 2. Demeester scoring system for diagnosis of GORD using 24 pH probe testing 
Components of 24-h Oesophageal pH Monitoring 
Percent total time pH < 4 
Percent Upright time pH < 4 
Percent Supine time pH < 4 
Number of reflux episodes 
Number of reflux episodes ≥ 5 min 
Longest reflux episode (minutes) 
 
The downside of this type of test is that by definition it is only assessing GORD and not 
gastric emptying or antroduodenal motility. It has also been shown that in some children, 
especially in neonates and infants, to be notoriously unreliable (Vandenplas et al., 1993) 
(Grant, 2001). In neurologically impaired children such as those with CP then it is now 
recommended that a combination of 24-hour multichannel intraluminal impedance-pH 
monitoring is used and has been shown to be much a more accurate and reliable method. 
Impedance can be defined as the opposition to current flow or the inverse measurement of 
the electrical conductivity of an organ’s wall and its contents. These studies mean that a 
food bolus or reflux can be measured. No bolus in the lumen of the foregut means there are 
fewer ions and so this equates to high impedance. In contrast a food bolus present in the 
lumen of the oesophagus means that there are many ions present and so there is low 
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impedance. These studies are very useful as they can detect acid and non-acid reflux in 
children who characteristically are not able to give a history of their symptoms. A study 
from London found that more than half of the reflux events in neurologically impaired 
children are nonacidic and would therefore go undetected by conventional pH probe 
studies. They concluded that children who are nasogastrically fed rather than orally fed are 
more likely suffer from reflux. (Del Buono, Wenzl, Rawat, & Thomson, 2006) 
 
Figure 5. A typical trace from a pH/impedance study. 
1.4.3 High Resolution Manometry and impedance 
In the 1990s the beginnings of high resolution manometry (HRM) began and with the 
ongoing development in technology these techniques have greatly improved since their 
infancy. HRM is measures intraluminal pressure changes using a series of pressure sensors 
no more than 1 cm apart. HRM can be used to investigate many different types of motility 
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disorders and was heralded as the new gold standard tool for investigation of motility 
disorders. (Roman et al., 2009) The first challenge was to understand what normal was. 
(Herbella, Aprile, & Patti, 2014) This led to studies of normal subjects and many different 
patients and led to initial Chicago classification. (Bredenoord et al., 2012) This has since 
been recently been updated and revised. (Pandolfino et al., 2009; Pandolfino et al., 2008) 
 
Figure 6. High resolution manometry. An example of the topographic display from 
the multiple sensors placed down a patient’s oesophagus. 
The use of HRM and this classification is purely dealing with the proximal and distal 
oesophagus and the oesophago-gastric junction. It has been proposed as the investigation 
of choice pre- and post- operatively in those who undergo fundoplication as discussed 
later. (Fukahori et al., 2013) It does not assess gastric emptying or antroduodenal motility. 
(Kahrilas et al., 2015) More recently, techniques of high resolution mapping of gastric 
slow waves using electrodes have been designed to look at gastric motility and gastric 
dysrhythmias. In a similar way to HRM this type of mapping has been found to be possible 
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if electrodes are placed less than 10mm apart. Further work is needed into designing 
reliable gastric motility high resolution mapping. (Putney et al., 2015) 
1.4.4 Scintigraphy 
Nuclear medicine is a branch of radiology that involves administering radioactive isotopes 
and measuring their uptake and excretion from the body. In the 1980s studies showed that 
such tests were relatively easy to perform and could be used to investigate gastric emptying 
of radiolabelled meals, both solid and liquids. (Malmud, Fisher, Knight, & Rock, 1982) 
More recently its role as the gold standard for assessing gastric emptying has been 
cemented and the need to quantify what normal values are for children rather than using 
adult data has been highlighted. (Malik et al., 2016) In their study Malik et al studied a 
group of thirty healthy children and measure their gastric emptying by means of a (99m) 
Tc-labelled vegetarian meal. They found that the median the percent gastric retention at 30 
min, 1, 2, 3 and 4 h were 90%, 77%, 33%,16% and 7% and the median lag phase was 18 
minutes, but this had no correlation with gastric retention at 4 hours. It has also now been 
suggested that scintigraphy may have a role in investigating oesophageal transit time. 
(Maurer, 2016) 
 
Figure 7. Gastric emptying study using scintigraphy. An example of a gastric 
emptying study that shows significant delay in gastric emptying in a patient with cerebral 
palsy. 
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More recently another investigation that again may be of benefit in paediatric children is a 
new breath test as it is non-invasive. A group from Italy compared the 13C-acetate breath 
test (ABT) which has been used and ratified in adults in 60 children (30 normal controls 
and 30 children with known delayed gastric emptying). They found that the ABT breath 
test was reliable, cheaper and easier to perform in the paediatric population. (Gatti 2000) 
1.4.5 Endoscopy 
Endoscopy of the upper gastrointestinal tract allows direct visualisation of the oesophagus, 
stomach, first, second, third and even fourth part of the duodenum. In children, it requires a 
general anaesthetic and generally a flexible endoscope is used with the ability to take 
endoscopic biopsies. A series of typical views down the endoscope is shown below in 
Figure 8. It may be useful in the investigation of a patient with possible dysmotility as it 
can show whether there is any pathological changes of the oesophagus, stomach or 
duodenum. It can also be used to rule out any other causes for the patient’s symptoms such 
as eosinophilic oesophagitis or Helicobacter pylori. 
 
 
Figure 8. Endoscopy. The typical view down the endoscope of a normal (i) distal 
oesophagus, (ii) stomach, and (iii) and (iv) show the duodenum.    
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Traditionally biopsies have been limited to the mucosa and submucosa. More recently a 
new endoscopic muscle biopsy technique has been described by Rajan et al. They describe 
a series of three patients in adult practice with idiopathic gastroparesis and a “double 
resection clip assist technique” by dissected down endoscopically to the muscularis propria 
and then creating a “pseudopolyp” and then clipping the base of this and retrieving the 
biopsy. In the biopsies examined both inner circular and outer longitudinal muscle was 
identified and the specimens were examined for the presence of ganglia and interstitial 
cells of Cajal. (Rajan, Gostout et al. 2016) This is a novel technique which may become 
more commonly used and be adopted in paediatric practice, especially in patients with 
foregut dysmotility who may have already had multiple procedures including laparotomy 
or fundoplication and gastrostomy which can make laparoscopic biopsies difficult. The use 
of capsule endoscopy has also become increasingly popular in the last decade or so. A 
further variation on this is the modified magnetic capsule endoscope which allows the 
capsule to become attached to lumen of the stomach and, therefore, allows for ambulatory 
monitoring of gastric motility. This technique is in its infancy and its feasibility has only 
recently been demonstrated. (Kim, Choi, & Cho, 2014) Other studies have confirmed that 
wireless motility capsules can be useful in quantifying real time dysmotility, not just in the 
foregut but also in the lower gastrointestinal tract. (Rao, Mysore, Attaluri, & Valestin, 
2011) In practice, it may be that capsule endoscopy or wireless motility capsule may help 
complement information gained from the other many investigations described above. 
1.5 Current management 
1.5.1 Medications 
There are various medications that can be applied when it comes to trying to alleviate the 
symptoms that many patients with foregut dysmotility may have. The focus is on 
combatting any possible gastro-oesophageal reflux (GOR) that may be contributing to 
symptoms. Medication for GOR often starts with sodium alginate compound (gaviscon), 
ranitidine or a proton-pump inhibitor such as omeprazole. Several studies in the 1980s 
showed that gaviscon was helpful in alleviating reflux in children compared to placebo. 
(Buts, Barudi, & Otte, 1987; Buts & Leclercq, 1987) The efficacy of proton pump 
inhibitors (PPIs) has been the subject of much debate in recent years. A systematic review 
by Van der Pol found one study that showed a beneficial effect, 2 that showed no 
difference and 2 that showed no effect at all and therefore overall concluded that PPI 
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although well tolerated are not effective in infant and that there is little evidence for them 
in older children. (van der Pol et al., 2011) There also has been concerns raised that PPIs in 
infants and younger children may have immunosuppressive side effects. (Cohen, Bueno de 
Mesquita, & Mimouni, 2015) Rodent studies have also revealed a possible increased risk 
in oesophageal and pancreatic cancer risk with long-term use of PPIs (Dall’Olmo, L., et al. 
2014)). The risk in humans is not clear but has been described as extremely low especially 
if there the organism Helicobacter pylori is eradicated. (Graham, D. Y. and R. M. Genta 
2008) Another systematic review, however, stated that ranitidine and omeprazole are not 
only safe but can be effective in infants, but more so in older children. It did however, 
concede that there was less evidence for the use of domperidone or metoclopramide. 
(Tighe, Afzal, Bevan, & Beattie, 2009) 
If symptoms persist then domperidone may be tried. This is a peripherally selective 
dopamine D2 receptor antagonist and is essentially a prokinetic which has been used to 
enhance gastric emptying and relieve nausea and vomiting. Recently the therapeutic range 
of domperidone has, however, been significantly narrowed because of concerns regarding 
effects on patients that may have a prolonged QT. The arrhythmia inducing effects of 
domperidone have been described in animal models such as guinea pig hearts. (Drolet, 
Rousseau, Daleau, Cardinal, & Turgeon, 2000) It has been shown in some infants to 
prolong QTc time on ECG. (Rocha & Barbosa, 2005) All patients must now have an ECG 
prior to commencing domperidone and afterwards. (Djeddi, Kongolo, Lefaix, Mounard, & 
Leke, 2008) The need for this, however, has been questioned by some authors.(Ngoenmak, 
Treepongkaruna, Buddharaksa, & Khositseth, 2016) It has also been suggested that for 
some patients the reduced dose that is now deemed safe is in fact sub therapeutic. This is 
reminiscent in some ways of the medication cisapride which for many years helped 
children with poor gastric emptying but was removed from clinical practice due to 
concerns over studies linking it to serious cardiac arrhthymias. (McCallum, 1991, 1996) 
(Mt-Isa et al., 2015) (Maclennan, Augood, Cash-Gibson, Logan, & Gilbert, 2010) (Hegar, 
Alatas, Advani, Firmansyah, & Vandenplas, 2009) 
Many patients with neurological problems suffer from tonic posture and the medication 
baclofen is often used as a muscle relaxant. Baclofen is of course a GABA type B receptor 
agonist and is also known to reduce transient lower oesophageal sphincter relaxation and 
reflux. Indeed Kawai et al reported that administration of baclofen reduced the frequency 
of vomiting and acid reflux in neurologically impaired children. (Kawai, Kawahara, 
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Hirayama, Yoshimura, & Ida, 2004) Whilst baclofen’s use against GORD has been 
questioned to be effective especially in neurologically impaired children Omari et al 
conducted a randomised control trial of 30 children in which they compared baclofen to 
placebo and performed pH and manometric studies before and afterwards. They found that 
baclofen did reduce reflux and improved gastric emptying times. (Omari et al., 2006) More 
work is needed into the efficacy of baclofen for GORD rather than just relieving spasticity 
in children with cerebral palsy. 
Following the withdrawal of cisapride and the concerns regarding domperidone another 
two drugs came to the fore namely; metoclopramide and erythromycin. Metaclopramide is 
a dopamine D2 receptor antagonist and also a mixed 5-HT3 receptor antagonist/5-HT4 
receptor agonist. Erythromycin is a macrolide antibiotic but its prokinetic action is thought 
to be a result of agonism at motilin receptors. Neither of these is without controversy 
either. Some studies have linked increased side effects with metoclopramide such as 
hyperkalaemia and other studies suggested and increase incidence of pyloric stenosis in 
those infants treated with erythromycin although was not statistically significant. Other 
studies have suggested that at low doses erythromycin can be beneficial for children with 
motility disorders. (Cucchiara et al., 1997) There have subsequently been calls for more 
studies looking at the safety and effectiveness of both drugs. (Chicella, Batres, Heesters, & 
Dice, 2005; Ericson et al., 2015) (Curry, Lander, & Stringer, 2001) The repertoire of 
medications is, therefore, somewhat limited and has led to much work in the 
pharmaceutical industry to develop novel treatments. These include drugs 
pharmacologically related to cisapride such as mosapride which has been suggested as an 
alternative for treatment GORD in neurologically impaired children. (Komura et al., 2016) 
Furthermore, the next generation of 5-HT4 receptor agonists, namely YKP10811, has 
shown some promise on improving gastric emptying in dogs and is yet to be trialled in 
humans. (Yin et al., 2016) There has been work looking at neural stem cells as a possible 
treatment for a variety of conditions related to the enteric nervous system. Some of the 
initial results from animal studies are encouraging. (Burns & Thapar, 2014) The common 
theme that is most striking in terms of reviewing the concern over existing medication and 
the lack of effective treatments for foregut dysmotility in neurologically impaired children 
is that more research is urgently needed and this really adds to the case for the need for a 
robust animal model to study any potential new therapy whether it be medical or surgical. 
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1.5.2 Gastrostomy 
The suffix “-stomy” comes from the greek “stomata” meaning mouth or opening and so the 
word “gastrostomy” literally can be translated as an opening into the stomach i.e. the wall 
of the stomach brought up to the anterior abdominal wall and a tube inserted. There are 
various methods of surgically creating a gastrostomy. These include creating an open or 
Stamm gastrostomy, a technique often reserved for neonates. A “PEG” or percutaneous 
endoscopic gastrostomy can be fashioned by using an endoscope only and using a “pull 
technique” or it can be laparoscopically assisted either using the same technique or a “push 
technique”. The “push technique” is often reserved for when the patient is also undergoing 
a laparoscopic fundoplication (discussed below). Primary gastrostomy buttons are another 
low-profile device that can be used rather than a long tube coming out from the patient’s 
abdominal wall. All of these various techniques have their pros and cons and the paediatric 
surgeon should have them all in his or her armamentarium so that the best technique can be 
chosen on its merit on a patient by patient basis. Regardless of the technique used many 
patients who are neurologically impaired may be assessed by the speech and language 
team and found to have an unsafe swallow. This then means that the baby or child is fed 
initially by nasogastric tube and then after a period of time if the patient is tolerating 
gastric feeds then they are referred for insertion of gastrostomy. There is also evidence that 
children with cerebral palsy do not just have an unsafe swallow but are commonly 
malnourished. (Sullivan, 1997) There is also evidence that survival rates of children with 
cerebral palsy are increasing and that there is an increased survival rate in those who have 
a gastrostomy placed. (Plioplys, 2003; Plioplys, Kasnicka, Lewis, & Moller, 1998) 
The creation of a gastrostomy in neurologically impaired children such as those with 
cerebral palsy is common place but the evidence base is lacking. Two recent Cochrane 
reviews, both failed to identify any randomised control trials that were conducted to look at 
what is the best method to feed neurologically impaired children. Gantasala et al concluded 
that the effects of gastrostomy or jejunal feeding on children with cerebral palsy has not 
been studied and remains very much in doubt and also recognised that such interventions 
have a possible under recognised emotional impact on the family or patient’s carers. This 
Cochrane review called for a randomised controlled trial to be undertaken to address this 
issue and resolve the dubiety of how best to feed these children. (Gantasala et al., 2013) 
This echoed the results of the first Cochrane review almost a decade earlier. (Sleigh & 
Brocklehurst, 2004) A similar systematic review was conducted by the American Academy 
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for Cerebral Palsy and Developmental Medicine (AACPDM) and again found a lack of 
evidence but found ten studies that they examined. They again found that not all families 
were of the opinion that a gastrostomy had had a positive impact on the care of their child 
or overall family life. They also found a high rate of complications and called for further 
well-designed studies on the effect of placing a gastrostomy in children with CP. (Samson-
Fang, Butler, O'Donnell, & Aacpdm, 2003) 
1.5.3 Fundoplication and its controversy 
Fundoplication is a surgical procedure whereby the top of the stomach, known as the 
fundus, is wrapped round on itself at the oesophagogastric junction so as to treat reflux. 
There are many different types of fundoplications, but the most common type is a Nissen 
fundoplication which involves a 360 degree wrap as shown in Figure 9. 
 
 (A)  (B) 
Figure 9. An illustration showing a 360 degree Nissen fundoplication. (A) shows 
the fundus of the stomach being grasped ad the pulled behind the oesophagus ad then 
sutured into place to create what is referred to as a “long loose wrap”. Of note the white 
upside down “Y” structure is the vagus nerve. Care is taken not to damage this structure 
but it be seen to be incorporated into the wrap itself. Modified with permission from Basic 
Techniques in Pediatric Surgery: An Operative Manual edited by Robert Carachi, Sandeep 
Agarwala, Tim J. Bradnock (Carachi et al , Springer 2013) 
Often these patients undergo laparoscopic fundoplication at the same time as gastrostomy 
insertion to overcome the gastroesophageal reflux (GOR) part of their symptoms, or 
undergo laparotomy. Fundoplication itself especially in neurologically impaired children 
can result in the development or even progression of gastric dysrhythmia leading to 
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retching, vomiting, and food intolerance. Richards et al from London in fact showed in a 
very elegant study that two-thirds of neurologically impaired children compared to one in 
five normal children have evidence of gastric dysrhythmia on surface electrogastrography. 
They also demonstrated that post fundoplication those who retched beforehand were more 
likely to continue to retch, but also that one in four post fundoplication would have 
problematic retching that they did not have before. (Richards et. al, 1998) This 
phenomenon was further investigated by Richards et al using a ferret fundoplication model 
where they found that post fundoplication there was more serosal fibrosis of the stomach 
and oesophagus and this was more prominent in those with disrupted wraps in which they 
also found histological evidence of damage to the vagus nerve. These authors proposed or 
hypothesised that this damage may then “sensitize the emetic reflex” resulting in an 
increased incidence of post-operative retching. (Richards et al, 2003) 
Studies have shown that fundoplication may well alleviate reflux (Fukahori et al., 2013) 
and whilst some reviews quote more than 90% success rates (Di Lorenzo & Orenstein, 
2002) others question whether those children that undergo fundoplication need surgery at 
all. (Hassall, 2005) It remains debatable, therefore, whether fundoplication is the treatment 
of choice for children with CP as it is simply addressing GORD rather than antral or more 
widespread foregut dysmotility they are now thought to have. In Europe, there are some 
centres who suggest that the type of wrap needs to be more patient specific and that HRM 
and impedance studies (as discussed earlier) can determine who may benefit from a full 
360 degree Nissen type fundoplication and who may be more suited to an anterior wrap 
such as a Thal fundoplication or another type of procedure such as a Toupet type wrap. 
Esposito et al studied all three types of fundoplication and found them all to be effective 
and that surgeon’s experience dictated what type of wrap was used and that parents overall 
were happy with the surgical outcome for their child. (Esposito et al., 2006) An earlier 
study by the same centre concluded that laparoscopic fundoplication was safe in 
neurologically impaired children and whilst mortality rates were high these deaths were 
felt to be unrelated to the operation itself. (Esposito et al., 2003) It is recognised that post-
operative problems after fundoplication are more common in neurologically impaired 
children and in those with motility problems. (Di Lorenzo & Orenstein, 2002) Some 
centres have acknowledged that re-do fundoplication is difficult in these children and now 
advocate oesophagogastric dissociation as a last resort in children who have had a “failed 
fundoplication.” (Goyal, Khalil, Choo, Mohammed, & Jones, 2005) 
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1.5.4 Jejunal feeding methods 
Due to the controversy surrounding the effectiveness of fundoplication in children with 
CP, many centres have increasingly turned to trying jejunal feeding instead. This means 
feeding the child directly into the distal small bowel i.e. bypassing the stomach, and 
therefore reflux, but also the entire foregut and so may help bypass motility issues also. 
This can be done by means of a nasojejunal tube or gastro-jejunal tube often an extension 
placed onto an existing gastrostomy or by a surgically fashioned jejunostomy either by an 
open procedure or more recently a laparoscopic-assisted procedure. The latter has been 
described and reported to be safe and effective in neurologically impaired children. (C. 
Esposito, 2005) (Esposito, Alicchio, Escolino, Ascione, & Settimi, 2013) Other studies 
have described a modification of this technique percutaneous laparoscopic-endoscopic 
jejunostomy and again although successful in cases of foregut dysmotility had rare but the 
life-threatening complication of small bowel volvulus around the jejunostomy. (Belsha, 
Thomson, Dass, Lindley, & Marven, 2016) Surgical placement of such tubes has been 
shown to improve feed tolerance reduce the incidence of pneumonia presumably as a result 
of aspiration in neurologically impaired children. (Egnell, Eksborg, & Grahnquist, 2014) 
Wales et al retrospectively compared fundoplication and gastrostomy to radiologically 
placed jejunal tubes often without the need for general anaesthesia and although an 
alternative the majority of children (85%) with jejunal tubes rather than a surgical 
jejunostomy had complications of the tube either breaking, blocking or becoming 
dislodged. (Wales et al., 2002) Such problems and associated with jejunal tubes are widely 
reported in the literature and these tubes are known to have significant morbidity. (Godbole 
et al., 2002) Although this complication is less likely to occur in those with surgically 
placement or roux en y jejunostomy the tubes can still block or dislodge. (Gilchrist, Luks, 
DeLuca, & Wesselhoeft, 1997) Major complications such as small bowel volvulus may 
occur in up to 1 in 5 patients especially in the first six months following the procedure and 
there is a 5% mortality risk associated with the surgical procedure itself. All of these risks 
need to be explained during the consent process with the parents. (D. Smith & Soucy, 
1996) 
1.5.5 Coeliac plexus blockade, splanchnectomy and gastric emptying 
The coeliac plexus is a group of post ganglionic nerve fibres formed from the splanchnic 
nerves. The splanchnic nerves arise from the lower eight thoracic sympathetic ganglia. 
These sympathetic fibres are vasomotor and inhibitory to peristalsis and are known to carry 
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sensory fibres to the abdominal viscera. It follows, therefore, that interrupting this network 
can not only interrupt nocioreceptive or pain pathways but can also affect foregut motility. 
Coeliac plexus blocks (CB) and thoracoscopic splanchnectomy (SP) have been employed 
and widely reported in adult practice to benefit patients with severe pain from pancreatitis 
and pancreatic cancer. (Baghdadi, Abbas, Albouz, & Ammori, 2008; Buscher, 2002; 
Cuschieri, Shimi, Crosthwaite, & Joypaul, 1994; Ihse, Zoucas, Gyllstedt, Lillo-Gil, & 
Andren-Sandberg, 1999; Kang et al., 2007; Lebovits & Lefkowitz, 1989) Another study in 
adult practice has shown that CB reduced gastro-intestinal dysfunction in neurosurgical 
intensive care patients. (Weinstabl. et al, 1993) As shown in the table below, in this study 
these patients underwent CB on day 3 of the study and by day 5 and 6 their gastric losses 
had all but gone. 
Table 3. The effect of CB on gastric losses in patients in a neurosurgical intensive care 
unit. Modified table from Weinstabl et al, 1993. This illustrates that CB can hugely and 
quickly improve gastric emptying in patients with severe brain injury. 
 
The technique of coeliac plexus blockade is shown in the figure 10. The coeliac plexus is 
accessed through a posterior approach at the level of the first lumbar vertebrae and the 
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needle is advanced under fluoroscopic guidance with radiopaque dye and then the plexus is 
ablated by injecting it with local anaesthetic such as levobupivicaine. 
 
Figure 10. Technique of coeliac plexus block. Anteroposterior (left) and lateral (right) 
views on fluoroscopy of a coeliac plexus block. The needle can be seen and the radiopaque 
dye inserted to check position prior to injecting local anaesthetic such as levobupivicaine. 
The effect of coeliac plexus blockade is, however, often temporary and hence why patients 
proceed to splanchnectomy at which the splanchnic nerves are found by means of 
thoracoscopy i.e. placing a telescope into the chest and identifying the nerves and dividing 
them with diathermy. This is shown in the figure 11.  
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 (A)  (B) 
Figure 11. Thoracoscopic splanchnectomy (A) This shows a patient prepped and 
draped and undergoing thoracoscopy and (B) shows the view on the inside of the thoracic 
cavity and the splanchnic nerves are labelled GS (greater splanchnic nerve), LS (lesser 
splanchnic nerve) and L (the least splanchnic nerve). V is a vein. 
1.5.6 Our patient series 
Successful bilateral thoracoscopic splanchnectomy was first reported in two children with 
chronic intestinal pseudo-obstruction (CIPO) ten years ago.(Khelif, Scaillon, Govaerts, 
Vanderwinden, & De Laet, 2006) In our centre we have a series of patients that were 
identified prospectively between 2000 and 2008 as having symptoms of foregut 
dysmotility that had failed conventional management. Patients were treated with a varied 
combination of low dose metoclopramide, CB and/or thoracoscopic splanchnectomy (TS) 
as shown in the treatment algorithm below (Figure 12). Patients were followed-up 
routinely at clinic to review any improvement in their symptoms. The outcome measures 
were: pain relief and improvement in feeding difficulties. 11 patients (7 boys and 4 girls) 
were identified with a median age of 11 yrs. (3-21 years). Symptoms included constant 
retching, vomiting, severe abdominal pain and feeding difficulties. 7 had severe 
neurological abnormalities, 6 had had a fundoplication and 3 had a gastrostomy and others 
had had numerous laparotomies. Of the 11 patients 7 patients went on to have a celiac 
plexus blockade. This was often repeated multiple times and its effect on symptoms 
averaged at a median of 28 days. 5 of these 7 patients progressed to splanchnectomy. 
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(Carachi, Currie, & Steven, 2009) Almost all patients have shown complete relief of their 
symptoms following splanchnectomy and the procedure has been well tolerated. 
 
Figure 12. Treatment algorithm. This was used in our series of patients who had 
failed conventional treatment for symptoms of foregut dysmotility. Patients were first 
trialled on metoclopramide which as mentioned above has since been deemed no longer 
recommended for use in children. If no improvement was seen the patients progressed to 
CB and again after repeated response to this, patients progressed to TS. 
We have not performed these procedures recently as the evidence for such procedures was 
lacking and there was no longer a paediatric anaesthetist able to perform CB in children in 
our centre. This then led to our need to develop an animal model because as shown in the 
various systematic reviews we have discussed including Cochrane reviews there is a real 
difficulty in trying to conduct randomised controlled trials in neurologically impaired 
children and in those with CP. It is hoped that by developing a robust animal model and 
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then performing splanchnectomy on this model then there would be more impetus to 
conduct a randomised control trial in children. 
1.6 Developing the Animal model 
There are many different animal models of cerebral palsy. (Johnston, Ferriero, Vannucci, 
& Hagberg, 2005) The distribution of brain lesions is often diffuse and can include 
multiple cystic lesions in the white matter and diffuse cortical atrophy such as that seen in 
PVL in humans. As mentioned above there is no existing animal model of cerebral palsy 
and foregut dysmotility reported in the literature, although one paper from the Indiana 
group (Vane et al., 1982) did link surgically induced brain damage in cats to decreased 
lower oesophageal sphincter pressure and possible gastro-oesophageal reflux. 
1.6.1 Historical models i.e. what has been tried before? 
Historically there have been many different animal models of cerebral palsy using 
techniques which largely fall into four groups those that (i) induce antenatal or postnatal 
ischaemia by techniques such as endovascular balloon occlusion of blood supply to the 
placenta or ligation of the carotid artery (Jensen, Follett, Uehara, Mallard, Johnston) or (ii) 
maternal or foetal antenatal hypoxia (Baud et al., 2004; Mallard, Welin, Peebles, Hagberg, 
& Kjellmer, 2003) or (iii) a combination of carotid ligation and hypoxia (Sheldon, Chuai, 
& Ferriero, 1996) (McQuillen, Sheldon, Shatz, & Ferriero, 2003) or (iv) chemical lesions 
to the brain (Tahraoui et al., 2001). Rodent models resulting from either maternal or 
neonatal ischaemia often resulted in early death of offspring or rejection by the mother. 
Rodent brains are anatomically different and have less white matter than larger animals 
have also been tried including ovine models and baboons although these models are much 
more expensive. Baburamani et al developed a rabbit model by injecting 
lipopolysaccharide (LPS) into the uterus of pregnant rabbits and showed that these rabbits 
had brain damage on positron emission tomography imaging and had functional motor 
deficits. (Baburamani, Supramaniam, Hagberg, & Mallard, 2014) Ovine models have also 
been tried by injecting intravenous LPS into midgestation foetal sheep, an age which is 
similar in brain development to the preterm humans. These injections resulted in white 
matter injury and in higher doses showed evidence of inflammation of the neonatal brain. 
(Duncan et al., 2002; Nitsos, Newnham, Rees, Harding, & Moss, 2014). Asphyxia of foetal 
sheep has also been shown to result in white and grey matter injury.(Mallard et al., 2003) 
None of these models examined the effect of white matter injury on the gastrointestinal 
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tract. As mentioned above there is no existing animal model of cerebral palsy and foregut 
dysmotility reported in the literature. The only related paper is from the Indiana group 
(Vane et al., 1982) that did link surgically induced brain damage in cats to decreased lower 
oesophageal sphincter pressure and possible gastro-oesophageal reflux. This paper did not, 
however, focus on creating brain damage akin to that seen in cerebral palsy instead it was 
brain injury caused by raising intracranial pressure (ICP) by means of a burr hole and a 
inserting and inflating a balloon catheter. At the same time lower oesophageal sphincter 
pressure was measured and these authors found that by increasing the cat’s ICP they 
lowered the LES both acutely and it remained low 2 and 6 weeks post procedure. There 
was, however, no measurement of effect on gastric emptying or foregut motility per se and 
the animal’s brains were not examined at the end of the study to confirm what if any brain 
damage had been created. To the author’s knowledge, our model will be the first of its kind 
focusing on cerebral palsy and foregut dysmotility. 
A common theme in all of these animal models in terms of the effect on function is that 
most have tended to focus on damage to the motor cortex. This is well-recognised and is 
understood that not only is there loss of voluntary control of movement, but a disordered 
development of reflexes. A group in Newcastle (A. Chen, Dimambro, & Clowry, 2008) 
also focused on motor function and found that chemically induced lesions created by 
injecting the neurotoxin ibotenic acid into the motor cortex at on postnatal day 5 to 7 (P5-
7) in the rat were functionally and histologically similar to PVL. Although the technique 
only targeted the motor cortex and not areas which would affect gut motility it was 
reproducible and reported as a well-tolerated by the neonatal rat pups. 
In addition to animal models, there have been some interesting in vitro studies involving 
culturing and growing oligodendrolia and examining its response to various toxins to help 
understand the pathogenesis at play in the development of PVL. Oka et al found that such 
cells were particular susceptible to glutamate and that glutamate receptors may be a 
potential new target for new pharmacological treatments. (Oka, Belliveau, Rosenberg, & 
Volpe, 1993) Indeed the drug topiramate may be one such option and has subsequently 
been tried on a hypoxic rodent model with some effect. (Follett et al., 2004) 
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1.6.2 Theory behind our proposed cerebral palsy model 
Scientists have long known that the cerebral cortex is integrally involved in influencing 
autonomic function. In 1902 Pavlov famously described what is now known as “Pavlov’s 
dog” and this is an example of the phenomenon of ‘‘psychic’’ secretion of gastric juice and 
introduced the concept of cortico-visceral relationships. More recent work from the Pavlov 
institute on Wistar rats has found that autonomic representation in the rat insular cortex is 
organised in a viscerotopic manner similar to that of the well-known homunculus of the 
motor cortex (Aleksandrov, Bagaev, Nozdrachev, & Panteleev, 1996; Bagaev & 
Aleksandrov, 2006). It is thought that the gastrointestinal control area lies in the middle 
part of the insular cortex. Hurley-Guis et al in 1986 described the association of the medial 
frontal cortex with control of visceral function and prompted them to term this region the 
‘visceral motor cortex’ (Hurley-Guis KM 1986). Their experiments, again in rats, 
demonstrated that by electrically stimulating areas of the medial frontal cortex they could 
influence and measure changes in gastric motility. Bilateral intracortical microstimulation 
of medial frontal infralimbic and prelimbic cortical areas produced consistent reductions in 
gastric motility. The majority of responses consisted of reductions in gastric tone or in the 
amplitude of gastric contractions, or both. 
Based on the above, our hypothesis is that damage to the medial prefrontal cortex and/ or 
insular cortex may affect autonomic control including control of gastric motility and this 
forms the basis of our model of this particular aspect of cerebral palsy. We have, therefore, 
designed our proposed model based on creating lesions in these two cortical regions using 
the same method as Chen et al i.e. stereotactically targeting these areas with the neurotoxin 
ibotenic acid. We expect to see as Chen et al did that such lesions lead to disorder reflexes 
and pathways that may well apply to reflexes of the enteric nervous system, which might 
develop aberrantly in the absence of cortically controlled inputs from the vagus nerve and 
sympathetic fibres. Lesions in these areas of the brain may affect the control of gastric 
emptying and in turn gastric motility and will give us the animal model we need of this one 
aspect of cerebral palsy i.e. a CP model with associated gastrointestinal foregut 
dysmotility. This will be a new model that has not been studied or reported elsewhere. 
This does, however, logically lead to the question do we know that children with cerebral 
palsy have damage to these areas in the cerebral cortex? It has in the past been assumed 
that in most cerebral palsy patients the cerebral cortex is widely if not globally affected. 
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Neuroimaging of cerebral palsy patients is really still in its infancy and although more 
children are undergoing MRI scans many studies of such investigations to do not provide 
detailed or consistent anatomical descriptions of the individual patient’s brains or cortex. 
Atrophy is often commented on but limited to whether it involves grey or white matter or 
ventricles rather than specific areas of the cortex. (Korzeniewski SJ & Mark C. DeLano) 
The field of neuroimaging is, however, rapidly expanding and with the developments in 
functional MRI scanning and diffusion tensor topography may provide more detailed 
imaging of the brains of children with cerebral palsy. Englander et al recently published a 
study of CP patients using this relatively new technique of diffusion tensor tractography in 
17 children with severe CP. Whilst they did not specifically look at the insular or MPFC 
they confirmed the concept of diffuse and significant reduction in white matter connections 
both long and short and involving the sensorimotor cortex. This also for the first time 
reported that in CP there are structural disruptions between networks of connections within 
the white matter of the brain. (Englander et al., 2013) As stated at the start of this chapter 
this concept is critical to the development of our animal model. There is evidence in the 
literature that changes in the medial prefrontal cortex can lead to functional disorders of the 
bowel such as irritable bowel syndrome (IBS). (Seminowicz et al., 2010) (Tillisch & 
Labus, 2011) The other issue is at the moment these children often need to be sedated or 
anaesthetized for such scan so as to reduce the amount of movement artefact. This is not 
without significant risk in such patients and therefore the use of routine brain scans of 
children with CP has not been widely adopted. As scanners improve this may negate the 
need for sedation or anaesthetic and the scans themselves may also improve in the detail 
that can be sought and help not only to explain the patient’s symptoms but also may help 
target patient specific treatment. 
1.6.3 Pros and cons of our CP model 
The main “pros” of this model is that the technique described by Chen et al is easily 
adaptable to instead targeting different areas of the cerebral cortex. Ibotenic acid injection 
has already been shown to cause histologically similar lesions to PVL as we see in babies 
who go onto develop CP. (A. Chen et al., 2008) A possible advantage is that this model is 
expected to have excellent rates of animal survival on study compared to other induced 
maternal ischaemic models. This is important as we would like to study these animals for a 
prolonged period of time to allow us to measure their gastric emptying before and after 
splanchnectomy. There is also evidence from previous work using a rodent model, to 
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support and possibly explain the improvements we have seen clinically with CP and TS as 
it has been demonstrated in a “stress model” in the rat, using corticotrophin releasing factor 
(CRF) that the over activity of the sympathetic nervous system delays gastric emptying and 
that this can be counteracted by celiac plexus ablation.(Lenz, Burlage, Raedler, & Greten, 
1988) In terms of performing splanchnectomy in rats the procedure is a more 
straightforward than in humans. As discussed earlier splanchnectomy is often performed in 
adult surgical practice thoracoscopically, as we have done in some children, i.e. through 
the chest, however in the rat the splanchnic nerves are found below the diaphragm making 
it easier and safer in our cerebral palsy model to divide these via laparotomy with 
diathermy. We plan to then investigate what effect this has on gastric emptying and foregut 
motility this may provide further evidence for splanchnectomy as another surgical tool in 
these difficult cases.(Aihara et al., 1978; Sapru, 1982) 
The main downside of this model is that although the technique of injecting neonatal brains 
with ibotenic acid is proven to create brain lesions similar to that of PVL we are not 
mimicking or creating a physiological similar model to that which is thought to occur ante- 
or perinatally in humans. This model has been chosen in part to improve animal survival in 
our study and also to reduce cost as a rodent model is significantly less expensive than 
trying to create a larger animal model or a model that involves performing procedures on a 
pregnant animal. 
1.6.4 How to assess gastric emptying (GE) in our CP model? 
In the literature there are many different methods of assessing gastric emptying in rodents. 
The majority, however, involve the use of chemical markers such as phenol red, 
performing surgery or sacrificing the animal to assess gastric emptying or involve the use 
of scintigraphy with a chemically specified meal after a long period of fasting. (Ito, Isobe, 
Tsuchida, & Higuchi, 1996; Shoji et al., 1997; van der Velde, Koslowsky, & Koopmans, 
1999) Each of these methods was considered in turn but those that involved sacrificing 
animals were deemed not suitable as the animals in our study design need to go on to have 
repeated gastric emptying studies i.e. before and after brain injection and before and after 
splanchnectomy for a prolonged period of study. We accept that scintigraphy would be the 
gold standard for our study much like in clinical practice, however, this was not readily 
available in our research centre and would have involved huge expense and training in this 
technique. There was a readily available X-ray machine and water soluble contrast and so 
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the decision was made at least for this study to perform simple water soluble contrast 
swallows and meals. There are few non-invasive techniques reported in freely-feeding 
animals. It has previously been shown that gastric emptying increases toward the end of 
the lactation period in rat pups. We decided to modify the barium grain method (Sakurai et 
al., 1996) and use water soluble contrast rather than barium grains, as done in clinical 
practice in children and babies. Gastric emptying time would therefore be the time from 
when the stomach was full to completely empty on time lapsed X-rays in animals placed in 
X-ray compatible plastic tubes. This would allow a non-invasive method of a water-soluble 
contrast meal in a conscious and prior to the study freely suckling pup and therefore a more 
reliable and “real” and useful method of assessing gastric emptying in pre-weaned rats. 
1.7 Rationale 
In summary, cerebral palsy is a condition which is on the increase because more and more 
children born prematurely are surviving. There is a real spectrum of children with CP in 
terms of how they are affected from a developmental point of view and a motor function 
point of view. The effects of CP on bowel functional especially the foregut is still under 
recognised, but it is now widely believed that children with CP commonly suffer not just 
from GORD but from foregut dysmotility leading to symptoms such as vomiting, retching 
and abdominal pain and feed intolerance commonly previously attributed solely to GORD. 
It has also become apparent over the last decade that evidence is absent in terms of how 
best to manage these patients and the options open to clinicians and surgeons are limited 
and of those that are available many have serious complications. 
This has led us to conclude that there is a much needed animal model of cerebral palsy and 
foregut dysmotility, to allow us to study why CP leads to such symptoms and problems 
with feeds, and to investigate whether new treatments whether it be surgical or medical 
may show promise. 
We have noted from previous clinical experience that thoracic splanchnectomy (TS) can 
help with improving gastric emptying and associated symptoms as described above when 
all else fails. This is a procedure commonly performed in adult patients as a day case and 
hence why we wish to perform the technique on our animal model to see if we can further 
cement the usefulness of this procedure for this specific group of challenging parents. 
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1.8 Hypothesis 
It is our hypothesis that foregut dysmotility in children with cerebral palsy is a result of 
over activity of the sympathetic nervous system and that this leads to an imbalance in the 
autonomic nerve supply to the bowel as depicted in the Figure 13 below. Modification of a 
previous cerebral palsy animal model by targeting ibotenic acid at the MPFC and/or insular 
cortex will therefore lead us to develop a model of cerebral palsy with proven foregut 
dysmotility including delayed gastric emptying. 
Secondly, we hypothesise that by performing splanchnectomy on our model we may 
demonstrate a “re-balancing” of the neural control and so improve gastric emptying, again 
as depicted in the figure below. We hope by developing such a model and its further study 
will aid in the development of much needed treatment options for children with cerebral 
palsy and indeed other children who are neurologically impaired who have symptoms of 
dysmotility and delayed gastric emptying. 
 
 (A) Dysmotility  (B) Normal motility 
 
Figure 13. A schematic diagram illustrating the crux of our hypothesis i.e. that 
dysmotility (A) is the result of an imbalance between the autonomic nervous supply to the 
foregut and that by performing splanchnectomy the balance can be redressed as shown in 
(B). 
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1.9 Specific Aims 
1. We aim to investigate whether targeting certain areas in the cerebral cortex of neonatal 
rat pups i.e. the medial prefrontal cortex (MPFC) and/or the insular cortex will lead to 
lesions in the brain similar to PVL and to evidence of delayed gastric emptying that is 
proven and reproducible. We aim to develop such an animal model to try to provide 
the scientific basis for the improvements we have seen clinically. 
2. We aim to perform histological examination including immunohistochemistry on our 
CP model and compare this to controls so as to potentially reveal any difference in the 
foregut between the two groups. 
3. We aim to perform splanchnectomy on our established animal model to investigate if 
this will improve gastric emptying and enteric motility. This will attempt to explain the 
clinical improvements we have seen by examining the animals functionally after 
splanchnectomy and histologically. 
4. We aim to examine archived foregut specimens of children with cerebral palsy and 
known foregut dysmotility to see if there are any similarities between such biopsies 
and those take from our newly developed animal model. 
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Chapter 2 
Materials and Methods 
2.1 The animal model 
2.1.1 The choice of the rodent model 
The choice of a rodent model was based on several factors. These included easy 
availability of Sprague Dawley rats and the robustness of this species for repeated use i.e. 
being used on more than one protocol. The main advantage was that our model was based 
on a previous rodent model of cerebral palsy using a technique that was easy to learn and 
was reproducible. (A. Chen et al., 2008) Rodents have often been selected particularly, for 
mammalian neuroscientific research, because not only are they relatively cheap to look 
after and easy to acquire, but they are fairly resistant to infection and are big enough to 
place in a stereotaxic frame. Following on from this there is a very detailed atlas of the rat 
brain by Paxinos et al that provides stereotaxic coordinates for the areas of interest. 
(Paxinos and Watson 1996) Neonatal Sprague-Dawley rat pups were bred in house at the 
University of Glasgow Central Research Facility 
The average litter size of the Sprague Dawley rat is 10-11 pups. The pup’s birthweight 
differs depending on the litter size but ranges between 5.9-6.4 grams. The adult body 
weight is 250–300g for females, and 450–520g for males. The typical life span is 2.5–3.5 
years. Our study is split into two stages initially. Stage one is developing our animal model 
and stage two is performing splanchnectomys on this model. Finally, there is then a third 
stage analysing a historical cohort of human biopsies. This chapter describes the methods 
involved in each of these three stages.  
We performed brain injections as described below on postnatal day 5-7 as this was found 
by Chen et al to be the ideal time to create lesions similar to PVL and to essentially 
correspond to the window of time of white matter vulnerability. (A. Chen et al., 2008) The 
median weight at time of operation in stage one i.e. creating brain lesions was 13.5 grams 
(range 7.5-21 grams). They are commonly weaned at 3 weeks of age and were then on a 
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full adult diet. The median age at time of splanchnectomy was day 21 and the median 
weight at splanchnectomy was 64 grams (range 43.8-108gram). 
2.2 Animal management and care 
Animals were housed in the in Central Research Facility, University of Glasgow and were 
kept in a dedicated rodent room which was maintained at temperatures between 70 and 
72°F with a photoperiod of 12 hours light and 12 hours dark (7am-7pm and 7pm-7am). 
Humidity was controlled between 45-55%. As neonates, the pups were housed with their 
mother or dam and allowed to feed normally and kept in standard bedding until they were 
weaned around 21 days of age. They were then they were housed with their littermates 
depending on the stage of the study. All cages had environmental enrichment with wood 
shavings, cardboard tubes and sizzle nest. Their diet post weaning was BK Expanded diet 
provided by Special Diet Services and they were cared for in a free feeding environment. 
Cage changes were performed once weekly and rats were examined daily by a senior 
member of the technical staff familiar with the study. All animals were weighed regularly 
whilst on study. All procedures and surgery were conducted in accordance with the 
Animals (Scientific Procedures) Act 1986, under licenses issued by the UK Home Office 
(PPL 60/4262), by appropriately-qualified individuals. 
2.3 Gastric Emptying (GE) study technique 
There are many different techniques used in clinical practice to assess gastric emptying in 
humans and many techniques have been employed in animals in biomedical research such 
as the barium grain technique. (Sakurai et al., 1996) In this study gastric emptying time 
(GET) was recorded by gavaging 0.2mls of water soluble contrast Omnipaque 300 
(Iohexol 647mg equivalent to 300mg of organic iodine per mL) and placing animals awake 
in a x-ray compatible red rat restrainers (AH200AR supplied by Vet Tech Congleton 
Cheshire) similar to a Perspex ‘VetMouse Trap’ (Oliveira et al., 2011). Digital time lapsed 
x-rays were then performed using the Kodak FX Pro imaging system. Typical images from 
a GE study are shown below. The GET was measured as the time of gavaging the rat to the 
time the stomach was completely empty on imaging. This technique avoided the need for 
an anaesthetic which would have affected GET and also meant that animals were able to be 
freely feeding both as neonates and post weaning. 
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Figure 14. Images from rodent gastric emptying studies.  This pup has undergone a 
bilateral MPFC injection with ibotenic acid.  (i) shows contrast in the stomach (ii) shows 
contrast leaving the stomach and entering the small bowel (iii) shows an empty stomach 
with some contrast in the small bowel and contrast also refluxing back into the oropharynx. 
2.4 Anaesthesia – Phase 1 
2.4.1 Induction 
On the day of surgery neonatal rat pups (postnatal days 5-6) that were freely feeding from 
their mother were anaesthetised by injecting 0.3 μg/kg bodyweight fentanyl citrate and 10 
μg/kg fluanisine (Hypnorm®, Janssen) subcutaneously according to published guidance 
from Clowry and Flecknell. (Clowry, 2000) This technique was specifically investigated 
by Clowry and Flecknell because although there are various types of inhalational 
anaesthesia such as isoflurane and halothane, these agents can be difficult to use 
specifically when anaesthetising neonatal rat pups. This is because inhalational anaesthesia 
requires placing the very small pup’s nose in a face mask which can be challenging given 
the animal’s size. In addition, such apparatus can make it difficult to perform midline 
craniotomies and brain injections via a stereotaxic frame as shown below in the surgical 
protocols. This specific type of surgery on small neonatal animals also makes it difficult to 
scavenge excess inhalational gas and therefore limits the ability to reduce exposure to the 
person performing the procedure. For all these reasons, subcutaneous Hypnorm® was 
chosen. Induction with Hypnorm® usually occurs within 5-10 minutes. Adequate 
induction of anaesthesia was assessed by carefully pinching the toes of the pup’s hind limb 
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with a toothed forceps and observing for any pain or withdrawal reflex. Careful 
observation for movement of the animal was important prior to skin incision, not only to 
assess adequate induction of anaesthesia, but was also essential prior to positioning of the 
needle on the stereotaxic frame. 
2.4.2 Maintenance 
Hypnorm®, in addition to being used as an induction agent, can also be used to provide 
maintenance anaesthesia, but it is important to continuously observe for jerking 
movements as discussed by Clowry and Flecknell. Their paper (Clowry, 2000) 
demonstrated not only good depth of anaesthesia for neurosurgical procedures but also 
excellent survival rates, something which can be difficult to achieve when operating on 
such small neonates. These authors also stressed that whilst this drug is highly successful 
when given subcutaneously a high animal loss rate was noted when given intraperitoneally 
and this is not recommended and therefore this route was avoided in this study. 
2.4.3 Recovery 
The pups were then transferred to recovery where they were kept warm on a warming 
blanket, given oxygen and constantly stimulated by gentle prodding with cotton buds to 
prevent apnoea. All animals were monitored with a modified APGAR score post-
operatively as described by Zani et al (Zani et al., 2008)and shown in the table below. This 
is similar to the APGAR tool also used by Veronesi et al (Veronesi, Panzani, Faustini, & 
Rota, 2009) when monitoring neonatal canine puppies. This tool was used immediately 
post op and then when neonates where deemed fit they were returned to their mother. If 
analgesia was required Buprenorphine 0.01-.005 mg (0.005-0.015ml/100g body weight) 
was administered subcutaneously (Buprecare® 0.3mg/ml, Animal care Ltd supplied by 
Henry Schein Ltd Dumfries). The animals were then inspected daily for infection or suture 
removal and weighed regularly. Post-operative infection has not previously occurred in 
similar models but if this occurred this was treated by systemic administration of antibiotic 
or termination of the experiment by killing by a schedule 1 method. Suture removal can 
also sometimes occur and should this happen wounds would be re-sutured under 
anaesthesia on one occasion only. This did happen on one occasion. In addition, any 
animal displaying abnormal behaviour (lack of inquisitiveness, hunched appearance, 
boarding of the abdomen) would be discussed with our named vetinary surgeon (NVS). 
Similarly, animals were closely observed for potential effects of the lesion, created by long 
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needle and delivery of neurotoxin to the cortex of the brain. Previous procedures in a 
similar model (A. Chen et al., 2008) has been well tolerated. However, effects of the 
specific lesions we were attempting to generate is as yet unknown. If the condition of the 
animal were to cause concern advice would be sought from the NVS and if necessary 
animals would be killed by a Schedule 1 method. 
2.4.4 Endpoints 
In phase 1 animals were humanely killed on day 28 of life to allow histological 
examination of the brain to assess the extent of the brain injection and any evidence of 
white matter injury or features in keeping with PVL. Animals were euthanized by first 
administering an overdose of sodium pentobarbital, 1 ml (200mg in 1ml) per1.4kg body 
weight (Euthatal®, Merial supplied by Henry Schein Ltd Dumfries) subcutaneously and 
then placing the rat in a chamber with a rising concentration of CO2 (CO2 flow rate: 
0.2Lmin rising to 1L per min). Once animals were deeply anesthetised all four limbs were 
fixed with 23G needles (BD Microlance, UK). The thorax was opened with dissecting 
scissors and the heart and the great vessels were exposed. An 18G needle (BD Microlance, 
UK) was inserted into the right atrium of heart and the rat was perfused transcardially with 
0.9% saline, followed by buffered fixative (1 l/kg body weight) consisting of 4% 
paraformaldehyde (PFA®, Sigma-Aldrich, Poole, UK). A window was then made in the 
right ventricle with scissors to let returning blood. Complete fixation was determined when 
then tail and all four limbs of the animals were rigid. Following successful perfusion, the 
entire head with the animal’s brain were stored in 4%PFA. Once transferred to the 
histopathology laboratory samples were transferred to 10% neutral buffered formalin 
(NBF) for 72-96 hours. The brains were then dissected from the skull and were trimmed 
into 1mm thick slices at multiple levels. Similarly, all the bowel from the oesophagus to 
rectum was harvested and stored in 4%PFA prior to histological examination. The 
remainder of the carcasses were bagged and placed in a refrigerated locker until collection 
for incineration. 
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Figure 15. Post-operative rat pup having undergone craniotomy and brain injection. 
The pup is shown in recovery on a heat mat and is receiving oxygen and regular stimulation 
and monitored as per the modified APGAR score. 
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Table 4. The modified APGAR score. This is an easy and reliable scoring system 
modified from human clinical practice and validated in animal practice by Zani et al 
Appearance 
0 The pup rat is tonic and well hydrated 
1 The pup rat is slimmer but still tonic and hydrated 
2 The pup rat is skinny, floppy, and dehydrated 
3 The pup rat is gasping and in agony 
Response to touch 
0 The pup rat is alert (without stimulation) 
1 The pup rat responds to mild stimulation 
2 The pup rat responds to vigorous stimulation 
3 The pup rat is unresponsive notwithstanding a vigorous stimulation 
Natural activity 
0 The pup rat moves normally in the cage 
1 The pup rat, if put supine, is able to wriggle 
2 The pup rat, if put supine, is not able to wriggle 
3 The pup rat does not move its limbs and lays still 
Colour 
0 The pup rat skin colour is pink 
1 The pup rat skin colour is pale (just at the extremities) 
2 The pup rat skin colour is pale (whole body) 
3 The pup rat skin colour is grey 
 
2.5 Anaesthesia - Phase 2 
2.5.1 Induction 
The induction agent in phase 2 of the study was the inhalational agent, Isoflurane, instead 
of Hypnorm® as the licence for Hypnorm® ran out during the study and so this could no 
longer be supplied to our research facility. It was felt; however, now that the technique had 
been learnt in phase 1, the stereotactic frame could be modified to ensure that the rat pups 
were able to receive inhalational anaesthesia. Induction was, therefore, carried out as per 
current guidelines (Flecknell (2015) Laboratory Animal Anaesthesia, 4th edition, Elsevier). 
The animal was placed in an induction chamber and isoflurane or Isoflo® (100% 
weight/weight Inhalation vapour liquid, Abbott labs supplied by Henry Schein Ltd 
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Dumfries) was given at a flow rate of between 500-1000 ml/min until the animal was 
recumbent and not responding to painful stimuli to the hind limb. 
2.5.2 Maintenance anaesthesia 
The supply of isoflurane was then switched to the nosecone and the animal was positioned 
in the nosecone supplied with 1l/min of oxygen and 300-200ml/min of Isoflurane (Isoflo® 
100% weight/weight Inhalation vapour liquid, Abbott labs supplied by Henry Schein Ltd 
Dumfries). The animal was monitored throughout the procedure in terms of colour, 
respiratory rate and movement or reaction to painful stimuli. 
2.5.3 Recovery 
Animals in phase 2, undergoing laparotomy and splanchnectomy, were recovered in a 
similar manner to stage 1 i.e. oxygen, warming blanket and observed with the use of the 
Modified Apgar score and when deemed fit, returned to their cages with their cohort. If 
analgesia was required Buprenorphine 0.01-.005 mg (0.005-0.015ml/100g body weight) 
was administered subcutaneously (Buprecare® 0.3mg/ml, Animal care Ltd supplied by 
Henry Schein Ltd Dumfries). Again, animals were monitored for wound infection and 
suture removal as described above. 
2.5.4 Endpoints 
In phase 2 animals were kept on study for much longer than phase 1 to enable recovery 
from initial brain injection and subsequent gastric emptying studies both pre- and post-
splanchnectomy. Animals were, therefore, euthanized at 16 weeks of age following the 
completion of the surgical protocols. This was again performed in a similar method to 
phase 1 with an overdose of subcutaneous sodium pentobarbital, 1 ml (200mg in 1ml) 
per1.4kg body weight (Euthatal®, Merial supplied by Henry Schein Ltd Dumfries) and 
placed in a chamber of rising concentration of CO2. Once animals were deeply 
anesthetised all four limbs were fixed with 23G needles (BD Microlance, UK). The 
thorax was opened with dissecting scissors and the heart and the great vessels were 
exposed. An 18G needle (BD Microlance, UK) was inserted into the right atrium of heart 
and the rat was perfused transcardially with 0.9% saline, followed by buffered fixative (1 
l/kg body weight) consisting of 4% paraformaldehyde (PFA®, Sigma-Aldrich, Poole, 
UK). A window was then made with scissors to open the right ventricle to let returning 
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blood. Following successful perfusion, as described above, as in phase 1 the animal’s 
brains were dissected from the skull and all the bowel from oesophagus down to rectum 
was harvested and stored in 10% buffered formalin. Again, the remainder of the 
carcasses were bagged and placed in a refrigerated locker until collection for 
incineration. 
2.6 Surgical Protocols 
2.6.1 Midline Craniotomy and brain injections 
Neonatal Sprague-Dawley rat pups aged postnatal days 5-6 (P5-6) underwent midline 
craniotomies under anaesthesia to allow either unilateral or bilateral brain injections of the 
neurotoxin, ibotenic acid (IBA) (Tocris, Cat. No. 0285), in the medial prefrontal (MPFC) 
or insular cortex, using a digital stereotaxic frame. P5-6 was chosen as this has been 
shown to correspond to the stage of white matter vulnerability and that neurotoxin 
injections at this stage can mimic lesions that appear histologically similar to human peri-
ventricular white matter injury as seen in cerebral palsy. The anaesthetised animal was 
placed prone in a digital stereotactic frame (Harvard Apparatus limited) and fitted with an 
elite nanomite stereotaxic syringe pump (Harvard Apparatus Limited) and underwent 
midline craniotomy (Figure 18). An injection was then made of a 2.5 μl solution 
containing either 2.5 μg of IBA in 2.5μl sterile saline or 2.5μl sterile saline solution only. 
This was administrated with a 25μl Hamilton syringe over 1 minute and the needle was 
left to rest for 5 minutes and then carefully removed. The digital stereotactic frame was 
used to target either the insular cortex (IC) or medial prefrontal cortex (MPFC) using 
coordinates from the Paxinos rat brain atlas and using Bregma and the interaural line as 
landmarks (see the figures below). The IC is made up of four parts craniocaudally: the 
granular insular cortex (GI), the dysgranular insular cortex (DI) and the dorsal and ventral 
agranular insular cortex (AID and AIV respectively). The MPFC along with the anterior 
cingulate cortex (ACC) makes up the medial frontal cortex (MFC). The MPFC consists of 
three regions the cingulate cortex (Cg1), the prelimbic cortex (PrL) and the infralimbic 
cortex (IL). The standard nomenclature for the coordinates are similar to the more 
commonly used “xyz” coordinates used in mathematics, but instead are anteroposterior 
(AP) from Bregma, medial lateral (ML) and dorsal ventral (DV). The coordinates for the 
MPFC and IC used were ML 0.3mm, AP 2.7mm, DV3.2mm and ML 5.5mm, AP 1.0mm, 
DV 5.2mm respectively (Paxinos and Watson, 2006). The two figures below show these 
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two areas targeted in both coronal and sagittal views. Although these measurements are 
commonly used for adult rats rather than neonates, the coordinates were used as a guide 
for all neonates regardless of sex or weight. This was because this is the only guide 
available and so in particularly small animals the coordinates were adjusted slightly on a 
case by case basis. 
 
(A) Coronal view: aca = anterior commissure, ant; AcbC = accumbens nu, core; AcbSh = 
accumbens nu, shell; AID = agranular insular cortex, dorsal; AIV agranular insular cortex, 
ventral; AOP = anterior olfactory area, posterior part; Cg1 = cingulate cortex, area 1; Cl = 
claustrum; DEn = dorsal endopiriform nu; DP = doral peduncular cortex; DTT = dorsal 
tenia tecta; fmi = forceps minor corpus callosum; GI = granular insular cortex; ICj = 
islands of Calleja; IL = infralimbic cortex; lo = lateral olfactory tract; LO = lateral orbital 
cortex M1 = primary motor cortex; M2 = secondary motor cortex; mfba = medial forebrain 
bundle “a” component; Pir = piriform cortex; PrL = prelimbic cortex; S1J = primary 
somatosensory cortex, jaw region SL = stratum lucidum; Tu = olfactory tubercle. 
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(B) Sagittal view of the MPFC - for relevant abbreviations see Fig 15 (A) 
Figure 16. Rat brain atlas figure of the medial prefrontal cortex. 
(A) Coronal and (B) Sagittal views of “Bregma 2.7mm (Paxinos and Watson, 1996).” 
Figure reproduced kindly with permission sought from “Paxinos, George, and Charles 
Watson. The rat brain in stereotaxic coordinates: hard cover edition. Access Online via 
Elsevier, 2006”. The path between  and  shows the entry point and targeted region of 
the brain respectively. 
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(A) Coronal view of the IC: 2n = optic nerve; aca = anterior commissure, ant; AcbC = 
accumbens nu, core; AcbSh = accumbens nu, shell; AID = agranular insular cortex, dorsal; 
AIV agrainular insular cortex, ventral; CB cell bridges ventral striatum; cg = cingulum; 
Cg1 = cingulate cortex, area 1; Cg2 = cingulate cortex, area 2; Cl = claustrum; CPu = 
caudate putamen (striatum); claustrum; DEn = dorsal endopiriform nu; ec = external 
capsule; gcc = genu of corpus callosum; GI = granular insular cortex; ICj = islands of 
Calleja; ICjM = islands of Calleja, major island; IG = indusium griseum; LAcbSh = lateral 
accumbens shell; lo = lateral olfactory tract; LSD = lateral septal nu, dorsal part; LSI = 
lateral septal nu, intermediate; LSS = lateral stripe of the striatum; LSV lateral septal nu, 
ventral part; LV = lateral ventricle; M1 = primary motor cortex; M2 = secondary motor 
cortex; mfba = medial forebrain bundle “a” component; Pir = piriform cortex; Shi = 
septohippocampal nucleus; S1J = primary somatosensory cortex, jaw region; SDZ = 
primary somatosensory cortex, dysgranular zone; S1ULP = primary somatosensory cortex, 
upper lip region; Tu = olfactory tubercle; VDB = nucleus of the vertical limb of the 
diagonal band; VP = ventral pallidum. 
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(B) Sagittal view of the IC – for relevant abbreviations see Fig 16 (B) 
Figure 17. Rat brain atlas figure of the insular cortex. 
(A) Coronal and (B) Sagittal views of “Bregma 2.7mm (Paxinos and Watson, 1996).” 
Figure reproduced kindly with permission sought from “Paxinos, George, and Charles 
Watson. The rat brain in stereotaxic coordinates: hard cover edition. Access Online via 
Elsevier, 2006”. The path between  and  shows the entry point and targeted region of 
the brain respectively. 
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Figure 18. A neonatal rat pup in the stereotaxic frame. The pup is shown having 
been anaesthetised by subcutaneous Hypnorm® on a sterile drape positioned within the 
stereotaxic frame and undergoing brain injection through a midline craniotomy wound. 
Pups underwent either unilateral or bilateral injections in each of the two regions (MPFC 
or IC) or sham injections of normal saline. The craniotomy wound was then closed with 
6/0 vicryl interrupted sutures. All animals were monitored with a modified APGAR score 
post-operatively. Gastric emptying studies were then performed (as described above) 
between 7 and 21 days postoperatively to look for any delay in gastric emptying times 
(GET) and animals were weighed regularly. GET was recorded by gavaging 0.2mls of 
water soluble contrast and performing time lapsed x-rays as described above. The pups 
were then perfused on day 28 of life and their brains examined with Haematoxylin and 
Eosin and Cresyl Violet staining to assess the extent of the brain lesion created. (see 
below) 
2.6.2 Splanchnectomy 
In rodents the splanchnic nerves are positioned just below the diaphragm and so can be 
approached by midline laparotomy. (Sapru, 1982) This has the advantage of not having to 
go through the chest, which would most likely result in a higher animal loss. Prior to 
operating on live animals that were on study laparotomy was performed on rodent cadavers 
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and not only was the technique practiced but the splanchnic nerves were resected and 
analysed histologically to further confirm that what we were targeting was correct. We 
then progressed to operating on live animals. Once under adequate depth of anaesthesia the 
rat was prepped, shaved and draped and a midline laparotomy wound was made. The linea 
alba was then easily identified and the peritoneal cavity opened safely. A unilateral left-
sided splanchnectomy was then performed by first delivering the bowel and then the 
stomach and spleen were reflected out the way taking care not to damage the spleen or 
liver. Unilateral splanchnectomy was performed for two reasons; the first being that to 
attempt right sided splanchnectomy in such a small animal would have meant retracting 
and dissecting in close proximity to the liver which would have vastly increased the risk of 
bleeding and the subsequent rate of animal loss. Secondly and more importantly, in the 
human literature, it has been widely reported that unilateral splanchnectomy is not only 
successful, but also less risky. For example, several papers have shown that left sided 
splanchnectomy alone is effective for controlling pain in patients with inoperable 
pancreatic cancer. (Lica, Jinescu et al. 2014) (Leksowski 2001, Masuda, Kuramoto et al. 
2014) The splanchnic nerves were then divided with bipolar diathermy and the animal 
closed with two-layer closure using 2/0 vicryl ® and 5/0 vicryl ® interrupted buried 
subcuticular stitches for skin. The animal was recovered as described above. All animals 
underwent splanchnectomy whether they had a sham brain injection with normal saline or 
a bilateral MPFC with IBA. No sham splanchnectomys were performed. 
 
Figure 19. A timeline of phase 2 of the study. 
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The craniotomy and brain injection were performed on day 5 to 7 of life followed by the 
first GE study pre splanchnectomy, then laparotomy and splanchnectomy and then a 
second GE study. 
 
Figure 20. Intraoperative photograph showing midline laparotomy. 
Cotton buds are holding stomach and spleen medially and handheld bipolar diathermy to 
divide the branches of the splanchnic nerves. 
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Figure 21. Intraoperative view of the splanchnic nerves. 
This photo and accompanying illustration show the three branches of the splanchnic nerves 
highlighted having reflected the stomach and spleen out the way. The nerves are then 
divided with bipolar and then animal closed and recovered. 
2.7 Laboratory Analysis 
The laboratory analysis undertaken differed between phase 1 and phase 2 of our study. In 
phase one, we were developing our CP model and so all brains of the rats were analysed to 
assess the extent of the unilateral or bilateral lesion created either in the IC or MPFC, 
regardless of whether IBA was used or normal saline (i.e. a sham operation). In phase 2 
brains were stored but lesion analysis was not repeated. Also in both phase 1 and phase 2 
foregut biopsies were examined following perfusion of the animals. Perfusion and biopsy 
retrieval was performed by the author. Sectioning, embedding and immunohistochemistry 
techniques were performed by Mrs Lynn Stevenson and her team at Vetinary Biosciences, 
University of Glasgow. Histological and pathological advice was sought from Dr 
Francesco Marchesi and Dr Joshua Leach when interpreting slides. 
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2.7.1 Brain lesion analysis 
In phase 1 following the sacrifice and perfusion of animals on day 28 of study, as 
described earlier in this chapter, brains were dissected from the skull and transferred into 
10% neutral buffered formalin. Two coronal sections were collected from each specimen 
and processed to paraffin blocks. The two samples were embedded in the same block. Two 
consecutive sections from each block were then stained with Haematoxylin and Eosin (HE) 
and Cresyl Violet (CV). The approximate level of sectioning into 4µm slices was estimated 
on the basis of the anatomical structures identified and in the histological sections. The 
sections were then examined to assess the extent and site of the brain lesion created. This 
involved assessing for loss of cortical neurons and/or ventricular dilatation i.e. features in 
keeping with the development of PVL. 
2.7.2 Collection of foregut specimens 
Collection of foregut specimens occurred after perfusion for all the animals i.e. in phase 1 
and 2. This involved taking four 1x1cm biopsies as shown in the diagram below. The 
specimens were taken from consistent sites in the foregut, as shown in the diagram below, 
namely (1) the distal oesophagus, (2) the midpoint of the greater curvature of the stomach, 
(3) the antrum of the stomach and (4) the second part of the duodenum. Samples were 
stored in 10% neutral buffered formalin. 
 
Figure 22. Schematic diagram of the foregut specimens. 
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Four points were chosen at which samples were taken i.e. distal oesophagus, midpoint of 
greater curvature, antrum and second part of duodenum. 
All reagents are made in house at Veterinary Biosciences, University of Glasgow. The 
samples were then washed with water and stained in Gills Haematoxylin for 5minutes. The 
sections were again washed in water and the allowed to differentiate in 1% acid alcohol. 
They are then washed in water again and underwent bluing before being counterstained 
with Putts Eosin for 5 minutes and then again washed in water. The sections were then 
dehydrated, cleared, and mounted. This protocol allows all nuclei to be stained blue and all 
other tissue components various shades of red or pink. 
2.7.3 Histological assessment of foregut samples 
In phase 1 the histological assessment of foregut samples was split into three stages. The 
first stage consisted of an initial “spot the difference” analysis by the author comparing 
known sham animals to known animals with different brain lesions i.e. bilateral or 
unilateral IC or MPFC lesions. Following this two vetinary pathologists were asked to 
perform a blinded analysis of duodenal samples and to allocate these specimens into three 
groups: “no change”, “mild change” and “significant change”. The third stage then 
involved further examination of samples identified as showing a difference in stage 1 and 
2. This third stage involved using a modified pathology scoring system. This scoring 
system was based on concepts described by Day et al which set standards for analysing 
bowel samples in different species i.e. quantifying villi height and width “per x40 stretch” 
or the number of a particular cell type “per 100 enterocytes” etc. (Day et al., 2008) The 
scoring system used in our study is summarised in the table below and allowed more 
accurate comparison between specimens from sham animals and those animals that 
underwent injection with IBA in different sites of the brain. In terms of how such variables 
were measured e.g. the length and width of villi and the thickness of the muscularis and 
submucosa then slides were digitalised by using the EVOS™ FL Auto Cell Imaging 
System (Thermo Fischer Scientific, Loughborough, UK) and then images were analysed 
using ImageJ software (Schneider, Rasband, & Eliceiri, 2012) allowing accurate 
measurement of structures in µm. This third stage in the analysis of specimens was 
performed by the author and further corroborated by a senior vetinary pathologist. 
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In phase 2 a similar spot the difference analysis was made this time between not only 
shams and our CP model but of the two groups post laparotomy and splanchnectomy. 
Again, once the spot the difference analysis was undertaken the scoring tool described 
above was employed for biopsies to streamline a more detailed comparison between the 
CP model and shams. 
Table 5. Modified pathological scoring system for assessing intestinal specimens. 
This comprises 14 pathological features and how they are assessed on a slide in a standard 
fashion to aid statistical comparison ( based on concepts from Day et al (Day et al., 2008). 
Pathological feature Image Measured by: 
1. Villous number  
 
Counting all villi in the FOV* x40 
and then multiplying by number of 
FOVx40 per slide 
2. Number of bifid villi 
 
Counting number of bifid villi at x40 
along length of biopsy and then 
dividing by the total of number of 
villi  
3. Villous height  
 
Measuring the height (µm) of each 
villus in the FOVx40 for each 
FOVx40 along the length of the 
slide. The median was then 
calculated. 
4. Villi width 
 
Measuring the width of each villus 
(µm) at the same level per FOVx40 
for each FOVx40 along the length of 
the slide. The median was then 
calculated. 
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Pathological feature Image Measured by: 
5. Lamina propria (LP) width 
 
Measuring the width of each LP(µm) 
in each villus in the FOVx40 for each 
FOVx40 along the length of the 
slide. The median was then 
calculated. 
6. Crypt height 
 
Measuring the height (µm) of each 
crypt in the FOVx40 for each 
FOVx40 along the length of the 
slide. The median was then 
calculated. 
7. Inter-crypt distance  
 
Measuring the inter-crypt distance 
(µm) in the FOVx40 for each 
FOVx40 along the length of the 
slide. The median was then 
calculated. 
8. Thickness of muscularis 
 
Measuring the thickness of the 
muscularis (µm) (inner and outer 
layers and total thickness) in each 
FOVx40 and for each FOVx40 along 
the length of the slide. The median 
was then calculated. 
9. Thickness of submucosa 
 
Measuring the thickness of the 
submucosa (µm) in each FOVx40 
and for each FOVx40 along the 
length of the slide. The median was 
then calculated. 
10. Number of eosinophils 
 
Number of eosinophils per 50 
enterocytes at x40 both epithelial and 
within the lamina propria 
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Pathological feature Image Measured by: 
11. Number of lymphocytes  
 
Number of lymphocytes per 50 
enterocytes at x40 both epithelial and 
within the lamina propria 
12. Number of myenteric neurons 
13. Number of submucosal neurons 
14. Total number of neurons 
 
Counting the number of 
submucosal/myenteric neurons at 
x40 along the length of slide and then 
dividing by the number of FOVs at 
x40 per slide.  
*FOV = field of view, usually at x40 magnification 
2.7.4 Immunohistochemistry 
Immunohistochemistry was employed to some samples in phase 1 and phase 2 of the study 
to try to elucidate any possible reasons for changes seen, and to help point to pathways that 
may be involved in such differences between the CP model and shams. All 
immunohistochemistry (IHC) was kindly performed by Mrs Lynn Stevenson (Veterinary 
Pathology, Public Health & Disease Investigation, University of Glasgow). A generic IHC 
protocol was followed using a DAKO Autostainer. Four antibodies were investigated in 
total namely Anti- Human CD117, Anti -iNOS, Anti -ChAT, and Anti-Jagged 1. A 
negative control antibody was used for each to check specificity. 
2.7.4.1 Anti-Human CD117 
The interstitial cells of Cajal (ICC) are now known to be the pacemaker cells of the foregut, 
hence they are top of our list in terms of investigating whether these cells show any 
difference in expression in our CP model with possible altered foregut motility. The 
formalin-fixed foregut samples were processed and embedded in paraffin wax. 2.5µm 
sections were cut using a Thermo Shandon Finesse microtome and put on charged slides 
and incubated at 57degrees Celsius for 1 hour. Sections were then dewaxed and rehydrated 
through graded alcohols to water then rinsed with buffer (Trisaminomethane buffer pH7.5 
and Tween) for five minutes. Heat-Induced Epitope Retrieval (HIER) was undertaken in 
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Sodium Citrate buffer pH6 using a Menarini Access Retrieval Unit. All subsequent steps 
were at room temperature. After a buffer rinse the sections were then loaded on to the Dako 
Autostainer. Endogenous peroxidise was blocked using Dako Real TM Peroxidase blocking 
(Dako Ref S2023) solution for five minutes followed by a 5 minute rinse with buffer. The 
sections were then incubated with the primary antibody (DAKO Ref A4502) Polyclonal 
Rabbit Anti-Human CD117(c-kit) for 30 minutes at room temperature. This primary 
antibody was diluted in Dako universal diluent (1:800 for the 1st batch and 1:400 for the 
repeats). The sections were then rinsed again twice with buffer for five minutes to wash off 
the primary antibody. Sections were then incubated with the secondary antibody Dako 
Envisin+ System horse radish peroxidase (HRP) labelled Polymer Anti-Rabbit ready to use 
(RTU)(Dako Ref K4003) for thirty minutes. The sections were then rinsed twice with buffer 
for five minutes and then twice for five minutes with Dako K5007 diaminobenzidine (DAB) 
followed by three 5 minute water rinses. They were counterstained with Gills Haematoxylin 
for 27 seconds then washed in water. Finally, the sections are dehydrated, cleared and 
mounted with coverslips using synthetic resin. The stained sections were then analysed 
using the EVOS cell imaging system and digitalised prior to analysis with ImageJ software 
to count the number of ICC in the biopsies of shams compared to IBA lesioned animals in 
phase 1 and to compare shams and CP model in phase2 post splanchnectomy. 
2.7.4.2 Anti-iNOS 
In chapter one, we discussed the pivotal role that nitric oxide (NO) plays in the normal 
motility of the foregut. Nitric oxide synthases are a group of enzymes that come in different 
forms and act as catalysts for the production of NO. iNOS or inducible NOS is found 
throughout the body and is thought to have a role in immunity and the level of iNOS is 
directly linked to the production of NO hence the reason for examining this antibody in our 
samples of the foregut. A similar generic IHC protocol to that described above was 
followed i.e. formalin-fixed foregut samples were processed and embedded in paraffin wax. 
2.5µm sections were cut using a Thermo Shandon Finesse microtome and put on charged 
slides and incubated at 57 degrees Celsius for 1 hour. Sections were then dewaxed and 
rehydrated through graded alcohols to water then rinsed with buffer (Trisaminomethane 
buffer pH7.5 and Tween) for five minutes. Heat-Induced Epitope Retrieval (HIER) was 
undertaken in Sodium Citrate buffer pH6 using a Menarini Access Retrieval Unit. All 
subsequent steps were at room temperature. After a buffer rinse the sections were then 
loaded on to the Dako Autostainer. Endogenous peroxidise was blocked using Dako Real 
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TM Peroxidase blocking (Dako Ref S2023) solution for five minutes followed by a 5 
minute rinse with buffer. The sections were then incubated with the primary antibody 
(Abcam ab15323) Polyclonal Rabbit Anti-iNOS for 30 minutes at room temperature. This 
primary antibody was diluted in Dako universal diluent 1:50. The sections were then rinsed 
again twice with buffer for five minutes to wash out any excess primary antibodies. 
Sections were then incubated with the secondary antibody Dako Envisin+ System horse 
radish peroxidase (HRP) labelled Polymer Anti-Rabbit ready to use (RTU)(Dako Ref 
K4003) for thirty minutes. The sections were then rinsed twice with buffer for five minutes 
and then twice for five minutes with Dako K5007 diaminobenzidine (DAB) followed by 
three 5 minute water rinses. They were counterstained with Gills Haematoxylin for 27 
seconds then washed in water. Finally, the sections are dehydrated, cleared and mounted 
with coverslips using synthetic resin. The stained sections were then analysed using the 
EVOS cell imaging system and digitalised prior to analysis with ImageJ software to assess 
the level of iNOS in biopsies of shams compared to IBA lesioned animals in phase 1 and to 
compare shams and the CP model in phase2 post splanchnectomy. 
2.7.4.3 Anti-ChAT 
As described in chapter 1 anti- ChAT acetylcholinesterase (ChAT) has been shown to be 
important in the control of foregut motility as we known that cholinergic neurons not only 
interact with the vagus nerve, but also may have a role in immunity by interacting with 
nearby intestinal macrophages. (Cailotto et al., 2014) The anti-ChAT antibody is designed 
to stain cell bodies and nerve terminals in both the central and peripheral central nervous 
system. In order to compare the levels of ChaT in foregut samples from our CP model 
compared to controls we used the same generic IHC protocol described above but the 
sections were incubated with the primary antibody (Abcam ab6168) Polyclonal Rabbit 
Anti-ChAT for 30 minutes at room temperature. The same secondary antibody was used as 
above and the IHC protocol completed and the stained sections were then analysed using 
the EVOS cell imaging system and digitalised prior to analysis with ImageJ software to 
assess the level of ChAT in biopsies of shams compared to IBA lesioned animals in phase 
1 and to compare shams and the CP model in phase2 post splanchnectomy. 
2.7.4.4 Anti- Jagged 1 
A fourth antibody was added following analysis of H&E slides because this analysis 
showed changes in villous architecture in duodenal biopsies in our CP model. Jagged 1 is a 
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cell surface protein or ligand involved in the notch signalling pathway which is a pathway 
crucial in making decisions on the fate of cells in many different organs throughout the 
body. Jagged 1 was examined because the Jagged-1/Notch-1/Hes-1 pathway has been 
shown to be involved in intestinal adaptation post small bowel resection (G. Chen et al., 
2013) and in the development and maintenance of normal villous architecture. (Sander, 
Brookes, & Powell, 2003; Sander & Powell, 2004) we only performed Jagged 1 analysis in 
our duodenal samples as we were specifically looking to see if we could marry the changes 
seen in villous architecture to the level of expression of Jagged 1. To assess this we 
compared IHC for anti-Jagged 1 in duodenal biopsies from our CP model compared to 
shams. Again, as described above, the generic IHC protocol was used and the sections 
were then incubated with the primary antibody (Abcam ab7771) Polyclonal rabbit Anti – 
jagged 1 for 30 minutes at room temperature. The same secondary antibody was used as 
above and the IHC protocol completed and the stained sections were then analysed using 
the EVOS cell imaging system and digitalised prior to analysis with ImageJ software to 
assess the level of Jagged 1 in duodenal biopsies of our CP model and shams. 
2.8 Retro-analysis of human foregut biopsies 
Patients were identified from the paediatric gastroenterology databases that were known to 
have a diagnosis of cerebral palsy and dysmotility. The online hospital patient records were 
then analysed to see which of these patients had had biopsies of their foregut including 
their duodenum. An application was then made to the hospital biorepository to examine 
these historical biopsies retrospectively. The H&E slides of these biopsies were then 
analysed jointly with a consultant paediatric pathologist using the same histological 
scoring tool as described and illustrated in table 4 above. (Day et al., 2008) 
2.9 Statistical analysis 
All values are expressed as medians or means +/- Standard Error of the Mean (SEM) unless 
otherwise stated. Statistical significance was set at P < 0.05 for all tests. All statistical 
analyses were performed using the biostatistics software package Graph Pad Prism 3.0 (La 
Jolla, CA 92037, USA). Statistical analysis in phase 1 comparing IBA injection groups to 
shams was undertaken by means of a Mann-Whitney test and a z-test was used to compare 
proportions or standard student’s t test. In phase 2 paired t tests were used when comparing 
pairs of data e.g. measurements of gastric emptying of the same animal before and after 
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splanchnectomy and two sample t tests when comparing two different groups of animals 
e.g. shams Vs CP model. Appropriateness of statistical analysis was checked kindly by Dr 
Alex McConnachie, Department of Biostatistics, University of Glasgow. 
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Chapter 3 
Results – Phase 1 
Establishing a CP model with foregut dysmotility 
The specific aims of Phase 1 of the study were two-fold: the first to show that by targeting 
certain areas in the cerebral cortex of neonatal rat pups i.e. the medial prefrontal cortex 
(MPFC) and or the insular cortex (IC) we can produce lesions in the brain similar to 
periventricular leukomalacia (PVL) and show that this leads to evidence of delayed gastric 
emptying. We need to develop a CP model that is reproducible and by developing such a 
model this will help provide the scientific basis for the improvements we have seen in 
clinical patients. The second aim in phase 1 was to undertake a thorough histological 
examination of the foregut of different brain lesioned animals compared to shams. This 
analysis will include immunohistochemistry and we hope to identify any possible changes 
in the foregut of our CP model compared to controls. 
3.1 Animals 
45 (postnatal day 5-7) pups were injected in total (28 male and 17 female). The median 
weight at time of operation was 13.5 grams (range 7.5-21 grams). Four pups died at the 
start of the study: two intra-operatively from haemorrhage (one L MPFC and one R 
MPFC) and two in the immediate post-operative period from anaesthetic complications or 
apnoea (both R MPFC). This is a recognised complication when anaesthetising and 
operating on such small neonatal animals. 
3.2 Difference in weight velocity 
Animals were weighed regularly throughout phase 1 of the study. Weight velocity means 
the rate at which the animal gained weight. Figure 23 shows a graph of the weight velocity 
of the different groups i.e. the shams compared to the various IBA injections, unilateral or 
bilateral IC or MPFC. It would appear from the spread of this graph that there is a 
difference between the weight velocities of shams compared to certain types of IBA 
injections namely right-sided MPFC and IC and bilateral IC. Standard t tests were used to 
Results – Phase 1  
79 
quantify the difference in mean weight gain between the shams and the various IBA brain 
lesions. These results are shown in Figure 23 and tabulated in Table 6 on the next page. 
This showed that weight gain or weight velocity was significantly reduced in four groups, 
the R MPFC and all insular cortex lesioned animals. It was also approaching significance 
in the bilateral MPFC group. It is still difficult, however, to be sure of the significance of 
this as the initial birthweight of the animal has a bearing on their ultimate weight gain and 
this is undoubtedly affected not only by the sex of the animal but also the initial litter size 
that the particular group of pups came from i.e. the larger the litter size the smaller the 
pups. 
 
Figure 23. Weight velocity of neonatal rat pups throughout Phase 1 
A scatter XY graph showing the weight gain of neonatal rat pups according to which group 
they belonged to i.e. which brain lesion they underwent: sham, unilateral or bilateral 
MPFC (medial prefrontal cortex), unilateral or bilateral IC (insular cortex). It can be seen 
that the weight gain or weight velocity was poorest in the RMPFC and insular cortex 
groups. The mean values are shown in table 6. 
Table 6 shows a comparison of mean weight gain between the different brain lesions and 
shams up until day 28 of life i.e. the end of Phase 1 of the study. MPFC = medial 
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prefrontal cortex and IC = insular cortex. Brain lesioned animals were compared to shams 
by means of a standard unpaired student’s t test. 
Table 6. Mean weight gain of neonatal rat pups throughout Phase 1 
Lesion 
Sham 
(n=9) 
L MPFC 
(n=5) 
R MPFC 
(n=3) 
BILATERAL 
MPFC 
(n=6) 
L IC 
(n=6) 
R IC 
(n=6) 
BILATERAL 
IC 
(n=6) 
Mean 
weight 
gain (g) 
67 66.5 32.9 59.1 38.3 44.2 39.7 
P-value 0.92 0.0001 0.07 0.0001 0.0002 0.0001 
 
3.3 Gastric Emptying Studies 
The various sites of neurotoxin injections and shams are shown in Table 7 with their 
corresponding median gastric emptying time (GET) in those that survived the craniotomy 
procedure and brain injection. Figure 25 shows the same data in a different format, by 
means of a Forest plot. GET was significantly prolonged in each IBA group compared to 
shams, but most interestingly 5 out of 6 of those with bilateral MPFC lesions demonstrated 
reflux during their contrast studies (Figure24). This was not seen in any of the other 
groups. There was also a difference seen between laterality of the brain lesion created and 
degree of prolonged GET. 
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 (A)  (B) 
Figure 24. Images from gastric emptying studies of two pups. 
Both pups had undergone IBA MPFC injections (A) has undergone a unilateral injection 
and show the arrow points to contrast in the stomach and (B) has undergone bilateral 
MPFC injections and the thin arrow shows some contrast in the stomach and small bowel 
and the thick arrow shows contrast also refluxing back into the oropharynx. 
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Table 7. Gastric emptying times comparing different brain lesions to those who 
underwent sham injections. Times were compared statistically by means of a Mann-
Whitney U test using GraphPad Prism. 
 
 
Figure 25. Forest plot comparing different sites of brain lesions and GET. 
The same data as displayed in table 6. RINSUL = right insular cortex, LINSUL = left 
insular cortex, BILAMPF = bilateral medial prefrontal cortex, RMPFC = right medial 
prefrontal cortex and LMPFC = left medial prefrontal cortex. The lines show the range of 
the GETs measure and the dot indicates the median GET in minutes. 
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3.4 Histological Analysis 
3.4.1 Brain lesion analysis 
In terms of cerebral histopathology what became immediately clear was that the MPFC 
lesions were easier to identify histologically compared to lesions of the insular cortex 
given its more lateral site in the rat brain. Out of 18 rats that underwent insular cortex 
lesions (12 unilateral and 6 bilateral) only in two of the brain specimens could any changes 
in the insular cortex be identified with confidence. In these two specimens, there was 
evidence of an increase in numbers of glial cells in the subcortical white matter in addition 
to areas of loss of substance or “cavitation” at the junction between cortical layers and 
subcortical white matter in the AID and AIV areas of the insular cortex (see Fig. 26 and 
27). As described in earlier chapters the MPFC consists of three regions the cingulate 
cortex, the prelimbic cortex and the infralimbic cortex. Figure 28 demonstrates the 
difference between the appearance of these regions of the brain in those who had 
undergone sham injection and those who had a unilateral MPFC lesion with IBA. Even on 
H&E staining there is evidence in the IBA injected brain of both loss of cortical neurons 
and ventricular dilatation. This is demonstrated by the further examples shown in Figures 
29 and 30. Figure 32 demonstrates an increased number of glial cells on H&E staining and 
by means of staining with cresyl violet. These changes were identified in 10 out of 14 
animals that underwent MPFC IBA injections. In two out of the fourteen rats that 
underwent MPFC IBA injections the lesions were too lateral as shown in Figure 32 with 
lesions and changes seen in the lateral prelimbic cortex and extending into the fmi (forceps 
minor of the corpus callosum) rather than limited to the MPFC. This is probably a 
reflection of the size of the neonatal animal and using stereotactic coordinates designed for 
larger subjects. This was because, as discussed in chapter 2, there are no published 
neonatal rat brain coordinates. These two rat pups were noted retrospectively to be from a 
larger litter and, therefore, at the smaller end of the spectrum in terms of birthweight and 
hence weight at operation. 
In summary, in terms of our brain lesions analysis the MPFC was much easier to 
consistently target than the insular cortex. 10 out of 14 (71%) rat brains showed 
histological evidence of lesions and 2 showed lesions that were too lateral. We have 
demonstrated histological changes consistent with PVL i.e. loss of cortical neurons, 
ventricular dilatation and increased number of glial cells. 
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Figure 26. Microphotograph of IC IBA lesion. This photograph shows typical 
appearances of the rat pup brain following IBA injection into the insular cortex. 
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Figure 27. Microphotograph showing cavitation in IC. This photograph shows the 
same area of “cavitation” in the insular cortex at a higher magnification. 
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 (A)  (B) 
Figure 28. Coronal section showing the MPFC in (A) a pup that had undergone a 
sham injection and (B) a pup that undergone a Left MPFC IBA injection. Both the 
images are projected in an anteroposterior fashion so that the right-hand side of the picture 
corresponds to the left side of the animal’s brain. M2 =Motor cortex, Cg1 = Cingulate 
cortex, PrL = Prelimbic cortex and IL = Infralimbic cortex 
 
Figure 29. Another example of a left sided MPFC lesion again with the left side of 
the brain projected to the right of the page. There is obvious dilatation of the left 
ventricle compared to contralateral side 
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Figure 30. Microphotograph of left MPFC lesion. This is the same section as in 
Figure 28 but this time at a higher power showing an increase in glial cells on the side of 
the brain injected. 
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Figure 31. Increased glial cells in the MPFC following IBA injections. 
The four slides above show H&E slides at x4 and x10 magnifications of the IL region of 
the MPFC and then below the same sections this time stained with cresyl violet (CV) to 
better define the increased number of glial cells. 
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Figure 32. Attempted Right sided MPFC lesion. 
The microphotograph above shows the brain of rat pup in which a R sided (to the left of 
the page) MPFC was attempted but the injection was too lateral and subtle changes were 
instead found in the lateral aspect of the prelimbic cortex (PrL) and into the forceps minor 
of the corpus callosum (fmi). 
3.4.2 Foregut analysis 
Foregut sample analysis was performed in all pups that had undergone either shams or 
MPFC lesions, unilateral or bilateral. Samples of the foregut of IC lesioned animals were 
taken but not examined. This was due to the finding above that following the GE studies and 
brain analysis it was clear that although animals with unilateral or bilateral IC lesions did 
demonstrate poor weight gain and poor gastric emptying the brain lesions were not easily 
identifiable; nor reproducible. The MPFC injections, however, were more reliable and this 
group demonstrated poor weight gain which despite small numbers was approaching 
statistical significance. The bilateral MPFC group were also the only group on GE studies to 
show evidence of possible gastro-oesophageal reflux. These results, therefore, ruled out IC 
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lesions as our potential CP model and we began to focus on the unilateral and bilateral 
MPFC lesions compared to shams. As previously described in chapter 2 the analysis of the 
foregut samples involved 3 stages. The first was a “spot the difference” analysis by the 
author of all four foregut samples i.e. the distal oesophagus, the midpoint of the greater 
curvature of the stomach, the antrum and the second part of the duodenum, comparing the 
shams to the IBA MPFC lesioned animals. This initial spot the difference showed no obvious 
difference between the shams and IBA lesioned animals in terms of the proximal three 
samples i.e. oesophagus, greater curvature or antrum. This is illustrated in table 8. 
In the spot the difference analysis looking at the different gastric specimens it was difficult to 
appreciate any consistent differences between gastric biopsies from different groups. This was 
also made more difficult because in the rat the stomach may be divided into two main regions: 
the forestomach, a non-glandular region lined by stratified squamous epithelium, and the 
glandular stomach. In retrospect, the junction between the two i.e. the midpoint of the greater 
curvature of the stomach was not the ideal sample site, but comparison of the oesophageal and 
antral specimens also showed no appreciable difference between the groups. This is again 
illustrated by examples of such specimens in table 7. It was a different story, however, with the 
duodenal specimens as these looked quite different between the three groups. In stage 2 of the 
histological analysis i.e. the blinded analysis, the two pathologists labelled 6 samples as 
showing significant change and these correlated with 5 out of 6 samples that had come from the 
bilateral MPFC group i.e. our CP model. This was encouraging and so we decided to score the 
duodenal specimens from the unilateral and bilateral MPFC lesioned animals and shams using 
the scoring tool described in chapter 2. The villi height and width were measured as a more 
quantitative assessment of villous blunting and atrophy, a feature seen often particularly in any 
cases were there has been damage to the villous enterocytes. The number of villi was counted as 
a way of calculating the percentage of bifid or fused villi, a potential marker of inflammation or 
disordered architecture. Lamina propria width and intercrypt distance were measured as a 
means of quantifying any difference in the presence of oedema. Crypt height was measured in 
an attempt to identify any proliferative response occurring in these animals. We hypothesised 
that the thickness of the muscularis may be different owing to the fact that we’ve shown these 
same animals have delayed GET and so we measured this and similarly we counted the number 
of neurons in the myenteric and submucosal plexus. We also counted the number of eosinophils 
and the number of lymphocytes in the epithelium and in the lamina propria per 50 enterocytes. 
Table 9 shows the results of the analysis in descending order of significance starting with the 
most significant finding first. From these results, it can be seen that villous width and height and 
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thickness of the submucosa were all significantly increased in our CP model i.e. bilateral MPFC 
injection. Other result comparisons that were approaching significance included decreased 
number of submucosal neurons and increased number of bifid villi. In addition, the thickness of 
the longitudinal muscle was raised as was the number of eosinophils but this was not 
significant. There was no change was seen in the total number of neurons and lastly there was 
no difference in total thickness of the muscularis contrary to what we had anticipated. 
In summary, our foregut analysis has revealed that although there no obvious differences 
between our proposed CP model and shams in terms of oesophagus or stomach specimens 
there was a difference between the duodenal specimens. On further more in detail analysis 
this involved a significant difference in villous architecture as well as a decreased number 
of submucosal neurons and an increased number of bifid villi. 
Table 8. Table of microphotographs of HE Slides comparing foregut biopsies 
between unilateral and bilateral IBA MPFC lesioned animals and shams. 
 Sham Unilateral MPFC Bilateral MPFC 
Oesophageal 
specimen 
   
Greater 
Curvature 
specimen 
   
Antral 
specimen 
   
Duodenal 
specimen 
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Table 9. Comparative histological scoring of duodenal specimens only between 
the three groups: shams, unilateral MPFC injection and bilateral MPFC injection i.e. 
CP model 
Median Sham 
Unilateral MPFC 
Brain injection 
Bilateral MPFC 
Brain Injection (CP model) 
Villous width (µm) 109.9 
(86.1-135.8) 
125.5 
(97.3- 158.5) 
p=0.24 
133.1. 
(109.7-204.5) 
p=0.03 
Villous height (µm) 388.9 
(314.7-496.8) 
551.2 
(342.8-601.6) 
p=0.06 
500.4 
(429.5-576.3) 
p=0.04 
Thickness of submucosa 
(µm) 
49.1 
(24.9-56.2) 
66.1 
(60.4-87.5) 
p=0.002 
72.8 
(49.7-104.1) 
p=0.02 
No. of submucosal 
neurons per x40 FOV 
3.1 
(2.1-5.2) 
3.2 
(1.6-5) 
p=0.69 
 
2.1 
(0.9-3.5) 
p=0.06 
No. of lymphocytes in 
Lamina Propria per 50 
enterocytes 
8.5 
(5-24) 
9.0 
(1-12) 
p>0.99 
6.0 
(5.0-7.0) 
p=0.08 
Intercrypt distance (m) 52.2 
(40.4-69.9) 
134.4 
(43.2-214.1) 
p==0.06 
59.9 
(50.3-77.8) 
p=0.09 
Total number of 
lymphocytes per 50 
enterocytes 
19 
(10-32) 
14.5 
(3-26) 
p= 0.52 
8.5 
(5-21) 
p= 0.10 
% Bifid Villi 6.9 5.0 
p=0.39 
10.2 
p=0.1 
Outer longitudinal (m) 30.0 
(21.1-53.9) 
23.0 
(12.9-33.4) 
p=0.13 
43.3 
(22.3-48.9) 
p=0.13 
No. of myenteric neurons 
per x40 FOV 
2.4 
(1.25-3.8) 
1.3 
(0.8-1.3) 
p=0.06 
1.5 
(0.6-2.6) 
p=0.14 
Width of lamina propria 
(m) 
37.8 
(33.5-46.5) 
45.4 
(28.2-108.2) 
p=0.24 
46.2 
(36.1-94.1) 
p=0.18 
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Median Sham 
Unilateral MPFC 
Brain injection 
Bilateral MPFC 
Brain Injection (CP model) 
Total number of 
eosinophils* 
7.5 
(4-12) 
6.5 
(4-10) 
p=0.47 
11.0 
(5-16) 
p=0.22 
No. of epithelial 
lymphocytes* 
8.0 
(5-18 
6.5 
(2-14) 
p=0.37 
4.5 
(1-14) 
p=0.22 
Total no. of neurons per 
x40 (FOV) 
5.25 
(4.0-9.0) 
4.25 
(2.4-6.4) 
p=0.26 
4.15 
(2.9-8.74) 
p=0.24 
No. of Epithelial 
eosinophils* 
0.5 
(0-6) 
1.0 
(0-6) 
p>0.99 
2.5 
(1-9) 
p=0.29 
No. of eosinophils in 
Lamina propria* 
7.5 
(0-14) 
4.5 
(3-8) 
p=0.57 
9.0 
(1-10) 
p=0.29 
Crypt height 
(m) 
189.2 
(129.1-284.4) 
187.7 
(140.1-245.3) 
p=0.93 
213.9 
(141.9-283.0) 
p=0.59 
Inner circular 
(m) 
65.5 
(55.8-90.6) 
52.2 
(26.3-79.8) 
p=0.13 
62.1 
(49.1-80.9) 
p=0.59 
Total thickness of 
muscularis (m) 
* = per 50 enterocytes 
101.3 
(85.6-142.2) 
74.2 
(43.4-116.1) 
p=0.13 
108.4 
(60.6-133.9) 
p=0.87 
 
3.5 Immunohistochemistry 
Following the results described above, in terms of our analysis of foregut biopsies, we 
elected to perform immunohistochemistry comparing specimens from our sham animals to 
those animals that had undergone bilateral MPFC IBA injections as it was becoming clear 
from our ongoing assessment that this was now the brain lesion site and technique that was 
becoming the focus of our proposed CP model. What also became clear during both the HE 
analysis and the initial IHC studies was that the most obvious differences in the foregut 
specimens was in the duodenum and so whilst IHC was performed on all specimens for 
anti-human CD117 subsequently IHC for the remaining three antibodies: anti-iNOS, anti-
ChAT and anti- jagged 1 was only performed on the duodenal specimens. 
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3.5.1 Anti-Human CD117 
The interstitial cells of Cajal (ICC) are now known to be the pacemaker cells of the 
foregut, hence they were top of our list in terms of investigating whether these cells show 
any difference in expression in our CP model which we have demonstrated to have altered 
foregut motility. When examining and reporting numbers of ICC it is important to use the 
correct nomenclature and to realise that the different subsets of ICC are expressed 
differently throughout the GI tract and that this can vary between species. An example of 
this is that it is widely recognised that expression of ICC varies throughout the different 
regions of the stomach e.g. the fundus is different to the pylorus, but the small bowel and 
colon are much more predictable. This is certainly something we confirmed when looking 
at our specimens as it was often particularly difficult to distinguish ICCs in the oesophagus 
and stomach whereas they were much easier to identify in the duodenal specimens. This is 
demonstrated in table 10. To clarify for the purposes of this thesis we are adopting a 
similar nomenclature as described by Hanani et al. (Hanani, Farrugia, & Komuro, 2005; 
Komuro, 2006). Therefore, ICC-SMP and ICC-SM refers to the ICC found between the 
submucosa and circular muscle layer in the colon and gastric pylorus, respectively and 
ICC-DMP equates to the deep muscular plexus located between the inner and outer 
circular muscle in the duodenum and ICC-CM and ICC-LM are found within the circular 
and longitudinal muscle layers, respectively. Lastly ICC-MPs are those found in the 
myenteric plexus between the circular and longitudinal muscle layers. As described in 
chapter 2, 1x 1cm biopsies were taken from the second part of the duodenum and the 
specimens were stained with anti-c-kit (CD117) to examine for the presence of interstitial 
cells of Cajal. As shown in table 9 the deep muscular plexus interstitial cells of Cajal 
(DMP-ICC) were more readily identifiable in the duodenal specimens and it is the author’s 
interpretation that this equates to the human submucosal plexus rather than myenteric 
plexus. Therefore, as this was the only population of ICC that was consistently seen only 
this population was counted. The numbers of DMP-ICCs were counted along the length of 
the specimen and were recorded as the number of cells per x40 field of view seen and was 
compared to the numbers seen and counted in the pups that had undergone sham injections. 
Specimens were analysed from 12 rat pups: 6 that had undergone bilateral MPFC 
injections (our CP model) and 6 had undergone sham injections. 
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Table 10. Table of microphotographs showing anti – CD117 IHC. All four sites of 
foregut specimens are shown comparing the two groups. (    = deep muscular plexus 
interstitial cells of Cajal) 
 Sham CP model 
Oesophagus 
  
Greater 
curvature 
  
Antrum 
  
Duodenum 
  
 
The median number of DMP-ICC per x40 FOV was 2.7 (1.4-4.3) in the sham animals 
compared to 2.0 (1.36-2.45) in the CP group (p=0.04). This, therefore, indicates a 
reduction in the number and organisation of the DMP-ICC. This is an important finding as 
we have shown that out CP model shows significantly reduced numbers of a subpopulation 
of interstitial cells of Cajal compared to shams. 
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3.5.2 Anti-iNOS antibody staining 
Nitric oxide (NO) is essential for normal foregut motility, interacting with both the smooth 
muscle of the foregut and the ICC network described above. It is present in different forms 
including inducible nitric oxide and this is produced through a pathway involving the 
enzyme inducible nitric oxide synthase or iNOS. This antibody therefore targets this enzyme 
and therefore, highlights the presence of NO in the tissues, in this case the duodenum. Six 
specimens of duodenum from each of the two groups were analysed for the presence of 
iNOS. It was not possible to blind the author to which specimens were from which cohort 
and so the digitalised slides were analysed using ImageJ’s IHC tool to quantify objectively 
the area fraction stained with the antibody. This is a standard method of calculating the 
percentage pixel stained with the antibody i.e. brown staining in a standard x10 field of view 
allowing statistical comparison between slides. The results are shown in Table 11. 
On comparing these values by means of an unpaired t test there was a significant 
difference in the level of staining between the two groups. The mean percentage pixels 
stained was 5.360 ± 0.8480 N=6 in the sham group compared to 0.5867 ± 0.2052 N=6 in 
the CP model group (p=0.0003). Therefore, there was a significantly reduced expression of 
iNOS in the CP model group. 
  
 Sham  CP model 
Figure 33. Comparison of duodenal specimens staining for the anti-iNOS antibody. 
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These examples show a typical reduced expression in the specimens from the bilateral IBA 
injections group i.e. our CP model compared to shams. 
This a comparison between the two groups: those that had undergone sham brain injections 
with normal saline and those that undergone bilateral MPFC IBA injections i.e. our CP 
model. The “%pixels” is the percentage of pixels stained in a standard x10 FOV (field of 
view). 
Table 11. Results of IHC analysis comparing levels of staining for anti-iNOS 
antibody. 
Sham  CP model  
Area fraction stained (µm) %pixels Area fraction stained (µm) % pixels 
158536 5.04 5244 0.17 
92464 2.94 1049 0.03 
173051 5.5 41135 1.31 
270209 8.59 32813 1.04 
109106 3.47 16531 0.53 
208232 6.62 14706 0.47 
 
3.5.3 Anti– ChAT antibody staining 
As described in chapter 1 NO is not the only substance at play and acetylcholinesterase 
(ChAT) has also been shown to be important in foregut motility in a number of ways. 
ChAT interacts with both the vagus nerve and enteric neurons as well as intestinal 
macrophages. (Cailotto et al., 2014) Immunohistochemistry was therefore performed using 
the antibody anti-ChAT on duodenal specimens from the bilateral MPFC IBA group 
compared to shams. Six duodenal specimens were compared from each group. As stated 
previously it was not possible to blind the author to which specimens were from which 
cohort and so the digitalised slides were analysed using ImageJ’s IHC tool to quantify 
objectively the area fraction stained with the antibody. Figure 34 shows an example of a 
comparison between a sham duodenal specimen and a specimen from our proposed CP 
model. In this example, there appeared to be a subjective increase in the staining for anti-
ChAT in the submucosal plexus, however, on reviewing all 12 specimens it was evident 
that the staining for anti-ChAT antibody was not consistent throughout the length of the 
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specimen in some specimens compared to others. It is unclear why this was the case and 
different concentrations of the antibody were tried with no real change in outcome. The 
ImageJ DAB analysis was undertaken nonetheless in exactly the same manner as for anti-
iNOS. The results are shown in Table 12. On comparing these values by means of an 
unpaired t test there was no significant difference in the level of staining between the two 
groups. The mean percentage pixels stained was 3.272% ± 0.8129% in the sham group 
compared to 4.04% ± 0.9391% in the CP model group (p=0.55). Therefore, there was no 
significant difference between the expression of ChAT in either group. 
  
 Sham  CP model 
Figure 34. Comparison of duodenal specimens stained with anti-ChAT. 
This shows an apparent increased staining in the submucosal plexus of the CP model 
compared to that of the Sham. 
This is a comparison between the two groups: those that had undergone sham brain 
injections with normal saline and those that undergone bilateral MPFC IBA injections i.e. 
our CP model. The “%pixels” is the percentage of pixels stained in a standard x10 FOV 
(field of view). 
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Table 12. Results of IHC analysis comparing levels of staining for anti-ChAT 
antibody. 
Sham  CP model  
Area fraction stained (µm) %pixels Area fraction stained (µm) % pixels 
106750 3.39 25008 0.8 
220838 7.02 95899 3.05 
97515 3.1 219191 6.97 
81067 2.57 82957 2.63 
75029 2.39 150549 4.79 
36520 1.16 188850 6 
 
3.5.4 Anti- Jagged 1 antibody staining 
The final antibody examined was anti-jagged1. The reason for looking at this particular 
antibody was in response to the changes in villous architecture noted between the sham 
group and the CP model. Jagged 1is a cell surface protein or ligand involved in the notch 
signalling pathway which is a pathway crucial in making decisions on the fate of cells in 
many different organs throughout the body. Jagged 1 was examined because the Jagged-
1/Notch-1/Hes-1 pathway has been shown to be involved in intestinal adaptation post small 
bowel resection (G. Chen et al., 2013) and in the development and maintenance of normal 
villous architecture. (Sander et al., 2003; Sander & Powell, 2004) we only performed 
Jagged 1 analysis in our duodenal biopsies as we were specifically looking to see if we 
could relate the changes seen in villous architecture to the level of expression of Jagged 1. 
To assess this, we compared IHC for anti-Jagged 1 in duodenal biopsies from our CP 
model compared to shams. 
Unlike the anti-ChAT IHC the anti-Jagged 1 results were similar to the anti-iNOS in that 
even before the ImageJ DAB analysis was undertaken it was clear that there was a 
difference in expression between the two groups and as expected the expression of Jagged1 
was clearly increased in the CP model group compared to the sham group. This is 
illustrated in Figure 35. The ImageJ DAB analysis was undertaken and the results are 
shown in Table 13. On comparing these values by means of an unpaired t test there was a 
significant difference in the level of staining between the two groups. The mean percentage 
pixels stained was 13.40% ± 1.652% in the sham group compared to 5.442% ± 2.260% in 
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the CP model group (p=0.0174). This is an important finding as we have demonstrated a 
significant increase in Jagged1 expression in the CP model group compared to shams 
possibly pointing to a mechanistic pathway for the changes in villous architecture we have 
seen. 
  
 Sham CP model 
Figure 35. Comparison of duodenal specimens stained with anti-Jagged1. 
This is an example showing increased staining of the CP model specimen compared to that 
of the sham specimen. 
The two groups were those that had undergone sham brain injections with normal saline 
and those that undergone bilateral MPFC IBA injections i.e. our CP model. The “%pixels” 
is the percentage of pixels stained in a standard x10 FOV (field of view). 
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Table 13. Results of IHC analysis comparing levels of staining for anti-Jagged1 
antibody between the two groups. 
Sham  CP model  
Area fraction stained (µm) %pixels Area fraction stained (µm) % pixels 
261031 8.3 27609 0.88 
321851 10.23 11234 0.36 
488851 15.54 434027 13.8 
589083 18.73 303193 9.64 
355703 11.31 210640 6.71 
513042 16.31 39661 1.26 
 
3.6 Discussion 
3.6.1 Choice of animal model 
Sprague-Dawley rats were chosen for our animal model as they are easy to source and care 
for and we were endeavouring to create a new model based on a previous rodent model 
which created similar lesions in the motor cortex. (A. Chen et al., 2008) This work showed 
that the model was well-tolerated by the neonatal rat pups and reproducible, it also 
illustrated that chemically induced lesions created by injecting the neurotoxin ibotenic acid 
into the motor cortex on postnatal day 5 to 7 (P5-7) in the rat were functionally and 
histologically similar to PVL. This model did not target any other cortical regions other 
than the motor cortex but could easily be adapted to target areas in the brain now known to 
be responsible for autonomic gastrointestinal control i.e. MPFC and IC. Rodents have been 
used as experimental models in anatomical research for many years especially in research 
focusing on the brain because so much is now known with regards to the rat brain as 
outlined by the Paxinos Rat Brain Atlas. (Paxinos, G., and Watson, C. (1996). The Rat 
Brain in Stereotaxic Coordinates, Compact 3rd Edition CDRom, Academic Press, San 
Diego.) It provides a stereotactic map as to how to target different regions in the brain and 
also show similarities between the brain of a rodent and that of a human. It could be 
argued, however, that although the Sprague Dawley rats provided a resilient animal model 
the neonatal pups were very small and can vary greatly in size depending on litter size. The 
small size of the neonatal rat pups (typically 15g at craniotomy) did make performing 
craniotomy and brain injections a challenge despite this the Paxinos coordinates were very 
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helpful especially when trying to target the MPFC. The atlas is, however, for adult rat pups 
not neonates and so the more lateral IC area was in retrospect always going to more 
difficult to inject successfully. We did consider using a larger model such as a pig; 
however, it was felt on advice from our NVS that creating a piglet with cerebral palsy may 
result in a large aggressive animal that was difficult to care for. 
Other animal models of cerebral palsy have been studied in the past including those that 
induce antenatal or postnatal ischaemia by techniques such as endovascular balloon 
occlusion of blood supply to the placenta or ligation of the carotid artery (Jensen, Follett, 
Uehara, Mallard, Johnston) or maternal or foetal antenatal hypoxia (Baud et al., 2004; 
Mallard et al., 2003) or a combination of carotid ligation and hypoxia (Sheldon et al., 
1996) (McQuillen et al., 2003) or chemical lesions to the brain (Tahraoui et al., 2001). 
Rodent models resulting from either maternal or neonatal ischaemia often resulted in early 
death of offspring or rejection by the mother. In addition, because rodent brains are 
anatomically different and have less white matter larger animals have also been tried 
including sheep and baboons although these models are much more expensive. Most 
models have also tended to focus on the resulting motor deficit and there is to the author’s 
knowledge no pre-existing model of cerebral palsy and foregut dysmotility. The only paper 
that has linked brain damage to foregut dysfunction was from the Indiana group (Vane et 
al., 1982) which did link surgically induced brain damage in cats to decreased lower 
oesophageal sphincter pressure and possible gastro-oesophageal reflux. This paper did not, 
however, focus on creating brain damage akin to that seen in cerebral palsy instead it was 
brain injury caused by raising intracranial pressure (ICP) by means of a burr hole and a 
inserting and inflating a balloon catheter. At the same time lower oesophageal sphincter 
pressure was measured and these authors found that by increasing the cat’s ICP they 
lowered the LES both acutely and it remained low 2 and 6 weeks post procedure. There 
was, however, no measurement of effect on gastric emptying or foregut motility per se and 
the animal’s brains were not examined at the end of the study to confirm what if any brain 
damage had been created. To the author’s knowledge, our chosen model is the first of its 
kind focusing on cerebral palsy and foregut dysmotility. 
3.6.2 Method of investigation of gastric emptying 
The gold standard for measuring gastric emptying is scintigraphy. This was not an option 
in our study as we did not have access to nuclear medicine equipment such as isotopes and 
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a gamma camera that would be suitable to study such small animals. Manometry and 
impedance would also have been interesting to study in our model, but again we did not 
have such equipment for such small animals available to try and to purchase would have 
been expensive. These are both investigations that perhaps in the future could be 
considered. The water soluble upper gastrointestinal (GI) contrast series can provide a 
crude and relatively easy way of measuring gastric emptying time (GET). There are many 
different methods of assessing gastric emptying in rodents. The majority, however, involve 
sacrificing the animal to assess gastric emptying. (Ito et al., 1996; Shoji et al., 1997; van 
der Velde et al., 1999) Such methods were not suitable for our purpose as the animals in 
our study needed to go on to have repeated gastric emptying studies i.e. before and after 
brain injection and before and after splanchnectomy for a prolonged period of study. There 
are, in fact few non-invasive techniques reported in freely-feeding animals. It has 
previously been shown that gastric emptying increases toward the end of the lactation 
period in rat pups. We decided to modify the barium grain method (Sakurai et al., 1996) 
and use water soluble contrast rather than barium grains, as done in routine clinical 
practice in children and babies. Gastric emptying time would therefore be the time when 
the stomach was full to completely empty on time lapsed X-rays in animals placed in X-
ray compatible plastic tubes. This would allow a non-invasive method of a water-soluble 
contrast meal in a conscious and prior to the study freely suckling pup and therefore a more 
reliable and “real” and useful method of assessing gastric emptying in pre-weaned rats. 
3.6.3 Histological brain lesions 
Identifying brain lesions that targeted the insular cortex (IC) proved difficult. This was 
most likely because there are no available stereotactic coordinates for neonatal rat pups and 
because the IC is more lateral in the rat brain. It is, therefore, possible that we did not 
manage to inject the correct area. Or it may be that due to its laterality the lesions were 
difficult to find histologically but were there. The latter is a possibility as it can be seen 
from our results that the rat pups that underwent unilateral or bilateral IC injections did 
show a difference in both their weight velocity and a delay in their gastric emptying on 
contrast studies. The other difference between the histological changes seen between 
MPFC and IC lesions is that not only were MPFC more consistently found on histological 
examination, but also MPFC lesions rather than showing just areas of cavitation seen in the 
IC lesions also showed decreased number of neurons and increased numbers of glial cells. 
This is a significant finding as there has been much focus recently in the literature in 
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relation to glial cells rather than neurons. Glial cells have now been referred to as the “the 
fulcrum of brain disease” (Giaume, Kirchhoff, Matute, Reichenbach, & Verkhratsky, 
2007). These cells appear to function in two ways but essentially act as fierce guardians of 
brain tissue in that they not only protect the brain tissue but they also act like natural killer 
cells endeavouring to wall off damaged areas essentially “to save the whole at the expense 
of the part”. This split personality of glial cells seems to be specifically seen when there 
has been an ischaemic brain injury like in preterm and perinatal ischaemia that can cause 
periventricular leukomalacia (PVL). PVL is thought to be the precursor of cerebral palsy 
and is typically characterised by diffuse injury of white matter surrounding the lateral 
ventricles often resulting in apparent ventricular dilatation as seen in those rats in our study 
that underwent MPFC injections. (Back & Rivkees, 2004) (Li et al., 2003; Li, Wang, & 
Rosenberg, 2009) These three features of PVL i.e. ventricular dilatation, white matter and 
neuronal loss and increased glial cells are not only seen in our MPFC lesioned group but 
were similar to the changes seen in the work by Chen et al. (A. Chen et al., 2008) Chen et 
al, unlike in our study, also immunostained for myelin basic protein (MBP) and non-
phosphorylated neurofilaments (NPNF) and showed that both of these were significantly 
reduced in the IBA lesioned group compared to controls. This is again perhaps something 
we could look at analysing in our brain lesions in the future. The Chen et al model, as 
stated previously, was focused on the motor cortex and was the CP model we were 
modifying in order to create a CP model with foregut dysmotility. These similar brain 
lesions in the MPFC were therefore encouraging and began to focus our efforts on the 
MPFC group as being our sought-after CP model. 
3.6.4 Gastric emptying studies after brain lesions 
Delayed gastric emptying was found in all animals with brain lesions with IBA regardless 
of whether lesions were later confirmed to be in the targeted cortical area or not. The 
difference in GET in each IBA group was statistically significant compared to shams as 
illustrated in table 7 and figure 25. Our proposed model of bilateral MPFC was only just 
statistically significant with a mean GET of 57.8 minutes compared to a mean of 46.8 
minutes in the sham group (p= 0.0496). The most significantly delayed GET was in the 
bilateral insular cortex group with a mean time of 67.1 minutes (p=0.0008). This result is 
difficult to interpret as numbers are small. An explanation could be that the IC injections 
were in the right place but that we were unable to locate them consistently on pathology. 
Our results have also shown a difference on the effect on GET depending on the side of the 
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brain injected. This raises the questions as to whether laterality is important or not, 
however, this may be particular to the rodent species as there are recognised differences 
between gender in some aspects of brain morphology (Paxinos, G., and Watson, C. (1996). 
The Rat Brain in Stereotaxic Coordinates, Compact 3rd Edition CDRom, Academic Press, 
San Diego.) It could be the case that this is due to bias as the numbers in this study are 
small and the difference may not be true if a further larger study were undertaken. It is, 
therefore, difficult to comment further on this. 
Another important finding that singled out the bilateral MPFC group as the forerunner for 
our CP model was that eighty-three percent of the pups with bilateral MPFC lesions 
showed reflux on the GET study. There has always been debate as to whether rodents are 
capable of reflux or not. It is well recognised that they do not vomit, but there is evidence 
in the literature rats are capable of demonstrating some degree of reflux. This relates to 
gavage induced reflux which is recognised phenomenon and is often encountered in the 
pharmaceutical industry (Damsch et al 2011, Damsch et al 2011) The reflux seen in the 
bilateral MPFC IBA group is not gavage related as all animals were gavaged with the same 
amount of contrast and using the same technique including the shams and the other types 
of IBA brain lesions. It was only those, although not all, who underwent bilateral MPFC 
IBA injections that demonstrated evidence of reflux on their contrast study. It should, 
however, also be borne in mind that, as in humans, contrast studies are not the best 
imaging modality to diagnose reflux. The same papers cited above by Damsch et al 
highlight examining nasal histology of rats as a further means of quantifying the presence 
of reflux. This is akin to examination of airways in children looking for lipid laden 
macrophages and other inflammatory changes as a way of diagnosing reflux. In the rat 
study they found evidence of inflammation and areas of necrosis. They also found food 
material within the inflammatory exudate indicating reflux and/or aspiration of stomach 
contents. We did not examine the nasal passages of our rats but certainly nasal histology is 
again something we could consider for future work on our model. 
3.6.5 Histological differences in duodenal specimens 
The differences seen in the duodenal specimens between the shams and unilateral and 
bilateral MPFC are interesting but probably raise more questions than answers in terms of 
their aetiology. It is difficult to know whether the histological changes contribute to or are 
a result of delayed gastric emptying. For example, the fact that the villi are larger and 
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wider in the bilateral MPFC IBA group is this part of the aetiology of delayed GET? Or 
maybe it is biologically significant due to increase absorptive ability due to the reduced 
motility? Other results that were approaching significance included decreased number of 
submucosal neurons and increased number of bifid villi. These comparisons would have 
become significant if we had had larger numbers in our study. The author concedes that 
counting neurons on HE slides is a fairly crude tool to look for neuronal changes and hence 
is why we went onto stain for anti-ChAT and anti- iNOS. The increased number of bifid 
villi is sometimes seen in an inflammatory process but one would expect that if this was 
purely an inflammatory response that the villi would be shorter and flattened and atrophic 
looking as seen in coeliac disease. Another finding that goes against the changes seen as 
being purely an inflammatory response is that the number of total number of lymphocytes 
per 50 enterocytes was in fact reduced 8.5 in the bilateral MPFC (CP model) group 
compared to 19 in the shams (p=0.10). Interestingly the total number of eosinophils per 50 
enterocytes was raised 11.0 in the CP model compared to 7.5 in the shams (p=0.22). This 
was not, however, a significant increase and is therefore difficult to comment further on. 
3.6.6 Reduction in number of duodenal Interstitial cells of Cajal 
Prior to discussing the duodenal ICC, it is worth mentioning that these cells were looked 
for in the rest of the foregut but could not be reliably identified in either the distal 
oesophagus or the stomach. Initially the author was concerned that what was identified in 
these specimens was faint and almost sporadic but on further examination of the literature 
it would appear that this is not uncommon. (Komuro, 2006). Perhaps in retrospect electron 
microscopy of such samples would have been more rewarding when searching for the ICC 
in these locations. When analysing the number of DMP-ICC cells found in the duodenum 
of our CP model compared to shams there appeared to be a reduction in the number and 
organisation of the DMP-ICC. The counting technique using ImageJ was checked by one 
of the vetinary pathologists and although appears real and statistically significant, it is 
important to point out that there were only 6 specimens of duodenum examined in the two 
groups and therefore numbers were small. It may be that a reduction in ICC is involved in 
the pathogenesis of impaired motility in patients with cerebral palsy or it may be in 
response to delayed gastric emptying. There is also some work in the literature supporting 
the idea that ICC can apparently reduce in number because of damage to their networks in 
response to inflammation. Bettolli et al showed this very elegantly in their paper that in 
patients with appendicitis compared to controls the networks of ICC are damaged and 
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difficult to see, but are still present when examined by means of electron microscopy. 
(Bettolli et al., 2012) They also showed that this damage is temporary as they also 
examined appendices from those patients undergoing interval appendicectomy i.e. 
appendicectomy following a prolonged course of antibiotics and such damage was not 
seen. It may be that the apparent reduction we have seen was in response to gastric 
emptying rather than the cause and it difficult to comment on this when ICC cells could not 
be reliably identified in the antral specimens. In addition to perhaps in the future 
conducting electron microscopy it would also be worth examining specimens from animals 
allowed to survive even longer post operatively. In phase 1 rats were sacrificed on day 28 
of study and it would be worth seeing if the animals were allowed to live for longer 
following their brain injection whether indeed the gastric emptying time might return to 
nearer normal but also whether the duodenal changes we have seen including numbers of 
ICC also return to normal or show some signs of recovery. 
3.7 Further immunohistochemistry analysis 
There is currently much controversy amongst researchers as to what is the best way to 
quantify differences in staining of specimens and immunohistochemistry (IHC) in a 
meaningful and consistent way. Even the experienced and blinded research pathologists 
can differ in the opinion of intensity of staining and inter-observer variability can be a 
difficult hurdle to overcome. Hence, in recent years, technology has been used to try to 
combat this with the advent and popularity of programmes such as ImageJ. (Jensen et al., 
1994; Varghese, Bukhari, Malhotra, & De, 2014) (Rizzardi et al., 2012) Whilst some 
papers endorse this type of analysis there are authors who are of the opinion that such 
analysis is not recommended as antigen-antibody reactions are not what is referred to as 
stoichiometric i.e. the “brownness of the stain” does not necessarily reflect the level of 
reaction between the tissue and the antibody. Given that the author is not a pathologist and 
there was not time for blinding of a pathologist to examine IHC by a traditional scoring 
method, it was felt that using the ImageJ IHC toolbox was the most reliable method to aid 
comparison between specimens from the two groups. 
3.7.1 Anti- iNOS staining 
The gut is a major source of NO and is made by the conversion of L-arginine to L-
citrulline and NO. This conversion by oxidation is catalysed by on three forms of the 
enzyme nitric oxide synthase (NOS). It is felt that levels of different types of NOS reflects 
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the amount of NO in the tissues. The predominant form in the enteric nervous system is 
nNOS (neuronal nitric oxide synthase) and studies have shown a reduction in nNOS in 
mice can lead to increased relaxation of the lower oesophageal sphincter (LOS) and 
gastroparesis. (Mashimo & Goyal, 1999). Several studies have shown a relationship 
between gut dysfunction and inhibition or low levels of NO for example in conditions such 
as pyloric stenosis (Vanderwinden, Mailleux, Schiffmann, Vanderhaeghen, & De Laet, 
1992), Hirchsprungs disease (Larsson et al., 1995) and achalasia (Mearin et al., 1993). We 
did not examine nNOS, which perhaps in retrospect we should have, but we have shown a 
clear reduction in the iNOS expression in the duodenum of our proposed CP model. The 
reason we chose to examine iNOS was that it is known to be found in epithelial cells and 
neurons and also it is known to remain activated for longer and result in more NO 
production than perhaps the other isoforms making it possibly easier to identify in our 
specimens. The reduction we have seen in our CP model may be explained by impaired 
motility, but it is also known that iNOS is produced in disease states often as a response to 
inflammation and its production is affected by bacterial pathogens, inflammatory cytokines 
and macrophages.(Han, Fink, Yang, & Delude, 2004) Indeed, there is much work ongoing 
to attempt to pharmacologically reduce iNOS so as to create a further anti-inflammatory 
agent. (Chiou, Chen, & Lin, 2000) Therefore, it could be argued, that the significant 
reduction in iNOS in our model compared to the sham specimens further supports the 
theory that the microscopic changes we have seen in villous architecture are not related to 
an inflammatory process but to the pathogenesis of impaired gastric emptying and 
dysmotility. It would be prudent therefore, that further study of our model would include 
assessment of nNOS levels rather than just iNOS. The results of this particular antibody 
whilst interesting and clearly different between the two groups may raise more questions 
than answers as to why we are seeing the changes we have seen in our CP duodenal 
specimens. 
3.7.2 Anti- ChAT staining 
Despite some specimens that appeared to have increased staining or expression of ChAT in 
the submucosal plexus the overall quantitative comparison revealed no appreciable 
difference between the two groups. There also appeared to asymmetrical and inconsistent 
staining at times in the anti-ChAT specimens which is difficult to explain as all IHC 
protocols were standardised and followed as such. It maybe that there was a problem with 
poor fixation of the tissue at the time of the specimen retrieval, but either way it is 
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disappointing that no real conclusions could be made despite trying different 
concentrations. We had expected that the level of ChAT may be raised in our CP model 
bowel specimens, as we commonly see in Hirschsprungs disease, but perhaps further study 
of this antibody and our CP model may be more productive in the future. 
3.7.3 Anti-jagged 1 
Finally, anti-jagged 1 was our last antibody examined as it was singled out due to the 
observation of deranged villous architecture in the duodenum of our CP model. Previous 
studies have highlighted the importance of the notch pathway and Jagged1 in the general 
homeostasis of the adult gut. (Sander et al., 2003; Sander & Powell, 2004) 
Immunochemistry and subsequent analysis of our duodenal specimens clearly showed an 
increased expression in our CP model. The possible reasons for this include a response to 
poor gastric emptying and the need for widened and taller villi to try to maximise 
absorptive capacity. On the other-hand it could be as a result of a failure in the 
notch/jagged1 pathway or possible derangement of a negative feedback mechanism and 
hence uncontrolled expression leading to poor maintenance of villi structure and function 
therefore leading to poor motility. There is also relatively recent evidence in the literature 
relating intestinal motility to the Notch pathway. Indeed, Jia et al showed for the first time 
that the pathway is involved in the enteric nervous system. They showed, however, the 
opposite finding to what we have seen in our CP model. Instead of increased jagged 1 
expression they found that in Hirschsprungs disease there was downregulation of Notch-1 
and Jagged-2 mRNA. (Jia, Zhang, Chen, Gao, & Wang, 2012) The Notch pathway has also 
been implicated along with other pathways such as Wnt and bone morphogenic 
protein/TGF- beta in the pathogenesis of irritable bowel syndrome. (Ratanasirintrawoot & 
Israsena, 2016) Many studies have described the Notch pathways important role in the 
development in the enteric nervous system and the differentiation of epithelial stem cells 
and normal gastric formation. (Le Guen, Marchal, Faure, & de Santa Barbara, 2015) 
(Faure, McKey, Sagnol, & de Santa Barbara, 2015; Okamura & Saga, 2008; Takashima et 
al., 2011; Theocharatos et al., 2013) The Notch pathway is closely linked with Hedgehog 
signalling and both are needed for normal enteric nervous development. (Liu & Ngan, 
2014) Perhaps the increased jagged1 expression we have found in the duodenal specimens 
of our CP model reflects an interruption and subsequent disorganisation of this signalling 
pathway which may be a factor in the impaired gastric emptying we have demonstrated. 
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3.7.4 Phase 1 summary 
In conclusion, at the end of phase 1 we have succeeded in achieving our first aim of 
creating a new model of cerebral palsy that demonstrates evidence of poor gastric 
emptying and foregut dysmotility. This CP model is created by injecting ibotenic acid 
bilaterally into the MPFC via midline craniotomy on postnatal day 5 to 7. We have 
demonstrated that we can create lesions in the brain similar to PVL with evidence of 
ventricular dilatation, neuronal loss and increased number of glial cells. We have also 
shown that when such lesions are created in the brain this results in delayed gastric 
emptying and an increased risk of gastro-oesophageal reflux. Lastly and importantly we 
have linked these lesions in the cortex of the brain to structural changes in the villous and 
crypt architecture in the foregut. Therefore, for the remainder of this thesis when referring 
to the CP model this will be synonymous with bilateral MPFC IBA injections. 
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Chapter 4 
Results – Phase 2 
As stated in chapter 1 the aim of phase 2 of the study was to perform splanchnectomys on 
our established CP model and find out if this improves gastric emptying and enteric 
motility. This will attempt to explain the clinical improvements we have seen in our small 
series of patients. It will also help confirm whether our thesis of an imbalance of the 
sympathetic and parasympathetic nerve supply to the bowel can be rectified by this simple 
procedure. We then plan to examine the animals functionally by means of further gastric 
emptying (GE) studies after splanchnectomy and also histologically by means of further 
foregut specimens similar to that discussed in chapter 3. As also mentioned in chapter 2, 
prior to splanchnectomy on live animals, cadaveric laparotomies on rodents were 
performed to not only practice the technique but to ensure that what we identified as the 
three branches of the splanchnic nerves was accurate. In these cadaveric laparotomies 
therefore the splanchnic nerves were resected and analysed histologically. The histological 
analysis, which was corroborated by our vetinary pathologist, showed three bundles of 
myelinated nerve fibres, supported by a fibrillary stroma (endoneurium) with scattered 
small blood vessels and surrounded by connective tissue sheath consistent with 
perineurium. It, therefore, importantly confirmed that what we were targeting was indeed 
the three branches of splanchnic nerves. 
4.1 Animals 
In phase 2 twenty-six pups were used in total, 14 female and 12 male. The median weight 
at the time of operation was 64grams (range 43-108.1 grams). As can be seen in the flow 
diagram (Fig.36) there were 13 pups in each group i.e. the CP model and the sham group. 
One animal died from a sham injection from post-operative apnoea and two animals, one 
from each group, died from bleeding from the suprarenal artery. This problem of bleeding 
from the suprarenal artery was encountered within the first few splanchnectomys and again 
much like the procedures in phase 1 of our study there was a learning curve and once we 
knew that the suprarenal artery lay so close to our dissection field then we subsequently 
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managed to avoid injuring it in future laparotomies. Of note it is important to point out that 
in both cases the bleeding was controlled but due to the small size of the animal and 
therefore its small circulating blood volume subsequent resuscitation attempts were futile. 
This, therefore, left us with 12 in the CP group and 11 in the sham group. 
 
Figure 36. Phase 2 Flow diagram 
Flow diagram showing the numbers of animals in each group and the animals lost both 
pre- and post splanchnectomy. 
4.2 Difference in weight velocity 
As stated in chapter 2 the pups in phase 2 of the study went through a timeline of GE study 
pre- and post splanchnectomy and were weighed regularly and their relative weight gain or 
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“weight velocity” was plotted. Figure 37 shows a graph comparing the weight velocity of 
the two groups. At first glance it would appear that there is no real difference between the 
two groups, however, in retrospect if we compare the two groups in terms of the mean 
weight at the start of the study i.e. on the day of brain injections (postnatal day 5) there is a 
significant difference. The sham group have a mean start weight of 12.45 grams (10.3-
14.3grams) compared to a mean start weight of 16.35grams (12.2-15.2grams) in the CP 
model group (p=0.013). This was not noticed at the time of the study but in retrospect was 
most likely due to a difference in random litter size and selection i.e. a small litter size in 
the CP model group resulting in larger offspring as opposed to the sham group. When 
comparing overall weight velocity over the course of phase 2 between the two groups then 
there is no appreciable difference. The mean weight velocity in the shams was 126.8 grams 
(106.2-142 grams) compared to 137.3 grams (108.1 -158.1 grams) in the CP model, 
p=0.272. 
 
Figure 37. Scatter XY graph showing weight velocity in phase 2. 
Graph showing the weight velocity of the two groups i.e. the shams and the CP model over 
the course of phase two of the study. There is no significant difference in overall weight 
velocity, but of note the shams were significantly smaller in retrospect but demonstrated 
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catch up growth compared to the CP group. As shown by the blue arrow splanchnectomy 
was performed mostly between day 20 and day 22. 
4.3 Gastric Emptying Studies 
As stated in chapter 2, in phase2 of our study gastric emptying (GE) studies were 
conducted according to a timeline. This was following brain injections and then pre- and 
post splanchnectomy. The purpose of repeated GE studies served to be two-fold. It was not 
only necessary to measure GE in the same cohort pre- and post splanchnectomy but also 
provided an opportunity to repeat and re-demonstrate what was shown in phase 1. This is 
essential so as to further corroborate our decision to adopt bilateral MPFC IBA injections 
as our cerebral palsy model by yet again demonstrating that a further group that have 
undergone this type of injection show delayed gastric emptying compared to controls. This 
is illustrated in Figure 38. The mean GE time in the CP model was 56.0 minutes compared 
to 42.18 in the controls or shams (p=0.0024). Both groups then underwent midline 
laparotomy and splanchnectomy. In the CP model group this reduced the GET from 56.9 
minutes to 39.25 minutes, Figure 39 (p= 0.0005). Then, interestingly, there is the other 
group that had undergone sham brain injections also underwent splanchnectomys and their 
GET also reduced significantly from 42.18 to 29.18 minutes (p=0.0045) Figure 40.  
The main message in this chapter is summed up in Figure 41. This shows our most 
important finding yet which is that the GET of the CP model after splanchnectomy was 
similar to the GET of the shams in phase 1. In other words, we have again proven that our 
CP model works i.e. injecting IBA into the MPFC bilaterally significantly delays GET.  In 
addition, we have shown that splanchnectomy returns this GET to near normal values. Our 
hypothesis was that the delay in GET was due to an imbalanced autonomic nervous system 
with sympathetic overdrive. Our results go a long way towards proving this as we have 
shown that by performing splanchnectomy we can “redress the balance”. 
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Figure 38. Graph confirming our CP model in phase 2. 
This graph shows that we have evidence of delayed gastric emptying time (GET) in the CP 
model compared to shams in phase 2 as first shown in phase 1 (chapter 3.) 
 
Figure 39. Graph showing splanchnectomy improves GET in our CP model. 
A graph showing that our CP model has a statistically significant improvement in gastric 
emptying time (GET) following unilateral splanchnectomy by means of midline 
laparotomy and division of the splanchnic nerves with diathermy. 
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Figure 40. Splanchnectomy on shams and effect on GET. 
This graph shows that not only was there a fall in the GET of the CP model but also when 
splanchnectomy was performed on sham animals i.e. those that had undergone a brain 
injection with normal saline rather than IBA, the GET fell significantly. 
 
Figure 41. Redressing the balance: GET of our CP model pre- and post-
splanchnectomy. Post splanchnectomy the values are comparable to the shams i.e. the 
GET has been brought back down to normal. 
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4.4 Histological analysis 
As stated in chapter 2, in phase 2 of the study histological analysis was not repeated on 
brain specimens, although these were stored they were not later analysed for time and 
monetary reasons. It was also because it was felt that phase 1 had shown that this lesion 
could be produced consistently and therefore, it was not necessary at this stage. Instead the 
histological analysis of phase 2 will focus on the foregut analysis of specimens taken post 
splanchnectomy. Duodenal specimens were examined using the same modified scoring 
tool as illustrated in chapters 2 and 3, from Day et al. (Day, Bilzer et al. 2008) As before 
the villi height and width were measured as a more quantitative assessment of villous 
blunting and atrophy, a feature seen often particularly in any cases were there has been 
damage to the villous enterocytes. The number of villi was counted as a way of calculating 
the percentage of bifid or fused villi, a potential marker of inflammation or disordered 
architecture. Lamina propria width and intercrypt distance were measured as a means of 
quantifying any difference in the presence of oedema. Crypt height was measured in an 
attempt to identify any proliferative response occurring in these animals. We hypothesised 
that the thickness of the muscularis may be different again owing to the fact that we’ve 
shown these same animals that had had delayed GET now have normal GET post 
splanchnectomy. We also measured this and similarly we counted the number of neurons 
in the myenteric and submucosal plexus. We also counted the number of eosinophils and 
the number of lymphocytes in the epithelium and in the lamina propria per 50 enterocytes. 
The main question we wanted to answer from this part of the analysis was whether some of 
the changes we reported in the duodenum of our CP model in chapter 3 e.g. increased 
villous width and height and thickness of the submucosa, decreased number of submucosal 
neurons and increased number of bifid villi, were still present or absent post 
splanchnectomy. Table 14 shows the results of the analysis and compares it to our previous 
CP model and sham results from phase 1 of the study. 
Initially, on reviewing the slides from the post splanchnectomy animals the so-called “spot 
the difference” analysis was interesting as it appeared that all the duodenal specimens 
appeared the same. There was no obvious difference between the previous shams from 
stage 1 and that some of changes seen in the duodenum in the CP model group appeared to 
have resolved. It can be seen, however, going down the table and through the different 
features that this was not necessarily the case. For example, at first glance the villous 
architecture looked like it may be more normal post splanchnectomy but then the villi 
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height and width measurements were more akin the to the CP model rather than the 
previous shams although it is important, as has already been stated, to point out that the 
post splanchnectomy animal was 16 weeks old at the endpoint of the study. Their bigger 
size may go some way to explain why the measurements and villous height and width were 
not similar to previous smaller sham or control animals but more like the pre-
splanchnectomy CP model. We had sham animals that underwent splanchnectomy but in 
retrospect it would have been better for comparison if we had had a further group of our 
CP model that underwent a sham laparotomy without splanchnectomy. This would have 
made this histological analysis easier.  
   
Sham CP model 
Pre splanchnectomy 
CP model 
Post splanchnectomy 
Figure 42. H&E of duodenal specimens in phase 2. 
Three microphotographs comparing the typical appearance of duodenal specimens from 
each of the three groups, the shams, the CP model and the CP model post splanchnectomy. 
It can be seen the sham and post splanchnectomy appearances look similar with normal 
looking villi compared to the CP model that had not undergone splanchnectomy. These 
specimens showed broader more bifid villi with more disordered villous architecture. 
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Table 14. Comparative histological scoring of duodenal specimens in phase 2. 
This was between the three groups: shams, CP model (bilateral MPFC IBA injections) pre- 
and post splanchnectomy. The results are displayed in the same order as in chapter 3 which 
showed the most significant differences between the shams and CP model first. It is 
important to point out that these are not the same animals pre- and post splanchnectomy. 
The sham and CP model data is take from phase 1 when the animals were 28 days of life at 
the time of cardiac perfusion but the post splanchnectomy animals were on study for longer 
and were 16 weeks of age and much bigger at the endpoint of the study. This difference in 
size and age will therefore make comparison difficult for some measurements. 
Median Sham CP model CP model post 
splanchnectomy 
Villous width (µm) 109.9 
(86.1-135.8) 
133.1. 
(109.7-204.5) 
p=0.03 
165.11 
(117.4-204.19) 
p=0.0007 
Villous height (µm) 388.9 
(314.7-496.8) 
500.4 
(429.5-576.3) 
p=0.04 
606.43 
(455.69 – 820.06 
p=0.0028 
Thickness of submucosa (µm) 49.1 
(24.9-56.2) 
72.8 
(49.7-104.1) 
p=0.02 
67.30 
(61.85-128.86) 
p=0.0028 
No. of submucosal neurons 
per x40 FOV 
3.1 
(2.1-5.2) 
2.1 
(0.9-3.5) 
p=0.06 
4.0 
(2-6) 
p=0.0193 
No. of lymphocytes in Lamina 
Propria per 50 enterocytes 
8.5 
(5-24) 
6.0 
(5.0-7.0) 
p=0.08 
10.0 
(5-28) 
p=0.2145 
Intercrypt distance 
(m) 
52.2 
(40.4-69.9) 
59.9 
(50.3-77.8) 
p=0.09 
39.29 
(14.73-91.66) 
p=0.0128 
Total number of lymphocytes 
per 50 enterocytes 
19 
(10-32) 
8.5 
(5-21) 
p= 0.10 
26.0 
(14-46) 
p=0.0854 
% Bifid Villi 6.9 10.2 
p=0.1 
 
3.1 
p=0.022 
Outer longitudinal muscle 
thickness(m) 
30.0 
(21.1-53.9) 
43.3 
(22.3-48.9) 
p=0.13 
44.799 
(21.14-84.054) 
p=0.0052 
 
Results – Phase 2  
120 
Median Sham CP model CP model post 
splanchnectomy 
No. of myenteric neurons per 
x40 FOV 
2.4 
(1.25-3.8) 
1.5 
(0.6-2.6) 
p=0.14 
2 
(1-4) 
p=0.579 
Width of lamina propria 
(m) 
37.8 
(33.5-46.5) 
46.2 
(36.1-94.1) 
p=0.18 
54.355 
(37.95-63.14) 
p=0.0096 
Total number of eosinophils* 7.5 
(4-12) 
11.0 
(5-16) 
p=0.22 
6.0 
(5-8) 
p=0.0366 
No. of epithelial lymphocytes* 8.0 
(5-18 
4.5 
(1-14) 
p=0.22 
7.0 
(6-11) 
p=0.776 
Total no. of neurons per x40 
(FOV) 
5.25 
(4.0-9.0) 
4.15 
(2.9-8.74) 
p=0.24 
6.5 
(5-8) 
p=0.514 
No. of Epithelial eosinophils* 0.5 
(0-6) 
2.5 
(1-9) 
p=0.29 
2.5 
(1-7) 
p=0.543 
No. of eosinophils in Lamina 
propria* 
7.5 
(0-14) 
9.0 
(1-10) 
p=0.29 
2.0 
(1-6) 
p=0.0847 
Crypt height 
(m) 
189.2 
(129.1-284.4) 
213.9 
(141.9-283.0) 
p=0.59 
192.02 
(133.66-328.33) 
p=0.637 
Inner circular muscle 
thickness (m) 
65.5 
(55.8-90.6) 
62.1 
(49.1-80.9) 
p=0.59 
62.24 
(32.31-144.03) 
p=0.989 
Total thickness of muscularis 
(m) 
* = per 50 enterocytes 
101.3 
(85.6-142.2) 
108.4 
(60.6-133.9) 
p=0.87 
105.42 
(55.07-195.54) 
p=0.813 
 
 
Although, there was some difficulty comparing measurements of structures such as villi 
and muscle because of difference in animal size, table 13 does show some potential 
differences in cell populations which may have been affected by splanchnectomy. For 
example, rather than a reduction in the number of submucosal neurons seen in a field of 
view (FOV) at magnification x40 as there was when we compared the CP model to shams 
there was in fact a statistically significant increase in numbers post splanchnectomy. The 
total number of lymphocytes also returned to a level similar to the shams and the total 
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number of eosinophils was significantly reduced. There was also a significant reduction in 
the number or overall percentage of bifid villi. This may suggest that the previous changes 
seen in our CP model may have had some inflammatory component but it is still not clear 
exactly what caused the changes seen previously some of which appear to be reversed post 
splanchnectomy. This is illustrated further in Figure 41 which shows a typical appearance 
of a sham duodenal specimen from phase 1, a CP model specimen and a CP model 
specimen post splanchnectomy. Much like in chapter 3 this histological analysis probably 
raised more questions than answers and hence why we elected to repeat the same 
immunohistochemistry post splanchnectomy to investigate and search for a reason why the 
appearance of the duodenum in our CP model has changed. 
4.5 Immunohistochemistry 
As described in chapter 3 it was difficult to appreciate histological differences between 
areas of the foregut other than the duodenum and as such in phase 2 immunohistochemistry 
studies were performed for the same four antibodies on all duodenal specimens taken post 
splanchnectomy. The first was anti-human CD117. As stated in chapter 3 we have already 
made the important discovery that the number of interstitial cells of Cajal or ICC is 
reduced in number in the deep muscular plexus in our CP model compared to shams. In 
this analysis, we wanted to investigate whether splanchnectomy affected the number of 
DMP-ICC and whether this was a possible explanation as to why the gastric emptying post 
splanchnectomy improved. Similarly, whether the expression of the remaining three 
antibodies: anti-iNOS, anti-ChAT and anti- jagged 1 were influenced by splanchnectomy 
in an attempt to further explain the mechanistic pathways which maybe at play in the 
improvements we have seen just clinically but also now in our animal model. 
4.5.1 Anti-Human CD117 
As described in chapter 2 and 3 this antibody allowed good visualisation of the interstitial 
cells of Cajal in the deep muscular plexus or DMP –ICC in the duodenum, which meant 
that the numbers of the cells could be counted along the length of the specimen and 
expressed per x40 FOV. Ten duodenal specimens were retrieved from rats, all of whom 
had undergone our CP model (bilateral MPFC IBA injections) and splanchnectomy. Figure 
42 illustrates the expression of these interstitial cells of Cajal in our CP model and then in 
our CP model post splanchnectomy. We found that in the post splanchnectomy group the 
median number of DMP-ICC per x40 FOV rose to 6.5 (2-16) compared to what we found 
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in phase 1 of our study where the median number of DMP-ICC per x40 FOV was 2.7 (1.4-
4.3) in the sham animals compared to 2.0 (1.36-2.45) in the CP group (p=0.04). This, 
therefore, indicates a substantial increase in the number and organisation of the DMP-ICC. 
In addition, throughout this analysis it was apparent although difficult to measure 
quantitatively that not only were the numbers of DMP-ICC increased, but importantly, they 
appeared more predictably and regularly as perhaps can be appreciated from the example 
in Figure 42. This may go some way to explain the significant improvement seen in our 
gastric emptying times in this group or again as mentioned above may be that the animals 
have had longer to recover from their surgery, which as mentioned in chapter 3 can be 
influenced by surgery and also may naturally increase in number over time in animals that 
are not only more mature but also bigger in size. 
 
Figure 43. Anti-Human CD117 pre- and post splanchnectomy. 
The figure above shows two microphotographs taken at x40 FOV showing cells stained a 
bronze/brown colour sitting deep to the submucosa. They are marked with a red arrow and 
in the CP model were found to be reduced and at times clumped together as shown above, 
however, in the CP model post splanchnectomy they were found more regularly and evenly 
spaced along this layer between the submucosa and the inner circular muscle. 
Results – Phase 2  
123 
4.5.2 Anti-iNOS antibody staining 
As discussed in all three preceding chapters, nitric oxide is one of the single most 
important compounds when it comes to normal intestinal motility. It is present in different 
forms including inducible nitric oxide and this is produced through a pathway involving 
the enzyme inducible nitric oxide synthase or iNOS. This antibody therefore targets this 
enzyme and therefore, highlights the presence of NO in the tissues, in this case the 
duodenum. Therefore, as before, six specimens were taken from the second part of the 
duodenum from animals that had undergone bilateral MPFC IBA injections (our CP 
model) and then subsequent splanchnectomy. These were then stained for anti-iNOS using 
the standard immunohistochemistry protocol discussed in chapter 2 and compared to area 
fraction stained of those that had undergone bilateral IBA MPFC injection only i.e. our CP 
model from phase 1. Figure 44 shows a typical example from each cohort. It was not 
possible to blind the author to which specimens were from which cohort and so the 
digitalised slides were analysed using ImageJ’s IHC tool to quantify objectively the area 
fraction stained with the antibody. The results are shown in Table 15. On comparing these 
values by means of an unpaired t test the difference between the means was -1.157 ± 
0.6579 (CI -0.3092 to 2.623), p=0.1092. These results would suggest that although we 
have shown in chapter3 that the level of iNOS was reduced in our CP model compared to 
shams, this level is not affected by splanchnectomy and therefore the improvement in 
gastric emptying time post splanchnectomy does not appear to be mediated by NO levels in 
the duodenum. 
  
CP model from phase 1 CP model post splanchnectomy 
Figure 44. Comparison of duodenal specimens pre- and post splanchnectomy. 
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The microphotographs in Figure 44 show the typical difference in staining for the anti-
iNOS antibody. Equivalent expression can be seen in the specimens from the bilateral IBA 
injections group i.e. our CP model and the CP model post splanchnectomy. 
This table shows analysis of staining for anti-iNOS between the two groups: our CP model 
(animals that had undergone bilateral MPFC IBA injections from phase 1) and the CP 
model that undergone splanchnectomy i.e. phase 2. The “%pixels” is the percentage of 
pixels stained in a standard x10 FOV (field of view). 
Table 15. Anti-iNOS antibody staining in phase 2. 
CP model 
(from phase1) 
 CP model post splanchnectomy 
(phase 2) 
 
Area fraction stained (µm) % pixels Area fraction stained (µm) % pixels 
5244 0.17 53492 1.7 
1049 0.03 6326 0.2 
41135 1.31 384743 1.23 
32813 1.04 9203 0.29 
16531 0.53 92713 2.95 
14706 0.47 128719 4.09 
 
4.5.3 Anti-ChAT antibody staining 
As described in chapter 3 acetylcholinesterase (ChAT) has been shown to be important in 
foregut motility in a number of ways. ChAT interacts with the vagus nerve and enteric 
neurons as well as intestinal macrophages. (Cailotto et al., 2014) When comparing sham 
animals compared to our CP model, no difference was found between the two groups in 
terms of the expression of the antibody. In phase 2 immunohistochemistry was performed 
using the antibody anti-ChAT on duodenal specimens from the bilateral MPFC IBA group 
(the CP model) post splanchnectomy from phase 1 compared to our CP model post 
splanchnectomy. Six duodenal specimens were compared from each group. As stated 
previously it was not possible to blind the author to which specimens were from which 
cohort and so the digitalised slides were analysed using ImageJ’s IHC tool to quantify 
objectively the area fraction stained with the antibody. Figure 44 shows an example of a 
comparison between the duodenal specimens from each group. Although there was no 
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difference found in ChAT expression in phase one we have shown that the animals post 
splanchnectomy do show a significant improvement in their gastric emptying time and 
therefore this stain was repeated to see if the ChAT pathway was involved in this 
functional improvement. The ImageJ DAB analysis was undertaken nonetheless in exactly 
the same manner as for anti-iNOS. The results are shown in Table 15. On comparing these 
values by means of an unpaired t test there was again no difference found in the level of 
staining between the two groups. The mean percentage pixels stained was 4.040 ± 
0.9391(N=6) in the CP model group compared to 4.803 ± 0.8553 (N=6) in the CP model 
post splanchnectomy group (p=0.56). From this we can conclude that in terms of the 
improvement in gastric emptying time seen post splanchnectomy this does not appear to be 
mediated by any difference in expression of ChAT. 
  
CP model from phase 1 CP model post splanchnectomy 
Figure 45. Comparison of duodenal specimens stained for anti-ChAT in phase 2. 
Microphotographs showing the typical appearances of staining for the anti-ChAT antibody 
showing equivalent expression in the specimens from the bilateral IBA injections group i.e. 
our CP model and the CP model post splanchnectomy. 
Table 16 shows the anit-ChAT staining analysis for the two groups: our CP model (animals 
that had undergone bilateral MPFC IBA injections from phase 1) and the CP model that 
undergone splanchnectomy i.e. phase 2. The “%pixels” is the percentage of pixels stained 
in a standard x10 FOV (field of view).  
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Table 16. Results of IHC analysis for anti-ChAT antibody in phase 2. 
CP model 
(from phase 1)  
CP model post splanchnectomy 
(phase 2)  
Area fraction stained (µm) % pixels Area fraction stained (µm) % pixels 
25008 0.8 189420 6.02 
95899 3.05 175313 5.57 
219191 6.97 144683 4.60 
82957 2.63 61759 1.96 
150549 4.79 93511 2.97 
188850 6 242027 7.70 
 
4.5.4 Anti-Jagged 1 antibody staining 
Jagged1is a cell surface protein or ligand involved in the notch signalling pathway which is 
a pathway crucial in making decisions on the fate of cells in many different organs 
throughout the body. Jagged 1 was examined because the Jagged-1/Notch-1/Hes-1 
pathway has been shown to be involved in intestinal adaptation post small bowel resection 
(G. Chen et al., 2013) and in the development and maintenance of normal villous 
architecture. (Sander et al., 2003; Sander & Powell, 2004). As in chapter 3 we only 
performed Jagged 1 analysis on our duodenal specimens as we were specifically looking to 
see if we could marry the changes seen in villous architecture to the level of expression of 
Jagged 1. In chapter 3 we found a significant increase in Jagged1 expression in the CP 
model group compared to the sham group corresponding to more deranged villous 
architecture compared to normal villous architecture in our control specimens taken from 
shams. Histologically, there appeared post splanchnectomy to be some return to normal 
villous architecture although this was difficult to quantify as the two groups were not 
comparable in terms of age or size at the endpoints of phase1 versus phase2 of the study 
when the foregut specimens were collected. It had been hoped therefore that anti-Jagged1 
antibody expression may clarify whether or not this pathway was involved in the 
improvements we have seen functionally and histologically post splanchnectomy. 
The ImageJ DAB analysis was undertaken nonetheless in exactly the same manner as for 
the other antibodies. The results are shown in Table 17. On comparing these values by 
means of an unpaired t test there was again no difference found in the level of staining 
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between the two groups. The mean percentage pixels stained was 5.442 ± 2.260 (N=6) in 
the CP model group compared to 6.892 ± 1.629 (N=6) in the CP model post 
splanchnectomy group (p=0.614). From this we can conclude that in terms of the 
improvement in gastric emptying time seen post splanchnectomy this does not appear to be 
related to any difference in levels of jagged 1 as these remain essentially the same in those 
animals sacrificed at 28 days post creation of our CP model and in those allowed to survive 
until 16 weeks that had underwent splanchnectomy. 
  
CP model from phase 1 CP model post splanchnectomy 
Figure 46. Comparison of duodenal specimens showing the typical staining for the 
anti-Jagged1 antibody in the specimens from our CP model post splanchnectomy 
compared to the phase 1 model that did not undergo splanchnectomy. 
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Table 17. Results of IHC analysis comparing levels of staining for anti-Jagged1 
antibody between the two groups: our CP model (animals that had undergone bilateral 
MPFC IBA injections from phase 1 and the CP model that undergone splanchnectomy i.e. 
Phase 2. The “%pixels” is the percentage of pixels stained in a standard x10 FOV (field of 
view).  
CP model 
(from phase 1)  
CP model post splanchnectomy 
(phase 2)  
Area fraction stained (µm) % pixels Area fraction stained (µm) % pixels 
27609 0.88 270388 8.95 
11234 0.36 90354 2.87 
434027 13.8 156533 4.98 
303193 9.64 87206 2.77 
210640 6.71 285487 9.07 
39661 1.26 399753 12.71 
 
Discussion 
4.6 Splanchnectomy method 
As mentioned previously our technique of splanchnectomy had some initial issues with 
bleeding and subsequent animal loss. This however, was at the start of performing the 
technique on live animals and despite practising on cadavers and ensuring as mentioned at 
the start of this chapter that we were indeed dividing the correct nerves, it still had a steep 
learning curve. Once the author realised how to avoid dissecting too close to the suprarenal 
artery the problems encountered with bleeding stopped. Another important consideration 
was that the splanchnectomy, as mentioned in chapter 2, were performed through an 
abdominal approach rather than through the thorax in humans. This was due to the 
variation in anatomy of the nerves in rodents compared to humans and was thought to be 
fortuitous as it was unlikely that such small animals would have tolerated and recovered so 
well from a thoracotomy versus laparotomy. Lastly, in terms of splanchnectomy technique 
this was unilateral rather than bilateral and the reason for this was two-fold. The first being 
that to attempt right sided splanchnectomy in such a small animal would have meant 
retracting and dissecting in close proximity to the liver which would have vastly increased 
the risk of bleeding and the subsequent rate of animal loss. Secondly and more importantly, 
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in the human literature, it has been widely reported that unilateral splanchnectomy is not 
only successful, but also less risky. For example, several papers have shown that left sided 
splanchnectomy alone is effective for controlling pain in patients with inoperable 
pancreatic cancer. (Lica, Jinescu, Pavelescu, & Beuran, 2014) (Leksowski, 2001; Masuda 
et al., 2014) 
4.7 Study design 
On reflection, there was one main issue with our study design. Instead of just having shams 
and our CP model undergo splanchnectomy it would have been more useful if we also had 
had a separate arm to the study with our CP model undergoing a “sham splanchnectomy”. 
At the time of designing the study it was felt to be appropriate so that the only difference 
between the two groups was the brain injection with neurotoxin, but a sham 
splanchnectomy would have meant that the histological evaluation would have been 
between two similar aged groups of animals e.g. in terms of measurements when looking at 
bowel specimens. This is an arm of the study which we could perhaps be included in future 
study of our model. 
4.8 Gastric emptying studies 
We had two main findings in phase 2 of our study, the first being that yet again, as in phase 
1, our CP model works. We have demonstrated that a further group of day 5-7 old neonatal 
rat pups that undergo bilateral MPFC IBA injections have delayed gastric emptying. 
Secondly, we have shown that unilateral splanchnectomy reverses this delay and brings 
gastric emptying time back to normal. This importantly reflects what we have seen in 
clinical practice and proves our hypothesis that the delay in gastric emptying in our CP 
model is a result of sympathetic overdrive and can be corrected. We have also shown that 
shams i.e. those that underwent normal saline injections into their MPFC had normal 
gastric emptying times, but this was further reduced following splanchnectomy. This is an 
interesting finding as it is not something we as paediatric surgeons have come across as we 
have not performed splanchnectomy on children who are otherwise well. As mentioned 
above splanchnectomy is performed in adult practice for patients with chronic pancreatitis 
or pancreatic malignancy as a means of controlling pain. On reviewing the literature, 
however, there are no reports to the authors knowledge of enhanced or prompter gastric 
emptying leading to symptoms in such patients and, therefore, this may indeed occur but 
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may not have been studied or reported before. It may simply be a reflection of the fact that 
regardless of the reason why splanchnic nerves are divided it decreases emptying time 
even if that GET was previously normal. We do not think this affects our finding that 
splanchnectomy improves GET in our CP model, other than being of academic interest the 
only other point this result adds is that we were consistent in dividing the splanchnic 
nerves regardless of the group of animals operated on. 
4.9 Histological changes post splanchnectomy 
When first reviewing the microscopic appearances of the foregut specimens in the post 
splanchnectomy group the appearance of taller wider more bifid villi seen in the original 
phase 1 CP model specimens seemed to improve. The specimens from the post 
splanchnectomy group looked more like the original sham specimens from phase 1. This, 
however, was difficult to quantify as measurements of the villous architecture were not 
comparable due to the animals different age and size as discussed above and also it is 
difficult to rule out that some of the improvements seen were simply related to the passage 
of time. It may be that if the original phase 1 CP model animals had been kept on study for 
longer i.e. that some of the histological changes may have been temporary and have 
disappeared with time. Two points, that go against this are that splanchnectomy not only 
improved the gastric emptying time of our CP model but also of our sham group, showing 
that its functional effect was real. Also, whilst the appearances of the villous architecture 
were difficult to quantify other histological changes were noteworthy post splanchnectomy 
for example a statistically significant increase in the number of submucosal neurons seen 
in a field of view (FOV) at magnification x40 when we compared duodenal specimens 
from the CP model post splanchnectomy model to the original shams. It could be argued 
therefore that the only possible mechanism we have found that could explain the 
improvement in gastric emptying time is an increase in submucosal neurons and increase 
and improved organisation in the number of deep muscular plexus interstitial cells of Cajal 
(DMP-ICC). Splanchnectomy also appeared to have an anti-inflammatory effect or some 
effect on the immune response seen in the foregut as the total number of lymphocytes also 
returned to a level similar to the shams and the total number of eosinophils was 
significantly reduced. There was also a significant reduction in the number or overall 
percentage of bifid villi. This may suggest that the previous changes seen in our CP model 
may have had some inflammatory component but it is still not clear exactly what caused 
the changes seen previously some of which appear to be reversed post splanchnectomy. 
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4.9.1 Immunohistochemistry post splanchnectomy 
As mentioned above there was no significant difference found in any of the three 
antibodies: iNOS, ChAT or jagged1 between the original CP model animals from phase 1 
and our CP model post splanchnectomy. The anti-human CD117, however, did show an 
increase in numbers of DMP-ICC and apparent increase in their regularity and organisation 
as shown in Figure 43. As discussed in chapter one several papers have shown that in 
biopsies from the antrum and pylorus of gastroparesis patients the numbers of ICC are 
reduced and there were also increased signs of inflammatory change. (Harberson et al., 
2010) Bashashati and McCallum 2015). This reduction in ICC numbers leading to 
intestinal dysfunction has now become known as “Cajalopathy”. It could be concluded 
from our findings that foregut dysmotility in our CP rodent model could indeed by part of 
the spectrum of “Cajalopathy”. This also something that has been recognised in post spinal 
cord injury patients who have neuropathic bowel and dysmotility and it is has been 
suggested that new treatments may be found by targeting various ion channels that smooth 
muscle and ICC cells rely on to function properly. New treatments could potentially then 
promote normal peristalsis.(Radulovic, Anand, Korsten, & Gong, 2015) It may be that a 
reduction in number and organisation of ICC is involved in the pathogenesis of impaired 
motility in patients with cerebral palsy and that splanchnectomy can reverse this. As 
already mentioned in chapter 3 we know that ICC networks are damaged in the presence of 
inflammation and that this effect is temporary. (Bettolli et al., 2012) We have shown that 
splanchnectomy appears to have an anti-inflammatory effect and that this may allow the 
ICC network to recover and allow gastric emptying times and foregut motility to improve 
and return to normal. 
4.9.2 Conclusions 
As stated in chapter one the aim of phase 2 of the study was two-fold. Firstly, to show that 
splanchnectomy performed on our now established animal CP model would improve 
gastric emptying and enteric motility. Secondly to attempt to explain the clinical 
improvements we have seen by examining the animals functionally after splanchnectomy 
and histologically. We have succeeded in completing both of these objectives. In chapter 3 
or phase 1 of the study we managed to link cortical lesions in the brain to functional and 
structural changes in the foregut. Whereas now we have gone one step further, and have 
shown that splanchnectomy can reverse the delay in gastric emptying time and also some 
of the histologically changes seen. 
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We have also shown that splanchnectomy improves the number and organisation of the 
interstitial cells of Cajal network in the deep muscular plexus of the duodenum previously 
found to be reduced in our CP model. In addition, we found that splanchnectomy increased 
the number of submucosal neurons and decreased the number of inflammatory cells in the 
duodenum. Further work is needed to explore the mechanistic pathways behind this. We 
hope further study of this model may provide greater insight into the pathogenesis of 
dysmotility associated with cerebral palsy and may help develop new treatments for this 
challenging group of patients. 
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Chapter 5 
Results – Phase 3 
As stated in chapter 1 the specific aim of this final phase of the study was to review a 
recent cohort of patients with CP who have known foregut dysmotility and to perform a 
retrograde analysis of archived human pathology specimens from these patients to see if 
we can identify any similarities histologically between these and our established animal CP 
model. As discussed in chapter 3 we found when establishing our CP model changes in the 
duodenum namely villous width and height and thickness of the submucosa were all 
significantly increased in our CP model i.e. bilateral MPFC IBA injection. Other results 
comparisons were approaching significance including decreased number of submucosal 
neurons and increased number of bifid villi. In addition, the thickness of the longitudinal 
muscle was raised as was the number of eosinophils but this was not significant. The 
question we wanted to try and answer in this chapter was: are such changes seen in clinical 
practice? It is important to state that duodenal biopsies are not routinely biopsied in such 
children, and when they are taken a prism such as the scoring tool described in chapter 2 
would not be implemented in the clinical setting; such in detail comparison is only really 
reserved for research purposes. 
5.1 Patient series 
Twenty-one patients were identified from the paediatric gastroenterology database of CP 
patients with known foregut dysmotility, eight female and thirteen male. Of the twenty-one 
patients with this diagnosis only ten had previously undergone duodenal biopsies. Of these 
ten patients the ages ranged from 1.08 years to 18.17 years with a median age of 5.88 
years. Symptoms included feed intolerance, vomiting, retching, faltering weight and 
intermittent abdominal distention and abdominal pain. All patients had undergone upper 
gastrointestinal contrasts and 8 had undergone gastric emptying studies by means of 
scintigraphy as described in chapter one. In terms of previous surgery, 5 had undergone 
fundoplication, 6 had a gastrostomy, 4 had a jejunostomy and 2 had undergone other 
procedures such as exploratory laparotomy. This series of patients are somewhat similar to 
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the original patient series discussed in chapter 1. None of these patients, however, had 
undergone celiac plexus blockade or thoracic splanchnectomy. 
5.2 Retrograde histological examination of archived human biopsies 
Having obtained ethical approval from our local biorepository laboratory all ten sets of HE 
slides were retrieved and analysed jointly with a paediatric pathologist. From the outset, it 
became clear the using the same scoring tool as described in chapter 2 and 3 would not be 
possible as the biopsies taken from paediatric patients were taken endoscopically and were 
not designed to be analysed for research purposes. This of course meant that the biopsies 
were not full thickness and were not orientated specimens. This meant that consistently 
counting and measuring villi was not possible and also that whilst we could often see and 
spot some neurons we could not always identify submucosa, let alone, any muscularis. 
Despite this we did manage to identify some bifid villi (see Figure 46 A-E) although it was 
not possible to reliably work out a percentage as not all biopsies had complete villi to 
calculate a denominator. We were also able to examine the width of some villi, which did 
in some samples seems short and thickened, but again as we could not reliably identify all 
villi or calculate a denominator as this was difficult to quantify. Some slides also showed 
evidence of inflammation with increased eosinophils and lymphocytes within the lamina 
propria. (Figure 47) 
As discussed in chapter one there is a new endoscopic technique known as “gEMB” or 
gastric endoscopic muscle biopsy that allows an endoscopic biopsy that included not just 
submucosa but also the intermuscular layer allowing examination of muscle and neurons 
and importantly the interstitial cells of Cajal (ICCs). This may allow a non-invasive and 
safe way to look for abnormalities of the enteric nervous and so called “Cajalopathy”. 
(Rajan et al., 2016) It is perhaps a technique we could employ in the future in our clinical 
practice, but at present is not available or practised at our institution. There are a few select 
cases of patients with cerebral palsy and foregut dysmotility who undergo formal 
jejunostomy with a roux-en-Y loop which results in a small amount of full-thickness small 
bowel being sent routinely for histopathological examination. Unfortunately, no ethical 
approval was granted to examine full thickness biopsies from such patients or to perform 
any immunohistochemistry. If this was granted future work could examine both the 
number of interstitial cells of Cajal and compare specimens to a group of controls. We 
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could also examine levels of iNOS and jagged1 to see if there were any other similarities 
between our human patients and our rodent CP model. 
 
  
Patient 1 – x10 FOV –  
showing an example of a bifid villi 
Patient 1 – x20 FOV –  
showing evidence of inflammation 
  
Patient 1 – x40 FOV –  
3 submucosal neurons seen with evidence of 
inflammatory cells. 
Patient 2 – x10 FOV –  
superficial biopsy with few complete villi 
  
Patient 2 – x20 FOV –  
some evidence of inflammation 
Patient 2 – x40 FOV –  
again some inflammatory cells and 2 neurons 
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Patient 3 – x10 FOV –  
superficial biopsy, some wider flatter villi 
Patient 3 – x20 FOV –  
some evidence of inflammatory cells in the  
lamina propria 
  
Patient 3 – x40 FOV –  
inflammatory cells in the lamina propria. 
Patient 4 – x10 FOV –  
superficial biopsy, but possible bifid villi 
  
Patient 4 – x20 FOV –  
possible increased crypt height 
Patient 4 – x40 FOV –  
inflammatory cells 
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Patient 5 – x10 FOV –  
very small superficial biopsy 
Patient 5 – x20 FOV –  
possible widened bifid villi 
  
Patient 6 – x20 FOV –  
widened villi with inflammatory cells  
within the lamina propria 
Patient 6 – x40 FOV –  
9 submucosal neurons seen 
  
Patient 7 – x10 FOV –  
irregular biopsy with only few villi 
Patient 7 – x20 FOV –  
possible increased crypt height 
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Patient 8 – x10 FOV –  
more villi in this specimen some of which appear 
wider and bifid in form 
Patient 8 – x20 FOV –  
evidence of inflammatory change between the crypts 
and with the lamina propria 
  
Patient 9 – x10 FOV –  
very superficial biopsy 
Patient 9 – x20 FOV –  
some broader more bifid villi seen. 
  
Patient 9 – x40 FOV –  
inflammatory cells and submucosal neurons seen 
Patient 10 – x10 FOV –  
incomplete villi and some crypts with inflammatory cells. 
Figure 47. Microphotographs showing duodenal endoscopic biopsies from patients 
with known CP, delayed gastric emptying and foregut dysmotility. FOV = field of view 
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5.3 Discussion 
As stated at the start of this chapter the specific aim of this final phase of the study was to 
review a recent cohort of patients with CP who have known foregut dysmotility and to 
perform a retrograde analysis of archived human pathology specimens from these patients 
to see if we can identify any similarities histologically between these and our established 
animal CP model. Unfortunately, this was not successful as only endoscopic biopsies were 
available for review not full thickness biopsies. Even endoscopic biopsies are not routine in 
patients with cerebral palsy hence the small numbers we identified. As these biopsies were 
very small and superficial it rendered true comparison with our rodent CP model near to 
impossible. We looked at getting ethical approval to compare endoscopic biopsies of 
normal controls but this was not possible in the time frame of our study. We also did not 
have ethical approval to perform immunohistochemistry on these archived samples; 
however, it would have been difficult to make conclusions from this given the superficial 
nature of the biopsies available. These results are disappointing but it was important to at 
least try to examine human biopsies from CP patient to investigate whether a link could be 
made to our rodent CP model. The major difficulty is that this was a retrograde analysis of 
biopsies that were taken for clinical purposes not for research. 
Direct comparison even if we had full thickness biopsies from this most recent cohort 
would also be difficult as these children are on various treatments such as the medications 
mentioned in chapter one including domperidone etc. Many of them have also undergone 
surgical procedures such as fundoplication, gastrostomy, jejunal feeding etc. Whilst many 
of these treatments having varying often poor success rates they may well influence the 
appearance of their duodenal specimens. Again, in retrospect what we ideally would have 
required would have been full thickness biopsies from children known to have CP and 
foregut dysmotility who had not had previous surgery or been on treatment that might 
influence the biopsies. In essence, this would not be possible or ethical as even we had 
access to the gEMB method of taking biopsies it is unlikely at present that such children 
would not have had surgery such as fundoplication or jejunal feeding or various and 
multiple medications. In some ways, this failure of achieving a direct comparison which 
we had hoped would give further credence for our animal model instead has reaffirmed the 
great need for an animal model as this group of children are so difficult to study. 
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Of note also is the fact that no child in our most recent cohort of patients has undergone 
coeliac plexus block or subsequent splanchnectomy. This is due to the fact the paediatric 
anaesthetist who previously performed the procedure of coeliac plexus block (which if 
successful lead on to splanchnectomy) has retired and there is a general consensus that the 
evidence for the procedure is lacking. This again demonstrates the need for our rodent CP 
model to be further studied and highlights the importance of phase 2 of our study in which 
we have clearly demonstrated that splanchnectomy does work. 
An important aside from going through this database is that it would appear more biopsies 
of not just the oesophagus and stomach but also the duodenum have been taken in recent 
years. The reasons for this may be two-fold. Firstly, in recent years there has been the 
development of a much-needed multidisciplinary complex feeding clinic at our institution 
for children with feeding difficulties the majority of whom are neurologically impaired. 
Secondly, there is increasing evidence in the literature that children with cerebral palsy are 
at increased risk of conditions such as eosinophilic oesophagitis (Napolis et al 2015) and 
possibly coeliac disease or autoimmune enteropathy potentially related to an early brain 
insult and a damaging or inflammatory effect on the bowel, through the gut-brain axis. 
(Stenberg et al 2014). Importantly, these conditions may cause symptoms similar to gastro-
oesophageal reflux or antro-duodenal dysmotility and therefore, should be ruled out by 
routine biopsy. 
In conclusion, from our limited examination of superficial endoscopic duodenal biopsies 
from only ten patients with known CP and foregut dysmotility it is difficult to draw any 
definite connection between the changes in our model and our human cohort. This may 
have been possible if we had had access to full thickness biopsies, controls and or tissue 
for immunohistochemistry, but this would be extremely difficult. All that can be concluded 
is that in some or our biopsies there is evidence of widened and bifid villi and there was 
also evidence of ongoing inflammation in places. Further, more in depth study is needed to 
rule in or out any true similarities or differences between our paediatric patients and our 
rodent CP model. 
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Chapter 6 
Perspective and Limitations 
With advancements in antenatal and neonatal care more and more children with cerebral 
palsy are surviving. (Babcock et al., 2009) Paediatricians have long recognized that many 
children with cerebral palsy have a poor quality of life because of severe retching, 
vomiting, and inability to tolerate feeds. (Reyes et al., 1993) There is also work by 
Campanozzi et al suggesting that treating feeding intolerance and improving nutrition and 
fat free mass that this can have a positive effect on motor function. (Campanozzi et al 
2007) Despite the increasing incidence of this clinical problem there are few management 
options available for these children. Of those options that are available in recent years there 
has been increasing debate as to the safety and efficacy of each of these. For instance, there 
has been issues with possible serious cardiac side effects of medication such as cisapride, 
leading to its withdrawal(McCallum, 1991, 1996) (Mt-Isa et al., 2015) (Maclennan et al., 
2010) (Hegar et al., 2009), and domperidone, leading to the need for every child to 
undergo an electrocardiogram and a much narrower prescribing window which can be sub 
therapeutic for certain children. (Drolet et al., 2000) (Rocha & Barbosa, 2005) (Djeddi et 
al., 2008) (Ngoenmak et al., 2016) Gastrostomy and jejunostomy tubes are also not without 
their issues with reports of significant and life-threatening complications such as enteric 
fistulas and small volvulus. (C. Esposito, 2005) (Belsha et al., 2016; Godbole et al., 2002) 
(Mammi P et al 2011) Fundoplication has been employed frequently in neurologically-
impaired children to alleviate gastro-oesophageal reflux but there have been concerns 
raised that this not only treats reflux rather than foregut dysmotility and indeed that 
fundoplication may in fact worsen antral dysrhythmia as shown by the work of Richards et 
al by means of animal studies examining ferrets post-fundoplication. (Richards C et al 
1998)  There is now a growing consensus in the literature that foregut dysmotility is 
underrecognized and underdiagnosed in children who are neurologically impaired. (Werlin 
SL et al 2004). 
As stated in chapter one, two Cochrane reviews have found no randomised controlled trials 
looking at how best to overcome complex feeding issues in neurologically impaired 
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children.(Gantasala et al., 2013))(Sleigh et al., 2004). Children with cerebral palsy are a 
difficult population to recruit to such trials and as such we recognised the great need for an 
animal model. The CP model we have created is a new animal model which whilst being 
based on a previously reported chemically induced model damaging the motor cortex by 
Chen et al, (A. Chen et al., 2008) is the first of its kind to combine a cerebral palsy model 
which results in delayed gastric emptying and foregut dysmotility. This type of study can 
be tremendously useful for providing the evidence needed to illustrate possible pathways 
involved in this complex condition and also for trialling and investigating possible new and 
much needed treatments. Here, our preliminary data demonstrates not only that our CP 
model is robust and reproducible but also that the foregut dysmotility seen may be related 
to a reduced number of interstitial cells of Cajal and reduced levels of iNOS. We have also 
shown changes in the villous architecture of the duodenum which appears to be related to 
an increased expression of the cell surface protein jagged 1. The Jagged-1/Notch-1/Hes-1 
pathway is a signalling pathway which is now thought to be pivotal in deciding the fate of 
cells in many different organs throughout the body. In addition, it has been shown to be 
involved in involved in intestinal adaptation post small bowel resection (Chen, Sun et al. 
2013) and in the development and maintenance of normal villous architecture. These three 
changes reduced ICC and iNOS and increased jagged1 require further investigation but 
could potentially be targets for future treatments. 
We have also demonstrated in our new CP model the same effect we have shown in a few 
select cases in clinical practice i.e. that splanchnectomy can reverse delay in gastric 
emptying. This supports our original hypothesis which was that foregut dysmotility is due 
to an imbalance of the sympathetic and parasympathetic autonomic nerve supply to the 
foregut and that splanchnectomy can be employed to redress this balance. However, this 
work has important limitations, which are described below. 
If we consider each phase of the study in turn then there are four possible limitations to 
consider in first phase of our study which involved the development of our CP model. The 
first limitation of this phase was that there were small numbers in each of the groups of 
neonatal rat pups undergoing each type of unilateral or bilateral brain injection either sham 
or with the neurotoxin ibotenic acid. Forty-five rats were used in total in this phase but this 
was split between seven groups as there was 9 shams and then n=5 and n=3 respectively in 
the unilateral MPFC group and n=6 in the bilateral MPFC and n=6 in the unilateral and 
bilateral insular cortex lesioned groups. These numbers were smallest in the first groups of 
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animals as there was a higher rate of animal loss at the start of the study due to a steep 
learning curve not only on the brain injection technique in such small animals but also in 
their anaesthesia and successful care in the initial post-operative period. 
The second limitation was that although we examined that brains and foreguts of the 
animals in detail at the end of phase one we did not attempt to examine the spinal cord 
either histologically or by means of neuronal tracer techniques for example using horse 
radish peroxidase. This is a technique along with others that is widely reported in the 
literature (Wang et al 1998) (Shin et al 2009) and could potentially have provided much 
needed information with regards to the brain– gut axis and potential differences between 
shams and our CP model. Shin et al successfully traced neurons mostly from the stomach 
to the nucleus tractus solitaries (NTS) in the brainstem and showed that activation of such 
neurons is affected by hyponatraemia and certain hormones. This is a technique the author 
would wish to learn and explore further as one of the first steps in further examining our 
new CP model. 
The third limitation was our method of assessing gastric emptying by means of gavaging 
radio-opaque contrast and taking time-lapsed X-rays was fairly basic and crude. As in 
clinical practice scintigraphy would have been the gold standard, but this was not available 
in our research facility. Other simpler, yet useful studies would have included pressure 
studies within the antrum and/or oesophagus similar to the paper previously described by 
Vane et al with their feline model. (Vane et al., 1982) Another option would be by means 
of a breath test such as that used by Toti et al 2014 in their rodent model of Parkinson’s 
disease. This study used a 13C]-octanoic acid breath test to show delayed gastric emptying 
in their model. This again is something we would consider performing on our model in the 
future.(Toti & Travagli, 2014) 
The fourth limitation in phase one of our study was that other than gastric emptying studies 
and regular weights no other samples such as stool or serum were taken from the animals 
during the study. As stated in chapter one not only has the gut-brain axis become a major 
focus for clinical research over recent years, so has the human microbiome project and it 
would have been of interest in retrospect to investigate the microbiota and flora of the 
bowel in our CP models compared to controls to assess any difference between the two 
groups. In terms of serological tests and there are several humoral factors that we could 
have investigated including cytokines for example vasoactive intestinal peptide or VIP. As 
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mentioned in chapter five there is recent evidence in the literature that there is a potential 
increased risk of anti TD6 antibodies and coeliac related disease in children with cerebral 
palsy (Stenberg R et al 2014) (Frih-Ayed, M., et al. 2006). This is something that would be 
relatively easy to test for in our model in terms of analysing serum for IgA/IgG class anti-
TG6 antibodies by ELISA and comparing levels between our CP model and shams. This 
would be of interest as in retrospect some of the appearances such as the loss of normal 
villous architecture in the duodenum of our CP model is reminiscent of changes often 
associated with coeliac disease. 
The main perceived limitation of phase two of the study was the lack of an arm of the 
study in which a group of the CP model animals underwent midline laparotomy and sham 
splanchnectomy perhaps by just grasping the splanchnic nerves with forceps rather than 
dividing them with bipolar diathermy. This approach would have allowed a more 
meaningful comparison in terms of assessing gastric emptying times between a matched 
cohort in terms of age and size and also in evaluation difference in subsequent foregut 
histology. Lastly, the main limitation of phase 3 of the study was that the only duodenal 
human biopsies we were able to examine in a group of CP patient with known foregut 
dysmotility were superficial endoscopic biopsies and therefore, this greatly limited our 
ability examine them and look for any possible changes that were akin or in any way 
similar to the changes we found unexpectedly in the duodenum of our CP model. 
Previous work by Richards et al in London (Richards C et al 1998 and Richards C et al 
2003) showed the effect of fundoplication on ferrets. Although not a limitation of this 
study as it was not one of our original aims it would be a potentially important study to 
instead perform just splanchnectomys and sham splanchnectomys to also perform 
fundoplication and/or gastrostomy on our model and assess its effect as this is what is 
commonly performed on this group of children in clinical practice despite the fact that we 
cannot always be sure what effect such a procedure is having on foregut motility, which 
may already be abnormal and pathogenic. 
Despite all the limitations discussed above this is still an important and much needed piece 
of work which has for the first time created a rodent model of cerebral palsy which 
demonstrates delayed gastric emptying and makes some attempt to explain the possible 
mechanistic pathways behind this. Not only have we successfully linked cortical lesions in 
the brain, similar to periventricular leukomalacia seen in cerebral palsy, to functional and 
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structural changes in the foregut we have also shown that splanchnectomy can reverse the 
delay in gastric emptying time. This provides further evidence for the use of this procedure 
in clinical practice and has emphasised the lack and need for clinical trials. Further work is 
needed to explore the pathways behind both our new CP model and the improvements seen 
following splanchnectomy. It is the authors hope that further study of this model may 
provide greater insight into the pathogenesis of dysmotility associated with cerebral palsy 
and may help develop new and much needed treatments for neurologically-impaired 
children. In addition to the study of this model in terms of foregut dysfunction, there is also 
evidence in the literature that the medial prefrontal cortex, the area targeted to create our 
new model, is also involved in autonomic bladder control, not just bowel.  (Sakakibara et al, 
2014) It may also be the case, therefore, that this model could be adopted to investigate the 
condition of neuropathic bladder in the future. We, therefore, speculate that this model is 
very exciting as it could be extremely useful for future research including possible 
treatments whether it be medical or surgical for foregut dysmotility in cerebral palsy as 
well as new treatments for different types of neuropathic bowel and potentially neuropathic 
bladder. 
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